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ABSTRACT

The objectives of this study were to evaluate the antimicrobial activity of
essential oil components (EOC) against Salmonella Typhimurium and Listeria
monocytogenes and evaluate changes in bacterial membrane composition by
observing changes in the fatty acids of Salmonella associated with exposure and
adaptation to (or growth in the presence of) cinnamaldehyde (CIN) and carvacrol
(CRV) EOC. Ten EOC were tested for efficacy using the broth microdilution and
macrodilution methods. Beta -caryophyllene, limonene, alpha -pinene, and thymol
were not lethal to Salmonella and Listeria at 2800mg/L. Dose-response models
showed that the most effective EOC against Salmonella were CIN and CRV
(50% probability of lethality with avg. of 280mg/L and 1080mg/L, respectively)
regardless of method. CIN (790mg/L) and RHO (1810mg/L) were the most lethal
against Listeria. CIN- or CRV-adapted or non-adapted Salmonella were
inoculated into broth containing 250mg/L CIN, 871mg/L CRV, or no EOC. At 2
and 24h, the saturated fatty acid (SFA) to unsaturated fatty acid (UFA) ratio in
the membrane of CIN- or CRV-adapted cells treated with CIN or CRV was
numerically higher than in the non-adapted cells treated with CIN or CRV.
Significant (p<0.05) changes were observed with CIN or CRV exposure. After 2h
of exposure to CIN, the non-adapted CIN-treated cells had lower total
phospholipid fatty acid (PLFA), lower C16:1w7c, and higher C18:0 and SFA than
the non-adapted control. After 24h of exposure to CIN, the non-adapted CINtreated Salmonella had lower Cy17:0 and Cy19:0 than the non-adapted control
vii

and higher C16:0 and SFA. Compared to the non-adapted control at 2h, the
non-adapted CRV-treated Salmonella had lower PLFA, and lower C16:1w7c,
Cy17:0, C18:1w9c, C18:1w7c, and UFA and higher C14:0, C18:0, SFA, and
SFA/UFA ratio. At 24h, the non-adapted CRV-treated cells had lower PLFA,
Cy17:0, C18:1w7c, and UFA and higher C16:1w7c and SFA than the nonadapted control. Antimicrobial treatment appeared to decrease the fluidity of the
Salmonella membrane by increasing SFA. This decreased fluidity may prevent
additional CIN and CRV from permeating. Growth in the presence of the
antimicrobial had a much smaller effect on the fatty acid composition. Additional
measurement of the membrane transition temperature from gel- to-liquidcrystalline phase would indicate fluidity.
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PART 1. INTRODUCTION

1

Introduction

In 2003 there were only 15,600 cases of foodborne infections that were
diagnosed in laboratories (CDC 2004). The number of cases caused by 9
identified pathogens was: 6,017, Salmonella; 5,215, Campylobacter; 3,021,
Shigella; 480, Cryptosporidium; 443, E. coli O157; 161, Yersinia; 138, Listeria;
110, Vibrio; and 15, Cyclospora. Of the 5,455 (91%) Salmonella isolates
serotyped, S. Typhimurium (759 cases) was the serotype most often isolated and
identified in human salmonellosis cases (14% o f foodborne salmonellosis
infections). Although 15,600 foodborne bacterial infections were diagnosed in
2003 (CDC 2004), it is estimated that there are over 2 million cases of
salmonellosis and 1600 cases of listeriosis that occur in the U.S. each year
(FDA-CFSAN 2003a, b).
The prevalence of L. monocytogenes in meats was found to be highly
variable with about 16% of products testing positive from 1971-1994. L.
monocytogenes serotype 4b has most often been associated with human
listeriosis outbreaks (Jay 1996). A more recent study found that 577 of 31,700
samples of ready-to-eat foods tested positive for L. monocytogenes (prevalence
of 1.82%) (Gombas and others 2003). The latest multistate outbreak of listeriosis
was in the northeastern U.S. in 2002 with 46 confirmed cases and seven deaths
(CDC 2002). Listeriosis is a concern because of the high mortality rate, which
can be as high as 70% when listeric meningitis occurs or more than 80% with
perinatal/neonatal infections (FDA-CFSAN 2003b).
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Characteristics of Gram-positive and negative membranes
L. monocytogenes is a Gram-positive bacterium. The Gram-positive cell
has an open, hydrophilic structure. It contains a thick and hydrated
peptidoglycan (PG) layer, which forms 90% of the cell wall. The PG layer is
covalently bonded to teichoic acids. Teichoic acids are acidic anionic
polysaccharides that give the cell wall a net negative charge. Teichoic acids bind
cations such as Ca2+ and Mg2+ . Lipoteichoic acid is a type of teichoic acid, which
has a glycerophosphate chain that is exposed on the cell surface at one end. At
the other end, lipoteichoic acid is covalently linked to a glycolipid situated on the
outer side of the cytoplasmic membrane. This glycerophosphate chain extends
through the cell wall. Important proteins that have a role in interacting with the
environment are covalently and noncovalently linked to the PG layer.
Teichuronic acids, which replace teichoic acids when phosphate concentrations
are low, have carboxylate groups that carry a negative charge (Atlas 1995a;
Lambert 2002).
The PG layer allows the penetration of molecules with a molecular weight
of 30,000 to 57,000 Da. Phenols, alcohols, aldehydes, and quaternary
ammonium compounds, which are small, can permeate readily. The permeability
of the cell wall may depend on the chemical structure of the PG layer, such as
the extent of cross-linking and glycan chain length (Lambert 2002).
S. Typhimurium is a Gram-negative bacterium. The Gram-negative cell
wall is complex and has multiple layers. The outer membrane, a thin PG layer,
and the periplasmic space form the outer layer of the cell wall. The periplasmic
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space is between the PG layer and the cytoplasmic membrane. The outer
membrane contains lipopolysaccharide (LPS), phospholipids, and proteins, such
as porins (Atlas 1995a).
The exterior layer of the outer membrane contains LPS that carries a net
negative charge. The innermost part of the LPS is lipid A that attaches the LPS
to the hydrophobic section of the outer membrane. Lipid A is a Nacetylglucosamine disaccharide linked to unusual fatty acids, such as caproic
and lauric acids. External to the lipid A is the central core polysaccharide, which
is a complex polysaccharide, and an outermost polysaccharide layer called the
O-antigen that extends into the environment. The negatively charged core of
LPS is stabilized by Ca2+ and Mg2+ cations that crosslink the LPS (Atlas 1995a).
On the interior of the outer membrane is a layer of phospholipids, which
consist of a phosphate polar head covalently bonded to a glycerol backbone,
which is ester-linked to two fatty acids. Interior to the inner layer of phospholipid
is the periplasmic space (Atlas 1995a). This space contains nutrient binding
proteins and lipoproteins, which have a fatty acid portion that associates with
phospholipids of the outer membrane and a protein region that is bonded to the
PG layer. This space contains proteins that create an active metabolic center
within the cell. Interior to the PG is the cytoplasmic membrane consisting of a
phospholipid bilayer with embedded proteins, such as enzymes and efflux
proteins (Denyer and Maillard 2002). The cytoplasmic membrane has an
important role in maintaining energy status, solute transport, and regulation of the
intracellular environment. Homeostasis is mostly affected by the fluidity of the
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cell membrane. Changes in the lipid composition of the cytoplasmic membrane
occur in response to external stimuli to maintain a relatively constant fluidity
(Sikkema and others 1995). Membrane fluidity is the “combined expression of
the effects of [fatty acid] chain conformation, lateral and rotational diffusion [of the
lipids within the membrane] and the resistance of the membrane to sheer forces”
(Denich and others 2003).
Porins are hydrophilic channels within the outer membrane that allow the
diffusion of small hydrophilic molecules with a molecular weight of up to 800 Da
for E. coli (Atlas 1995a; Denyer and Maillard 2002). Tightly packed LPS in
membrane of the Gram-negative cell is the cause of the very low permeability of
the outer membrane to hydrophobic compounds. In contrast, the cytoplasmic
membrane has a low permeability for polar and charged molecules, except for
water. Apolar molecules, such as cyclic hydrocarbons, can pass easily.
Permeability of the cytoplasmic membrane depends on the hydrophobicity of the
molecules. These hydrophobic molecules partition into the cytoplasmic
membrane and accumulate or are metabolized (Sikkema and others 1995).
The oil:water partition coefficient is the ratio of the concentration of a
substance in oil and in water at equilibrium and at a specified temperature. The
optimal oil:water partition coefficient (log P) for Gram-negative and Gram-positive
bacteria is 4.0 and 6.0 for the oil phase, respectively. Aromatic solvents with a
log P of 2.0 - 4.0 changed the cytoplasmic membrane organization in Gramnegative bacteria (Denyer and Maillard 2002). Carvacrol (CRV), a component
found in oregano and thyme essential oils, has a log P of 3.6, and prefers to
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partition to a nonpolar solvent rather than water (Ultee and others 2002).
Therefore, CRV may be more effective against Gram-negative bacteria since the
optimal log P of Gram-negative bacteria is closer to that of CRV.
Because Gram-positive bacteria have a more permeable cell wall they are
more susceptible to antibiotics than Gram-negative bacteria, which has the thick
outer LPS layer as a permeability barrier. Gram-positive organisms seem to be
more sensitive to lipophilic compounds than Gram-negative organisms because
of their lack of an outer membrane. Since LPS of the outer membrane is highly
hydrophilic, small hydrophilic solutes may pass through the porins, but the outer
membrane acts as a barrier to most hydrophobic compounds (Sikkema and
others 1995; Lambert 2002).
Essential oils and components
Natural antimicrobials, such as herbs and spices, have been used for
centuries to preserve and flavor food. Today, consumers desire high-quality,
minimally processed foods that have fewer preservatives and an extended shelflife (Brul and Coote 1999). Essential oils, which are obtained from plants by
extraction or distillation, contain flavor, aroma, and antimicrobial components.
They are used mainly for flavoring agents. Herbs, spices, and their components
are Generally Recognized As Safe food ingredients under conditions of
customary use (Ultee and others 1998). Studies have reported cinnamon, clove
and mustard to be highly active against various microorganisms. Other inhibitory
herbs and spices include allspice, bay leaf, caraway, coriander, cumin, oregano,
rosemary, sage and thyme (Zaika 1988). Carvacrol, the bioactive component
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found in oregano and thyme essential oils, is used to flavor baked goods,
nonalcoholic beverages, and chewing gum (Ultee and others 1999). Eugenol
and cinnamic aldehyde are used as flavorings in candies and baked goods (Kim
and others 1995).
Antimicrobial activity of essential oils
In the past two decades, many studies have reported the inhibitory and
lethal effects of essential oils tested against a wide variety of microorganisms in
various media and food products. In studies that compared various essential
oils, the most effective oils against bacteria were thyme, oregano, cloves,
cinnamon, lemongrass and bay (Deans and Ritchie 1987; Hammer and others
1999). For example, 0.03% (v/v) thyme and 0.12% oregano essential oils
inhibited the growth of Escherichia coli. However, comparison of the efficacy of
various oils is complex because their composition varies among the different
plant genera as well as within the same genus. Variation in composition of active
components may result from geographic origin, climate, processing, and variety
differences (Zaika 1988). Carvacrol and thymol, which are bioactive constituents
in oregano essential oil, are present in different percentages in various species of
Origanum.
Antimicrobial activity of essential oil components
The study of essential oil components (EOC) produces more useful data
about their mechanism than essential oils, which vary in their composition of
components. Table 1.1 describes selected essential oils and their major
antimicrobial components. Evaluation of these components may present
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Table 1.1. Plants and their bioactive components (Bauer and others 1997).
Main food-related plant source

Bioactive component

Base structure

Origanum and thyme oils

Carvacrol

Phenol

Clove oil

Beta-caryophyllene

Cyclic sesquiterpene hydrocarbon

Cassia and cinnamon bark oils

Cinnamic aldehyde

Aromatic unsaturated aldehyde

Clove and cinnamon leaf oils

Eugenol

Phenol

Citrus peel and caraway oils

Limonene

Cyclic terpene hydrocarbon

Sweet basil and sage oils

Linalool

Acyclic terpene alcohol

Rose and geranium oils

Rhodinol

Acyclic terpene alcohol

Rosemary oil

Alpha-pinene

Bicyclic terpene hydrocarbon

Origanum and thyme oils

Thymol

Phenol

problems because of the low water solubility of components, such as thymol,
carvacrol (CRV), eugenol, and trans -cinnamaldehyde (CIN) (Griffin and others
1999). The minimum inhibitory concentration (MIC) of CRV, CIN, and thymol
against S. Typhimurium were 150, 396, and 150 mg/L, respectively, using the
broth macrodilution method (Helander and others 1998). Eugenol was found to
inhibit the growth of E. coli O157:H7 and L. monocytogenes at 1000 mg/L
(Blaszyk and Holley 1998). The concentration of CIN needed to achieve a 50%
decrease in 1,500-2000 CFU/well of E. coli O157:H7, S. enterica Hadar, and L.
monocytogenes was 600, 400, and 100 mg/L, respectively (Friedman and others
2002). Although there have been several studies to investigate the efficacy of
some common constituents of essential oils, there are limited studies that
examine the mechanism of inhibition of essential oil constituents.
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Antimicrobial activity assay
A broth dilution assay is a type of invitro method that is conducted when
quantitative results are needed (Parish and Davidson 1993). A range of
concentrations of antimicrobials is prepared in non-selective broth. Consecutive
two-fold dilutions are typically prepared in clinical microbiology, but arithmetic
intervals may be used as well. A single concentration is dispensed into a tube
(broth macrodilution) or a lane in a microtiter plane (broth microdilution).
The test vessel is incubated with the test organism usually for 16-24 hours
at the optimum temperature of the organism (Parish and Davidson 1993). The
test vessel is observed for the lowest concentration at which there is no turbidity
or no growth. This is called the minimum inhibitory concentration (MIC). To
determine the minimum lethal or bactericidal concentration (MLC or MBC), 10100 ul are plated from the last tubes or wells with growth and all those with no
growth. The MLC or MBC is the lowest concentration that results in >99.9%
killing of the final inoculum (NCCLS 1993).
Four factors that affect results of antimicrobial tests are the test method,
medium, microorganism, and antimicrobial (Zaika 1988; Parish and Davidson
1993). Common test mediums include water, microbiological media such as
broth and agar, foods, beverages, or food systems with defined composition.
The pH is of particular importance since the activity of organic acids, such as
benzoic acid depends on the acid being in its undissociated form, which allows
the antimicrobial to penetrate the cell membrane more easily (Parish and
Davidson 1993). Most EOC are slightly soluble in aqueous systems like broth, at
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best (Zaika 1988). Therefore, e valuation of EOC may present problems, such
as visibility of growth end-points.
The application of the spice or component may include various
concentrations and botanical compositions. The form of the spice may be
ground, extract, infusion, or essential oil. EOC, such as CRV, are available
commercially in liquid or in crystalline form. The antimicrobial activity may be
detected by applying the component to agar with a paper disk or in a cup or
mixed with the test medium (Zaika 1988). The solubility of the essential oil or
component and method of preparing stock solutions of the oil or component may
influence antimicrobial activity. Assay methods have different sensitivity as well
(Friedman and others 2002). An antimicrobial could be effective in media but
exhibit lower antimicrobial activity in food, such as in high fat foods in which the
antimicrobial may partition into the food lipids (Zaika 1988).
Characteristics of the organism are important factor influencing results.
Strains may vary in genotype and phenotype (Parish and Davidson 1993).
Microorganisms that are antibiotic resistant are a concern since antibiotic
treatment for serious infections may be useless if the microbe is resistant.
Microorganisms may be tested in the form of vegetative cells or spores (Zaika
1988). The inoculum can be directly applied to the agar surface or mixed with
the medium. Actively growing cells in the log phase are more sensitive than
stationary-phase cells or spores (Parish and Davidson 1993). A higher inoculum
size (log 7 or 8) of log-phase cells are more rapidly killed than a stationary-phase
inoculum diluted to low inocula (log 4) (NCCLS 1993). Although population size
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and growth phase independently influence the rate of lethality, the inoculum size
will have the greatest effect on results (NCCLS 1993). The National Committee
for Clinical Laborato ry Standards (NCCLS) suggests an inoculum of log 5.7 for
testing aerobic bacteria using broth dilution assays. Studies of essential oils and
components are difficult to compare since a variety of assays have been used to
evaluate antimicrobials, but there is no standardized test method or format for
reporting assay results of antimicrobial activity of essential oils (Friedman and
others 2002).
Mechanisms of inhibition by changes in membrane function
Concentrations of essential oils that are lethal to bacteria tend to be much
higher than tolerable taste thresholds. However, essential oils can be used at
lower inhibitory concentrations (Brul and Coote 1999). Knowledge about the
mechanism of action of antimicrobials is needed to effectively combine
antimicrobial additives and food processing technology to prevent food from
spoilage and growth of pathogenic microorganisms without sacrificing
organoleptic qualities.
The mechanism of action of some antimicrobials, such as CRV, is the
disruption of the cytoplasmic membrane, which leads to a decrease in the proton
motive force of the bacterial cell (Ultee and others 2002). The energy for cell
processes is generated from a proton motive force (or hydrogen ion gradient),
which is established by the separation of protons across the cytoplasmic
membrane. During metabolism, the cell translocates protons out of the
cytoplasmic membrane that creates an excess of hydrogen ions and positive
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charges outside of the membrane. The concentration and electrical differences
between the inside and outside of the cell across the cytoplasmic membrane
produce the proton motive force, which consists of the proton potential (or pH
gradient) and electrical (or membrane) potential. Protons cannot diffuse across
the cytoplasmic membrane. They can only pass into the cell again through a
specific proton channel, ATPase. As protons pass through the channel, ATPase
catalyzes the conversion of ADP to ATP to provide energy for the cell to do other
work (Atlas 1995b).
The interaction of lipophilic compounds with the bacterial membrane
affects the structure of the cytoplasmic membrane, which may increase the
passive proton (ion) flux across the membrane. The leakage of protons
decreases the proton gradient and therefore dissipates the proton motive force.
Lipophilic compounds, such as CRV and ethanol, have been associated with
ATP depletion (Sikkema and others 1995; Ultee and others 1999).
CRV partitions into the cytoplasmic membrane. Ultee a nd others (1999)
investigated the mechanisms of action of CRV when it was added to a Bacillus
cereus cell pellet suspended in buffer. Viable cell numbers decreased
exponentially when vegetative B. cereus cells were incubated for 30 min with 150
- 451 mg/L CRV. This reduction was related to a change in the membrane
potential. CRV (2 mg/L) significantly decreased the membrane potential and
dissipated the potential at concentrations greater than 23 mg/L. CRV (38 mg/L)
reduced the pH gradient and dissipated the gradient at 150 mg/L and higher.
The intracellular potassium pool decreased and extracellular potassium pools
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increased with 150 mg/L CRV. Within 7 min, 300 mg/L CRV depleted the
intracellular ATP pool without a proportional increase in extracellular ATP. It was
concluded that CRV acted at the cytoplasmic membrane to increase permeability
to protons and potassium ions.
CRV and thymol totally disrupted the outer membrane of E. coli O157:H7
and S. Typhimurium as indicated by increased uptake of 1-Nphenylnaphthylamine (NPN), which is a probe that fluoresces in a hydrophobic
environment, and the release of LPS. Uptake occurred since the membrane was
no longer acting as a strong permeability barrier. CRV (300 mg/L) disrupted the
cytoplasmic membrane since it decreased the intracellular ATP pool and induced
a small, but not proportional increase, in the extracellular ATP pool of E. coli
O157:H7. Changes that occurred with thymol were similar, but less prominent.
This indicates that they had a measurable effect on the cytoplasmic membrane.
CIN did not affect NPN uptake and did not significantly affect intracellular or
extracellular ATP (Helander and others 1998).
Therefore, it appears that the mechanism of action of CIN is not
associated with an increase in permeability of the cell membrane. CIN is an
aromatic aldehyde. It has been suggested that the carbonyl group of aldehydes
can bind to metal ions, sulfhydryl groups, amino acids, and proteins (Bowles and
Miller 1993). CIN was found to be an effective inhibitor of histidine
decarboxylase activity of Enterobacter aerogenes. Therefore it was suggested
that binding of the CIN carbonyl group to the decarboxylase protein resulted in
loss of decarboxylase activity (Wendakoon and Sakaguchi 1995).
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Ramos-Nino and others (1996) developed multiple regression equations
that described the effects of physicochemical and structural properties of
benzaldehyde and benzoic and cinnamic acids on antibacterial activity. Steric
parameters contributed more to benzaldehyde activity, while lipophilicity and
ionization (pKa) parameters did not. Therefore, benzaldehyde was suggested to
act on the outside of the cytoplasmic membrane. In contrast, lipophilicity and pKa
of benzoic and cinnamic acid contributed most to their activity. They also found
that the greater the molecular size of the aldehyde, the lower the antibacterial
activity (Ramos-Nino and others 1996). This is the opposite of organic acids,
which show increased antimicrobial activity with increased chain length (Jay
2000).
One study found that CIN at 0.3 ml/L was lethal to B. cereus cells but no
significant amount of protein was lost. It was reported that treatment with CIN
caused exponential phase cells to become long and filamentous and inhibited
them from separating from each other (Kwon and others 2003).
Mechanisms of inhibition by changes in lipids
Lipophilic compounds, such as EOC, partition in the lipid bilayer
membrane of microorganisms. The polarity of the compound determines where
it accumulates in the membrane. Different compounds have preferential
accumulation sites and cause different perturbations of the membrane.
Accumulation of the compound correlates with its lipophilicity (Sikkema and
others 1995).
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Lipophilic molecules disrupt the interaction between lipids molecules and
the membrane proteins (enzymes) that they border. These compounds may
interact with hydrophobic regions of the enzymes. The interaction of these
compounds affect fluidity and fatty acid composition of the bacterial membrane,
which regulates the activity of membrane-embedded enzymes. This interaction
can also change protein conformation. It has been proposed that the
accumulation of lipophilic molecules in the membrane disrupts lipid-protein and
lipid-lipid interaction, leading to toxicity (Sikkema and others 1995).
Bilayer membranes can exist in three phases: gel (ordered lipid chains),
liquid-crystalline (disordered lipid chains) and hexagonal II (Ultee and others
2000b). Bacterial responses to the accumulation of hydrophobic compounds are
an attempt to: 1) maintain a sufficient ratio of liquid-crystalline lipid in the
membrane to restore membrane fluidity, 2) keep a balance between
phospholipids that facilitate or do not promote a bilayer, and 3) extrude the
hydrophobic compound through drug efflux systems. The fluidity of the
membrane affects the growth of the cell and the proper functioning and structural
integrity of the membrane (Denich and others 2003). For example, the
percentage of unsaturated fatty acids in E. coli phospholipids is usually about
50%. This percentage can decrease to 30% without ceasing bacterial growth. If
the percentage of saturated fatty acids decreases to less than 15% the
membrane permeability increases (Seltmann and Holst 2002).
Cells adapt to hydrophobic compounds by changing the fatty acid
composition (type of branching, chain length, and degree of unsaturation) and by
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changing the phospholipid head-group composition (Ultee and others 2000a).
The changes in bacterial lipids in the membrane are a defense mechanism used
to maintain optimal fluidity in the liquid-crystalline phase, which is required for
important cell processes. Lipids directly affect passive permeability and indirectly
affect cell processes because of their interactions with membrane proteins
(Russell and others 1995).
A modified fatty acid composition affects the lipid membrane melting point,
which influences membrane fluidity (Li and others 2002). For example, the
melting point of unsaturated fatty acids and branched-chain fatty acids is lower
than that of saturated fatty acids. Therefore an increase in these fatty acids
causes a decrease in the phase transition temperature and an increase in
membrane fluidity (Casadei and others 2002). Fatty acids with high melting
points, such as saturated, long, and straight-chain fatty acids, decreases
membrane fluidity (Juneja and Davidson 1993).
Changes in the fatty acid composition are influenced by various
environmental factors such as growth temperature and pressure (Casadei and
others 2002; Li and others 2002). At decreasing temperatures the lipids in the
membrane become ordered and the regions consisting only of lipids partly
separate from the regions rich with proteins (Seltmann and Holst 2002).
Changes in fatty acid composition of bacterial membranes have also been
studied in the presence of various antimicrobials, such as nisin (Mazzotta and
Montville 1997; Li and others 2002), sodium chloride, tertiary
butylhydroxyquinone, methyl paraben, and propyl paraben (Juneja and Davidson
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1993), acidulants (Juneja and others 1998), and phenolic compounds (acid
phenols and tannins) (Rozes and Peres 1998). Phenolic compounds were
shown to increase membrane fluidity, which influences membrane permeability
(Diefenbach and Keweloh 1994).
Post and Davidson (1986) reported a relationship (R=0.89) between the
ratio of saturated to unsaturated fatty acids (SFA /UFA) in the total lipid fraction
of the membrane of Gram-positive bacteria (S. aureus, B. cereus, and C.
perfringens) and susceptibility to butylated hydroxyanisole (BHA). SFA/UFA ratio
in Gram-negative bacteria (P. fluorescens, P. fragi, E. coli, and S. “anatum”
) was
not related to their susceptibility. The highest SFA/UFA ratio was found in the
two most resistant strains, which were S. aureus 12600 and LP (LD90 =293 and
304 mg/L BHA, respectively). C. perfringens was the most susceptible (LD90
=110 mg/L BHA) and had the lowest SFA/UFA ratio. It was suggested that the
higher SFA/UFA ratio increased the ordering of fatty acid alkyl chains, which
enhanced resistance. There was no relationship found between susceptibility
and individual fatty acids or SFA/UFA ratios of the polar lipid fraction.
S. aureus LP was more resistant to methyl:propyl (2:1) paraben (MIC =
900 mg/L), which is a phenolic compound, and had a higher percentage of total
lipid than sensitive S. aureus strains (Bargiota and others 1987). This resistant
strain also had lower cyclopropyl 17:0 and cyclopropyl 19:0 than sensitive
strains. It was suggested that parabens partition into the membrane lipids. This
absorption into the lipids may protect the cells from additional penetration. A
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decrease in cyclopropyl fatty acids may lower the permeability or interaction of
parabens by affecting membrane fluidity.
Keweloh and others (1991) also found that phenolic compounds increase
the permeability of the cell membrane. This study concluded that sublethal
concentrations of phenol in the g rowth medium for 3 hours impaired cell growth
and caused an increase in the saturated to unsaturated fatty acid ratio (increase
in 16:0 and decrease in 16:1 and 18:1) in the exponential growth phase, which
decreased the fluidity of the E. coli K-12 membrane. The authors suggested that
this decrease in fluidity was a defense mechanism to decrease the damage by
phenol. Additional phenol molecules would not reach the lipid bilayer to disrupt it
as easily because of tightly packed acyl chains in the more saturated membrane.
The increase in saturation would also reduce leakage of cellular metabolites.
When Pseudomonas putida adapted to phenol, the fatty acids converted
from cis- to trans- form. Since this conversion increased membrane ordering, the
membrane fluidity decreased (Heipieper et al., 1992; Sikkema et al., 1995). Cistrans conversion also occurred in bacteria deprived of nutrients. The trans/cis
ratio may be applied as an indication of starvation or stress (Guckert et al., 1986;
Sikkema et al., 1995).
EOC, such as CRV, disrupt the membrane (Brul and Coote 1999). In
liposomes prepared from E. coli phospholipids, cyclic hydrocarbons, such as
alpha-pinene (9300 mg/L), accumulated in the bilayer interior, which caused
swelling of the bilayer and therefore increased bilayer surface area (Sikkema and
others 1994). The accumulation disrupted interactions between the acyl chains,
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leading to increased membrane fluidity. It also caused decreased activity of
cytochrome c oxidase and increased permeability to protons, which decreased
the proton motive force. Cytochrome c oxidase is a membrane enzyme. The
partitioning of the hydrocarbon into the cytoplasmic membrane may have caused
the enzyme activity to decrease. This partitioning may have changed the
interactions between proteins and lipids, thickness of the membrane, membrane
fluidity, and/or phospholipid headgroup hydration (Sikkema and others 1994).
It has been suggested that CRV occupies more area than the typical
space between the fatty acid chains of two adjoining phospholipid molecules.
This interferes with the van der Waal interactions between the chains and
therefore increases fluidity (Ultee and others 2000b; Ultee and others 2002). If
the membranes become too fluid, additional CRV can continue to permeate the
membrane, accumulate, and cause more damage (Ultee and others 1998).
Ultee a nd others (2002) reported that CRV expanded model liposomal
membranes using fluorescent probes. They suggested that this swelling leads to
a destabilized membrane and therefore a leakage of ions. The phenolic hydroxyl
group of CRV is required for its antimicrobial activity since structurally similar
compounds were not as inhibitory. Since Griffin and others (1999) categorized
CRV in a group of oxygenated terpenoids of high antimicrobial activity associated
with higher hydrogen binding capacity, this hypothesis is reasonable. Also,
during exposure to CRV an influx of H+ and efflux of K + ions in B. cereus was
reported. The leakage of ions led to a drop in the pH gradient, destruction of the
membrane potential and depletion of intracellular ATP (Ultee and others 1999).
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Adaptation
If a factor or condition negatively influences bacterial growth or survival, it
is considered a stress (Yousef and Courtney 2003). Mild or sublethal stresses
are those that slow or stop bacterial growth without affecting viability. Stresses
that cease growth and result in some loss of viability are defined as moderate.
Extreme or severe stresses cause lethality to a majority of the bacterial
population. Stresses affecting bacterial growth or survival may be physical,
chemical, or biological.
When bacterial cells detect stresses that affect membrane fluidity, cell
protein structure, ribosomes, or nucleic acids, they respond both genetically and
phenotypically. This response involves transcription that results in regulatory
proteins being synthesized. Production of regulatory proteins may lead to
synthesis of other proteins that deal with the stress. Stress adaptation includes
“1) production of proteins that repair damage, maintain the cell, or eliminate the
stress agent, 2) transient increase in resistance or tolerance to deleterious
factors, 3) cell transformation to a dormant state, 4) evasion of host organism
defenses, and 5) adaptive mutations”(Yousef and Courtney 2003).
According to Yousef and Courtney (2003), stress adaptation is an
“increase of an organism’s resistance to deleterious factors following exposure to
mild stress.” In the food processing environment and in foods, pathogens are
frequently exposed to sublethal stresses. When a microorganism is exposed to
these stresses it may respond to protect itself, or adapt, to increase its tolerance
to the same or different type of stress. Other terms for adaptation include
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adaptive response, induced tolerance, habituation, acclimization, and stress
hardening.
The ability of an organism to survive a stress is defined as tolerance,
which is similar to resistance. When a microorganism is adapted to a stress, it
may also resist a similar or different stress that was previously lethal or injurious
to the cell (Yousef and Courtney 2003). For example, heating raw milk at
temperatures below pasteurization may cause bacteria to adapt to mild heat.
When the milk is used to make cheese, the bacteria are highly resistant to further
heat processing. Therefore, adaptations to sublethal stresses are important to
public health.
Mechanism of stress response
Stress responses depend on the stress and bacterial species.
Microorganisms respond to stress immediately due to a sudden experience of
stress or adapt to the stress over the long-term. To respond, a microorganism
must sense a stress through a sensor such as a lipid, protein, or nucleic acid. A
microorganism detects a stress when the stress affects the folding of mRNA, a
change in a protein’s half-life or structure, alterations in cellular metabolites, and
changes in the membrane structure or fluidity. The sensor causes a change in
transcription or translation of stress-related proteins, which alter cell physiology
to increase tolerance (Yousef and Courtney 2003).
The response can be general, which protects against various stresses, or
specific. Numerous changes in cell physiology, such as changes in cell envelope
composition and morphology, are caused by the general stress response. This
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results in decreased growth rate and entry into the stationary phase. General
stress response is controlled by sigma factors in E. coli and other Gram-negative
bacteria (Yousef and Courtney 2003).
Microorganisms have been shown to respond to heat, cold, acid, osmotic
stress, and oxidative stress (Yousef and Courtney 2003). One of the changes in
response to cold is a major alteration of the fatty acid composition of lipids in the
bacterial membrane to increase membrane fluidity. To increase fluidity in
response to cold temperatures, bacteria increase unsaturation or decrease the
chain length. Only minor changes occur in the head-group composition (Russell
and others 1995).
Monitoring stress response in research can be useful. The effect of mild
stresses may reveal if the organism becomes resistant or sensitized to further
stress. Adaptation is best observed at sublethal levels and during the
exponential phase of growth, although adaptation has been induced in the
stationary phase (Yousef and Courtney 2003). Research on the mechanisms
and effects on the membrane lipids by food antimicrobials will add to the
knowledge needed to keep foods safer yet minimize the use of additives and
processing (Russell and others 1995).
CRV is lipophilic and was shown to accumulate and expand membranes
treated with CRV. This swelling may cause a destabilized membrane in B.
cereus. Swelling increased fluidity as indicated by a decrease in the temperature
at which the membrane transitions from gel to liquid-crystalline phase (Tm). This
led to increased passive permeability and therefore a leakage of ions. In
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contrast, growth of B. cereus cells in the presence of 60 mg/L CRV reduced the
membrane fluidity since the Tm was higher than non-adapted control cells (Ultee
and others 2000a).
In the same study, iso-C13:0 and iso-C15:0 fatty acids increased in the
membrane lipid composition of B. cereus cells incubated with 60 mg/L CRV while
cis-C16:1 fatty acid decreased. These changes correlated with a decrease in
membrane fluidity of cells adapted to CRV. However, the decrease in long chain
fatty acids (C 18:0) did not correlate with the decrease in fluidity. Therefore, more
information is needed to understand these changes. Cells adapted to CRV had
additional phospholipids compared to non-adapted cells. There were no
noticeable differences in proportions of phosphatidylethanolamine (PE),
diphosphatidylglycerol (DPG), and phosphatidylglycerol (PG) (Ultee and others
2000b).
Further information is needed about the targets of essential oil
components. For example, since CRV accumulates in the membrane specific
information about where it inserts itself in the membrane may elucidate how CRV
may affect lipid-lipid and protein-lipid interactions. Responses to antimicrobials,
such as a change in fatty acid composition, should be determined as to whether
they enhance cell survival (adaptive response) or present evidence of toxicity.
Herbal or botanical antimicrobials offer an exciting new array of chemicals,
which may help to make foods safer by inhibiting growth of pathogenic bacteria.
Some herbs and essential oils have been used for thousands of years for both
flavoring and medicinal purposes. It is only now that we are beginning to
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understand the physiological activity of essential oils at the cellular level.
Information is needed on the mechanism and mode of action of herbal
antimicrobials to safely and economically use these powerful chemicals to not
only flavor foods but also to ensure safety and preservation.
Research objectives
The objectives of this research were to:
1) Evaluate the antimicrobial activity of ten essential oil components
against L. monocytogenes and S. Typhimurium
2) Compare results between the macro- to microdilution methods within an
essential oil component b y organism
3) Compare the antimicrobial concentrations needed to be effective
against the two organisms
4) Determine the effect of exposure to cinnamaldehyde and carvacrol on
the fatty acid composition of the bacterial membrane of Salmonella
5) Determine whether changes in the fatty acid composition of the
bacterial membrane of Salmonella occur due to growth in the presence of
cinnamaldehyde and carvacrol as a possible adaptive response
6) Determine whether reversal of these changes in fatty acid composition
occurs when the stressors, cinnamaldehyde and carvacrol, are removed.
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PART 2. ANTIMICROBIAL ACTIVITY OF SELECTED CHEMICAL
COMPONENTS FROM ESSENTIAL OILS AGAINST SALMONELLA
TYPHIMURIUM AND LISTERIA MONOCYTOGENES
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Abstract

The antimicrobial activity of essential oils is due to the presence of various
chemical components in the oil. The objective of this study was to evaluate the
antimicrobial activity of active chemical components of essential oils against
Salmonella Typhimurium and Listeria monocytogenes using broth microdilution
and macrodilution assays. Carvacrol (CRV), beta-caryophyllene, transcinnamaldehyde (CIN), eugenol (EUG), limonene, linalool (LNO), alpha-pinene,
rhodinol (RHO), and thymol were tested for antimicrobial efficacy using a 21-h or
24-h inoculum diluted to log 5.7 CFU/ml in phosphate -buffered brain-heart
infusion broth (pH 7.2) with 1% Tween 20 in microtiter plates (microdilution) and
glass tubes (macrodilution). Tween was used to solubilize the antimicrobial in
the aqueous phase. SAS/PROBIT dose-response models were used to analyze
the data. Beta-caryophyllene, limonene, alpha-pinene, a nd thymol were not
lethal to S. Typhimurium and L. monocytogenes at 2800 mg/L and 3200 mg/L,
respectively. LNO was more highly antimicrobial using the macrodilution
method. The most effective essential oil components against S. Typhimurium
were CIN and CRV (50% probability of lethality using an avg. of 280 mg/L and
1080 mg/L, respectively) with both methods. CIN (avg. 790 mg/L) and RHO
(avg. 1810 mg/L) were the most lethal essential oil components against L.
monocytogenes. L. monocytogenes required higher doses of antimicrobial
components to achieve lethality regardless of method.
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Introduction

Consumers desire high-quality, minimally processed foods that have fewer
preservatives and an extended shelf-life (Brul and Coote 1999). Essential oils,
which are obtained from plants by distillation, contain flavor, aroma, and
antimicrobial components. They are used mainly for flavors and fragrances.
Carvacrol (CRV), the bioactive component found in oregano and thyme essential
oils, is a flavoring agent in baked goods, nonalcoholic beverages, and chewing
gum (Ultee and others 1999). Eugenol and cinnamaldehyde (CIN) are used in
candies and baked goods (Kim and others 1995b). Essential oils of clove,
cinnamon, and allspice contain eugenol. CIN is a constituent of cinnamon and
cassia oils (Davidson and Naidu 2000).
In the past two decades, many studies have reported the inhibitory and
lethal effects of essential oils tested against a wide variety of microorganisms in
various culture media and food products. Studies have reported oregano, thyme,
clove, and cinnamon essential oils to be highly active against various
microorganisms (Lis-Balchin and Deans 1997; Hammer and others 1999 ;
Friedman and others 2002; Valero and Salmerón 2003). However, comparing
the efficacy of various oils is complex because the composition of bioactive
components within a genus, or even species, can vary due to a number of factors
such as climate a nd geographic origin (Zaika 1988).
Evaluation of these EOC presents challenges because of the low water
solubility of components, such as thymol, carvacrol, eugenol, and
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cinnamaldehyde (Griffin and others 1999). Kim and others (1995a) determined
that the minimum bactericidal concentration (MBC) of carvacrol against Listeria
monocytogenes and Salmonella Typhimurium was 500 mg/L and 250 mg/L,
respectively, using macrodilution broth method. The minimum inhibitory
concentration (MIC) of carvacrol, trans -cinnamaldehyde, and thymol against S.
Typhimurium were 150, 396, and 150 mg/L, respectively, using the broth
macrodilution method (Helander and others 1998). Eugenol was found to inhibit
the growth of E. coli O157:H7 and L. monocytogenes at 1000 mg/L (Blaszyk and
Holley 1998). The concentrations of CIN need to achieve a 50% decrease in
CFU in E. coli O157:H7, S. enterica Hadar, and L. monocytogenes were 600,
400, and 100 mg/L, respectively (Friedman and others 2002). Although several
studies have investigated the efficacy of some common constituents, little
information exists on the evaluation of less well-known components and their
mechanisms of action.
Although several studies have investigated the efficacy of EOC, only a few
have examined their mechanisms of inhibition. CRV was shown to cause
potassium ions to leak, reduce intracellular pH, destroy the membrane potential,
and deplete the intracellular ATP of Bacillus cereus cells, which would result in
lethality (Ultee and others 1999). Ultee and others (1999) investigated the effect
of carvacrol and cymene of the membrane of B. cereus. Cymene is structurally
the same as CRV except that it lacks the hydroxyl group. Both expanded the
membrane and decreased the membrane potential. While 150 mg/L CRV
completely destroyed the pH gradient, 268 mg/L of cymene did not. In addition,
32

carvacrol decreased the membrane potential more than cymene. Therefore, it
was concluded that the hydroxyl group in CRV was important for its antimicrobial
activity. One study found that CIN caused exponential phase cells to become
long and filamentous and inhibited them from separating from each other (Kwon
and others 2003). CRV disrupted the outer membrane of E. coli O157:H7 and S.
Typhimurium since it decreased intracellular ATP and increased extracellular
ATP in E. coli O157:H7. CIN did not disrupt the outer membrane or influence
intra- or extracellular ATP pools (Helander and others 1998).
Common methods used to test antibacterial activity are filter paper disk
diffusion, double plate, gradient plate, agar cup, and broth macro- and
microdilution (Zaika 1988). Since some components are hydrophobic, disk and
agar methods are less suitable and broth dilution assays are preferred (Davidson
and Naidu 2000). Difficulties encountered when working with essential oils and
their components include poor solubility, turbidity, and volatility. The
measurement accuracy of EOC has not been previously compared between the
two dilution methods. The objectives of this study were to evaluate the
effectiveness of the antimicrobial activity of selected EOC against L.
monocytogenes and S. Typhimurium using dose-response curves and to
compare the minimum lethal concentrations obtained from broth macro- and
microdilution assays.
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Materials and methods

Essential oil components
Materials and methods for microdilution or macrodilution assays were
based on the National Committee for Clinical Laboratory Standards Broth Dilution
Procedures with modifications as described below (NCCLS 1993). The efficacy
of carvacrol, beta-caryophyllene, trans -cinnamaldehyde, eugenol, (S)-(-)limonene, linalool, (1R)-(+)-alpha-pinene, (1S)-(-)-alpha-pinene, rhodinol (mixture
of citronellol and geraniol), and thymol were tested. Chemicals were purchased
from Aldrich (Milwaukee, WI), except trans-cinnamaldehyde (Fisher Scientific Acros, Fairlawn, NJ) and eugenol (Fluka, Buchs, Switzerland). Table of essential
oil component abbreviations and solubilities are in Table 2.1.
Stock solutions of EOC were prepared in ethanol, absolute (Aldrich, St.
Louis, MO). Sterile water dissolved into ethanol served as the control stock
solution. Aliquots (<160 µl) of freshly prepared EOC or control stock solutions
were added into 8 ml Brain Heart Infusion Broth, Modified (BHI, BBL, Sparks MD)
with 2% Tween 20 (Fisher Scientific, Fairlawn, NJ) with glass beads such that the
final concentration of ethanol did not exceed 1%. Tween and glass beads were
used to aid with dispersion of EOC in BHI. All BHI was prepared with phosphate
buffer (0.1M, pH 7.2 + 0.1) instead of water to prevent pH changes. The pH of
BHI was adjusted to 7.35 (+ 0.1) prior to autoclaving with 2N NaOH, after which
the final pH was pH 7.2 (+ 0.1). Glass tubes containing the EOC and BHI were
shaken vigorously forty times to disperse the oil-based components. Dispersions
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Table 2.1. Abbreviations, purities, and solubilities of essential oil components (Merck & Co, Inc. 2001).
Essential oil component

Abbreviation

Purity (%)

Solubility

Carvacrol

CRV

98

Beta-caryophyllene

CYP

>98

Trans-cinnamaldehyde

CIN

99

Eugenol

EUG

>99

Limonene

LIM

96

Practically insoluble in H2 O, miscible with alcohol

Linalool

LNO

97

Soluble in 4 volumes 60% a alcoho l

(1R)-(+)-alpha-pinene

RAP

98

Practically insoluble in H2 O

(1S)-(-)-alpha-pinene

SAP

>99

Practically insoluble in H2 O

Rhodinol

RHO

>83

Very slightly soluble in H2 O, miscible with alcohol

Thymol

THY

98

Essential oil components

EOC

Practically insoluble in H2 O, freely soluble in alcohol
Not available
Dissolves in 700 parts H2O, 7 volumes of 60% alcohol
1 ml dissolves in 2 ml 70% alcohol

1 g dissolves in 1L H2O or 1 ml alcohol
---

35

containing some components, such as CRV or RHO, became cloudy-white or
cloudy-yellow, respectively.
Preparation of EOC concentrations for assays
For the microdilution broth assay, 50 µl of a specific EOC in BHI were
dispensed into a microtiter plate (MIC 2000 Thermo Labsystems VWR Scientific
Products, West Chester, PA) with each lane containing a different concentration,
covered with tape and a lid, and frozen at -14.3°C in freezer bags to decrease
volatility of the 10 antimicrobials during preparation and storage. Plates were
stored for less than one week. To prepare for the macrodilution assay, 1 ml of
each antimicrobial concentration in BHI was dispensed into 4 glass tubes and
stored at 4°C. Stocks and dispersions for the macrodilution assay were prepared
two days before an experiment. Both microtiter plates and tubes were warmed to
room temperature half an hour before inoculation. The inoculum volume diluted
the antimicrobial concentrations by one-half.
A wide range o f concentrations was initially tested using all selected
EOC. Less effective EOC were eliminated from the study. Then the more
effective EOC were tested in a narrower range in smaller increments. The lowest
concentration tested allowed growth. No growth was detected at the highest
concentration. The final Tween concentration was 1% and ethanol concentration
was less than 1%. The concentrations tested for each EOC are shown in Tables
2.2 and 2.3. Some of the EOC were tested in smaller increments because they
were found to be more lethal in preliminary experiments. The effective EOC
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Table 2.2. Concentrations of essential oil components tested against L.
monocytogenes using microdilution and macrodilution broth methods.

Concentration range in mg/L (increments tested)
Component

Microtiter plates

Glass tubes

CRV

2200-3200 (200mg/L)

2400-3200 (200mg/L)

CYP

400-2000 (400mg/L)

2400-3200 (400mg/L)

CIN

400-1200 (200mg/L)

200-1200 (200mg/L)

EUG

1800-2800 (200mg/L)

2400-3000 (200mg/L)

LIM

400-2000 (400mg/L)

2400-3200 (400mg/L)

LNO

400-2800 (400mg/L)

2400-3200 (200mg/L)

RAP

400-2000 (400mg/L)

2400-3200 (400mg/L)

SAP

400-2000 (400mg/L)

2400-3200 (400mg/L)

RHO

1400-2200 (200mg/L)

1400-2200 (200mg/L)

THY

400-2000 (400mg/L)

2400-3200 (400mg/L)
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Table 2 .3. Concentrations of essential oil components tested against S.
Typhimurium using microdilution and macrodilution broth methods

Concentration in mg/L (increments tested)
Component

Microtiter plates

Glass tubes

CRV

800-2000 (200mg/L)

800-1600 (200mg/L)

CYP

400-2000 (400mg/L)

2000, 2800

CIN

200-800 (200mg/L)

200, 250, 300, 400, 600

EUG

1000-1600 (200mg/L)

1200-1800 (200mg/L)

LIM

400-2000 (400mg/L)

2000, 2800

LNO

1200-2000 (200mg/L)

1000-1800 (200mg/L)

RAP

400-2000 (400mg/L)

2000, 2800

SAP

400-2000 (400mg/L)

2000, 2800

RHO

800-1800 (200mg/L)

1200-3000 (200mg/L)

THY

400-2000 (400mg/L)

2000, 2800
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were more of interest. Therefore, smaller increments were tested to determine a
concentration at which there may be a threshold to its antimicrobial activity.
Bacterial culture preparation
Listeria monocytogenes serotype 4b ATCC 19115 and Salmonella
Typhimurium DT104 ATCC BAA-186 were obtained from the American Type
Culture Collection (ATCC, Rockville, MD). Experimental cultures were
maintained on Tryptic Soy Agar slants. A loopful of culture was to inoculate 9 ml
of BHI with L. monocytogenes or S. Typhimurium. The BHI tube was incubated
for 24h at 35°C. Then a loopful was transferred into 9 ml BHI. The BHI tube
inoculated with L. monocytogenes or S. Typhimurium was incubated at 35°C for
21h or 24h, respectively, to prepare the inoculum for experiments. The 21h or
24h culture was serially diluted to 10-3 in 9 ml and 99 ml BHI to prepare the
inoculum. A one ml aliquot from the 10-3 diluted culture was serially diluted in
0.1% peptone water and spread plated onto Standard Methods Agar (SMA) to
determine the inoculum size. The inoculum size in the10-3 diluted culture was
approximately log 6 CFU/ml.
Microdilution method. The 10-3 diluted inoculum (50 µl) was added to
the 50 µl of EOC in the microtiter plate to achieve a final concentration of bacteria
of approximately log 5.7 CFU/ml or log 4.7 CFU/well. Final volume in the well
was 100 µl. Microtiter plates were incubated at 35°C for 24 h on a microtiter
plate shaker.
Macrodilution method. One ml of the 10-3 diluted inoculum was added to
the tube containing 1 ml of EOC to achieve a final inoculum of approximately log
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5.7 CFU/ml. Final volume in the tube was 2 ml. Tubes were vortexed and
incubated in a shaking water bath at 35°C for 24h.
The MIC was determined as the lowest concentration of antimicrobial
agent that completely inhibited growth of the organism in the wells as detected by
the unaided eye. The MIC was difficult to determine in macrodilution and
especially microdilution methods because some EOC would appear turbid due to
the low solubility of EOC rather than due to bacterial growth. CRV and RHO
were two such antimicrobials. Therefore, it was necessary to subculture from the
wells to clearly determine if there was growth and to test antimicrobials using
macrodilution broth instead.
Although macrodilution method improved visibility of results, tubes
containing RHO and CRV appeared turbid with pellet, but when subcultured,
contained no detectable colonies. Within the tubes small droplets of carvacrol
were visible, especially at higher concentrations. The pellets may have been due
to the phosphate precipitation. Therefore, it was easier to evaluate effectiveness
by detecting growth on agar plates and finding the minimum lethal concentration
(MLC). MLC was determined as the lowest concentration that permitted no
growth after subculture.
To determine the MLC 10 µl was obtained from the microtiter wells or
glass tubes and plated onto SMA. Plates were incubated 35°C for 24h and
counted. MLC was determined according to the NCCLS Guidelines for the
Rejection Value for Each Initial Inoculum Concentration on the Basis of a Single
0.01-ml Sample. These guidelines suggest that when the number of colonies
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from a test vessel is equal to or less than the rejection value (which is >11 CFU
for a log 5.7 CFU/ml inoculum) the concentration of the antimicrobial in the test
vessel is considered lethal (99.9% or greater reduction in the final inoculum
(NCCLS 1993).
Statistical analysis
Three replications were performed for each antimicrobial and method.
The data were analyzed using SAS procedure PROBIT analysis (Statistical
Analysis System Institute, Cary, NC) to develop dose-response models. Since
the response of interest is lethality or nonlethality, the dependent variable is a
binary discrete variable. PROBIT is a type of logistic regression that fits
regression equations to categorical responses. Bacterial response, such as
probability of lethality, was plotted as a function of the dose (López-Malo and
others 2002).
The concentration of antimicrobial was transformed to log10 to obtain a
more linear regression line. First, PROBIT analysis was conducted to evaluate if
there was a difference among EOC stock solutions of a certain antimicrobial that
were prepared at different times within a certain method and organism. The data
were summarized across the EOC stock solutions, for each antimicrobial, within
a method and by organism. PROBIT analysis used the summarized data to
determine if there were dose effects and to generate dose-response curves to
compare the effectiveness across antimicrobials. Next, the data were analyzed
to compare methods within each organism. Lastly, the doses of each chemical
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were compared to determine if an organism required higher doses than the other
organism for the macrodilution method.

Results

PROBIT dose-response curves
The dose-response curves for L. monocytogenes and S. Typhimurium
exposed to EOC have a sigmoid shape since there is no response from the
population until the dose reaches a threshold response. When the higher
saturation dose has been applied no increase in response occurs. In this study
the initial region at lower doses is one of insignificant lethality. Then there is a
linear region of exponential inactivation (after a logarithmic transformation), and
then a final region where higher concentrations do not cause additional lethality
(López-Malo and others 2002).
The PROBIT procedure estimates the probability of successful response
(lethality) for a dose (concentration of antimicrobial), which is the independent
variable. Zero to 100% probability is the range of response. This probability is
based on regression parameters of the number of successful responses and the
total number of events and the threshold response rate. Dose-response curves
are useful when deciding what probability of lethality is desired in cost-benefit
analysis and risk assessment. Dose-response curves for L. monocytogenes
exposed to EOC are presented in Figures 2.1 and 2.2. The solid line represents
the regression line, which is used to obtain the prediction for the mean probability
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Figure 2.1. Probability of lethality of Listeria monocytogenes treated by essential oil
components using microdilution method (microtiter plates).
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Figure 2.2. Probability of lethality of Listeria monocytogenes treated by essential oil components
using macrodilution method (glass tubes).
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of lethality at a given dose. The dotted lines on each side of the mean predicted
probability represent the 95% confidence interval. The confidence interval is a
range of values that is expected to contain the mean predicted probability of
lethality in 95% of experiments.
L. monocytogenes
Microdilution method
The essential oil components (EOC) CYP, LIM, RAP, SAP, and THY were
not lethal to L. monocytogenes at 2000 mg/L and LNO was not lethal at 2800
mg/L against L. monocytogenes using the microtiter plate assay (Table 2.4).
CIN, CRV, EUG, and RHO exhibited lethality to L. monocytogenes at
concentrations greater than 760 mg/L. CIN was the most effective EOC,
followed by RHO (Table 2.4 and Figure 2.1). The difference between the doses
of CIN and RHO at 50% probability of lethality was approximately 1200 mg/L
(Table 2.4). At 99% probability of lethality, this difference was greater than 1700
mg/L. The MIC values of EUG and CRV were similar but less than that of CIN
and RHO.
Macrodilution method
CYP, LIM, RAP, SAP, and THY were not lethal at 3200 mg/L (Table 2.4).
Colonies grew abundantly on SMA plates after these samples were subplated.
Implementation of the macrodilution method determined that CIN was the most
effective EOC against L. monocytogenes followed by RHO (Table 2.4 and Figure
2.2). The difference between their doses at 50% probability was >800 mg/L
(Table 2.4). At 99% probability of lethality, this difference decreased to
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Table 2.4. Antimicrobial doses corresponding to 50% and 99% probability of lethality against L. monocytogenes.
Dose (mg/L) corresponding to
50% probability of lethality
Component*

Dose (mg/L) corresponding to
99% probability of lethality

Microtiter p late

Tubes

Microtiter plate

Tubes

CIN

818

760

875

1236

CRV

2704

2600

3698

3214

EUG

2500

2698

2877

3199

LNO

---

2582

---

2838

RHO

1986

1626

2600

1995

* Microtiter plate: CYP, LIM, RAP, SAP, and THY at 2000 mg/L and LNO at 2800 mg/L were not lethal.
Tubes: CYP, LIM, RAP, SAP, and THY at 3200 mg/L were not lethal.
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>700mg/L. CRV, EUG, and LNO and were similar in antimicrobial activity, but
not as effective as CIN and RHO.
Comparison of micro- and macrodilution methods for an
antimicrobial
In both the micro- and macrodilution methods, CIN was the most effective
against L. monocytogenes followed by RHO. CIN and CRV were as active in the
microtiter plates as in the tubes (Table 2.4). Statistically, it appeared that EUG
was more effective in the microtiter plates (p<0.01) than in the tubes and that
RHO was more effective in the glass tubes (p<0.01) than in the microtiter plates.
However, these differences were probably due to pipetting error. Since ethanol
has no surface tension, the volume transferred from the EOC stock solutions in
ethanol to the BHI broth was likely inconsistent. The differences between the
micro- and macrodilution methods for RHO and EUG were less than two-fold. A
two-fold difference in MIC values is considered to be within experimental error
(Inouye and others 2001).
S. Typhimurium
Microdilution method
CYP, LIM, RAP, SAP, and THY were not lethal at 2000 mg/L against S.
Typhimurium in the microtiter plates (Table 2.5). CIN was the most effective
EOC, followed by CRV, EUG, RHO, and LNO at 50% probability pf lethality
(Figure 2.3 and Table 2.5). The difference between CIN and CRV doses was
>700 mg/L at 50% probability of lethality and increased to >1000 mg/L at 99%
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Table 2.5. Antimicrobial doses corresponding to 50% and 99% probability of lethality against S. Typhimurium.
Dose (mg/L) corresponding to
50% probability of lethality
Component*

Dose (mg/L) corresponding to
99% probability of lethality

Microtiter plate

Tubes

Microtiter plate

Tubes

CIN

284

280

312

419

CRV

1033

1130

1380

1556

EUG

1227

1294

1282

2094

LNO

2056

1567

2576

1845

RHO

1535

---

2495

---

* Microtiter plate: CYP, LIM, RAP, SAP, and THY at 2000 mg/L were not lethal.
Tubes: CYP, LIM, RAP, SAP, and THY at 2800 mg/L and RHO at 3000 mg/L were not lethal.
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RHO
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Figure 2.3. Probability of lethality of Salmonella Typhimurium treated by essential oil
components using microdilution method (microtiter plates).
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probability (Table 2.5). CIN lacked a 95% confidence interval because there
were fewer distinct doses tested in the sublethal range. The 95% confidence
interval for LNO was wider since the concentration that may achieve a 100%
lethal dose was not prepared for the assay.
Macrodilution method
CYP, LIM, RAP, SAP, and THY were not lethal at 2800 mg/L in the glass
tube assay (Table 2.5). RHO was not lethal at 3000 mg/L. CIN was the most
effective EOC against S. Typhimurium followed by CRV, LNO, and EUG at 50%
probability of lethality (Figure 2.4 and Table 2.5). The difference between CIN
and CRV doses was >800 mg/L at 50% probability of lethality and increased to
>1100 mg/L at 99% probability (Table 2.5).
Comparison of micro- and macrodilution methods for an
antimicrobial
The inhibitory activity of CIN, CRV, and EUG was not different between
the macro- and microdilution methods when tested against S. Typhimurium.
LNO was statistically more effective against S. Typhimurium using the
macrodilution method (p<0.0001) and required 490 mg/L less to achieve a 50%
probability of lethality (Table 2.5). Since this difference was less than two-fold
the difference may have been due to pipetting error. Although the comparison
was not statistically analyzed, RHO seemed to be more effective in the microtiter
plates, since there was abundant growth of S. Typhimurium when samples were
subplated from glass tubes containing 3000 mg/L RHO. There was a strong
stock solution effect among different stocks of RHO when tested against L.
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Figure 2.4. Probability of lethality of Salmonella Typhimurium treated by essential oil
components using macrodilution method (glass tubes).
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monocytogenes in microtiter plates. The variation may be due to inconsistency
when pipetting stock solutions because of the low surface tension of ethanol. In
addition, it was difficult to determine if the variation in RHO antimicrobial activity
was due to loss of RHO during storage or incubation of plates because of the
volatility of RHO.
Comparison of effectiveness against L. monocytogenes and S.
Typhimurium
All figures show that CIN was much more bactericidal than the other
antimicrobials. RHO and CRV were the next most effective antimicrobials
against L. monocytogenes and S. Typhimurium, respectively. L. monocytogenes
required higher doses of CIN, CRV, EUG, LNO and RHO regardless of which
method was used. At 50% probability of lethality, >500 mg/L more of CIN was
needed to be effective against L. monocytogenes than S. Typhimurium. At 99%,
the concentration increased to >600 mg/L. For CRV to be lethal with 50%
probability, >1600 mg/L CRV was needed against L. monocytogenes. At 99%,
the concentration increased to >1900 mg/L.

Discussion

Statistical differences compared to scientific differences
A two-fold difference in MIC values is considered to be within experimental
error (Inouye and others 2001). Although the results of our study showed
statistical differences between the micro- and macrodilution methods for EUG,
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LNO, and RHO, they may not be scientifically significant since the differences
were much lower than a two -fold difference and may be due to experimental
error instead. The doses of CIN, CRV, and EUG needed to be lethal against L.
monocytogenes were more than two-fold higher than those against S.
Typhimurium and therefore scientifically significant.
Comparisons with other studies
When these results were compared with those of other studies, similarities
and differences were found. Studies of essential oils and components were
difficult to compare since there are various assays used to evaluate
antimicrobials, but there is no standardized test method or format for reporting
assay results of bactericidal activity (Friedman and others 2002). Sensitivities of
bacterial strains, method of growth, and phase of growth when the antimicrobial
was applied, and enumeration of survivors may affect results. Solubility of the oil
or component and method of preparing stocks may influence activity (Friedman
and othe rs 2002). Variations in experimental procedures, composition of
medium, and preparation of slightly soluble phenolics lead to wide differences in
results (Wen and others 2003).
In a microtiter plate assay of 96 essential oils and 23 oil components, CIN,
EUG, THY, CRV, citral, geraniol, perillaldehyde, carvone S, estragole, and
salicylaldehyde were the most effective components tested against L.
monocytogenes F2379 (Friedman and others 2002). Similarly, our study found
that CIN, EUG, and CRV were most lethal to L. monocytogenes. However,
doses of CIN, EUG, and CRV at 50% probability of lethality were about three to
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four times higher than the BA50 values of Friedman and others (2002) (Table
2.6). The BA50 values were determined from the linear regression model as the
dose that resulted in a 50% decrease in the number of CFU compared to that of
the negative control rather than through a dose-response PROBIT analysis.
BA50 value of THY was 770 mg/L, but our study did not find THY to be as
effective as the other antimicrobials. LIM and LNO were not evaluated above
2080 mg/L and 2890 mg/L respectively. The lower activity of LIM and LNO
agrees with these authors’findings that LIM and LNO were not effective at 6700
mg/L. Friedman and others (2002) did not evaluate RHO.
They tested these components against S. enterica serovar Hadar (isolated
from ground turkey). They found that THY, CIN, CRV, EUG, salicylaldehyde,
geraniol, isoeugenol, terpineol, perillaldehyde, and estragole were the most
active. Doses of CIN, EUG, and CRV at 50% probability of lethality of our study
were about two times higher than their BA50 values (Table 2.6). However, the
LNO dose at 50% lethality was about two-fold lower than the BA50 value. THY
was found to be effective at a BA50 value 340 mg/L but our study did not find it to
be effective. Friedman and others (2002) reported that LIM was not effective up
to 6700 mg/L and our study did not test it above 3300 mg/L. Similarly, they found
that CRV and LNO doses needed to inactivate S. enterica were lower than that of
L. monocytogenes, which agrees with our findings of the relative susceptibility of
Salmonella compared to Listeria.
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Table 2.6. Comparison of BA50 values adapted from Friedman and others (2002) and concentrations to
reach 50% probability of lethality from this present study using microdilution assay.

BA50 values (mg/L) from Friedman and others (2002)
L. monocytogenes

Concentration (mg/L)
to reach 50% probability of lethality

S. enterica

L. monocytogenes

S. Typhimurium

F2379

RM2388

serovar Hadar MH136

serotype 4b

DT104

CIN

190 + 10

80 + 10

330 + 140

818

284

CRV

830 + 100

860 + 100

540 + 0.01

2704

1033

EUG

610, 500

810 + 10

870 + 350

2500

1227

LNO

6700, 8500

6700, 6800

3700 + 400

-

2056

THY

770 + 100

770 + 200

340 + 20

-

-
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These differences in the lethality values between the two studies may be
due to their preparation in phosphate-buffered saline (PBS; pH=7.0) (Friedman
and others 2002). For example, to prepare the THY treatment, they vortexed the
THY solids in a microcentrifuge tube with PBS, warmed it for 4s, and vortexed it.
The preparation led to a more mixed suspension and therefore a higher
antibacterial activity than in this study. This may explain why our study found
that THY was less active than other antimicrobials, although it appeared to
dissolve in ethanol.
The variation in efficacy may be due to differences in inoculum size,
incubation time, and the- formation of mixed micelles from Tween and <1%
ethanol from the stock solution. The most influential factor in these assays is the
inoculum size (NCCLS 1993). Larger bacterial populations may be more likely
than smaller populations to have some more resistant cells, which can survive
and grow. Therefore, smaller populations will be more quickly and fully inhibited
(Amsterdam 1996). The susceptibility of antimicrobials increases with a smaller
inoculum size (Collins and others 1995). For example, the antimicrobial activity
of essential oils of oregano, thyme, and clove were found to increase with
decreasing inoculum level of Staphylococcus aureus and Salmonella Hadar
(Remmal and others 1993). The mean suggested inoculum is log 6 CFU/ml for
microdilution (NCCLS 1993). Friedman and others (2002) added 50-µl of 1,500
to 2,000 CFU/well in PBS to 100-µl of antimicrobial in microtiter plates. Since the
inoculum size in our study (log 5.7CFU/ml or 50,000 CFU/well) was considerably
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larger as recommended by NCCLS, this may explain the higher concentrations
required for lethality.
Another important difference between the studies was the incubation time.
Friedman and others (2002) incubated the microtiter plates for one hour, a
significantly shorter time compared to 24 h. They had found in previous
experiments with E. coli and S. enterica that the % kill by cinnamon oil, oregano
oil, and eugenol approached a maximum at 60 min and reached a plateau. The
strong influence of incubation time was demonstrated when ampicillin was tested
against S. aureus and E. coli strains. The MIC values for 24-h incubation were at
least two -fold more than those of 12-h incubation (Amsterdam 1996). The
method of determining survivors was different as well as the statistical model
used for the dose-response curve. It can be argued that lethality at 60 min
should also be demonstrated at 24h if the dose is actually lethal, rather than
inhibitory.
Furthermore, Friedman and others (2002) did not use Tween 20 to
increase solubility of the hydrophobic antimicrobials, but used vigorous shaking
in PBS. In our study the concentration of Tween was 1%. Tween 20 has been
reported to decrease the antimicrobial activity of oregano, thyme, and clove
essential oils and EUG. Dispersions of oregano, thyme, and clove essential oils
in 0.2% agar solution produced lower MIC values than those with 2% ethanol and
2.5% Tween. MIC values were lower with Tween 20 than with Tween 80
(Remmal and others 1993). In another study, Tween 20 was used at >0.25% to
increase eugenol solubility, but it decreased inhibitory activity (Blaszyk and
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Holley 1998). Blaszyk and Holley (1998) hypothesized that while Tween
increases the solubility of thymol in water, it decreases its solubility in the
cytoplasmic membrane since the membrane is hydrophobic. This may help
explain the much higher values of our study.
Friedman and others (2002) also tested various strains of S. enterica
serovars Meleagridis, Hadar, and Newport and L. monocytogenes F2379
(isolated from cheese associated with outbreak) and RM2388 (isolated from a
retail mint herb, serotype 1). They calculated the BA50 values for cinnamon bark
oil, oregano origanum oil, and eugenol. The differences in BA50 values were
less than two-fold among strains within a species. These authors noted that the
L. monocytogenes F2379, which was isolated from cheese associated with an
outbreak, seemed more resistant than the L. monocytogenes RM2388. They
believed that the F2379 strain had virulence factors that RM2388 lacked. It was
hypothesized that F2379 developed resistance while in the cheese, but RM2388
did not develop resistance in the mint. The authors emphasized the need to
ascertain if resistance is associated with the source of the isolate or a response
of the strain to adapt to the food processing environment. Since the strains in
our study are known to be associated with outbreaks, these strains may be more
resistant than the previous study because of their source or virulence factors.
In a study by Kim and others (1995a), the MBC value for CRV was three to five
times lower than the concentrations to achieve 50% probability of lethality against
S. Typhimurium and L. monocytogenes in our study (Table 2.7). The MBC
values for EUG and LNO were about three times lower against S. Typhimurium
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Table 2.7. Comparison of minimum bactericidal concentrations (MBC) adapted from Kim and others (1995) and
concentrations to reach 50% and 99% probability of lethality from this present study using macrodilution assay.

Concentration (mg/L) to reach:
MBC (mg/L) from Kim et al (1995)
L. monocytogenes S. Typhimurium

50% probability of lethality
L. monocytogenes

99% probability of lethality

S. Typhimurium L. monocytogenes

S. Typhimurium

Scott A

ATCC 6539

serotype 4b

DT104

serotype 4b

DT104

CRV

500

250

2600

1130

3214

1556

EUG

>1000

500

2698

1294

3199

2094

LNO

>1000

1000

2582

1567

2838

1845
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(Kim and others 1995a). Similarly, they found that higher concentrations of
antimicrobials were required to inactivate L. monocytogenes. It was unclear from
the article at which sampling time the MBC was determined. Although the
concentration of 1% Tween and inoculum size of log 6 were similar to our study,
the assay was conducted with a much larger volume of 20 ml of tryptic soy broth
(TSB) in flasks.
Structure and molecular characteristics associated with activity
In our study, the aldehyde component (CIN) was the most effective,
followed by the phenolics (CRV and EUG) and acyclic terpene alcohols (LNO
and RHO) (Figure 2.5). This agreed with the findings of Friedman and others
(2002), who found that the aldehydes and phenolics were very active. Phenolics
are believed to be the main antimicrobial components in many essential oils
(López-Malo and others 2002). CRV and THY are both phenolic and differ only
in the position of the hydroxyl group. The hydroxyl group is the necessary
characteristic required for the action of CRV against B. cereus to decrease the
membrane potential and pH gradient (Ultee and others 2002).
The carbonyl group of aldehydes has the capacity to undergo oxidation
and reduction reactions and nucleophilic additions which allows it to bind metal
ions, sulfhydryl and amino groups of membrane proteins (Bowles and Miller
1993). Cinnamaldehyde was found to be an effective inhibitor of histidine
decarboxylase activity of Enterobacter aerogenes and its carbonyl group was
suggested as the functional group (Wendakoon and Sakaguchi 1995).

60

Aromatic unsaturated aldehyde

Cinnamaldehyde

Phenolics

Carvacrol

Thymol

Eugenol

Acyclic terpene alcohols

Rhodinol

Linalool

Terpene hydrocarbons

ß-caryophyllene

(S)-(?
)-Limonene

(1R)-(+)-a-pinene (1S)-(-)-a-pinene

Figure 2.5. Structures of selected essential oil components.
61

In a study of the effect of structure and molecular characteristics on
antimicrobial activity, hierarchical cluster analysis arranged 60 terpenoids into
five groups based on their activity patterns against Pseudomonas aeruginosa, E.
coli O157:H7, Staphylococcus aureus, and Candida albicans (Griffin and others
1999). THY and CRV were in group I, EUG and LNO in group II, and LIM, RAP,
and SAP in group IV. Group I, which inhibited all four microorganisms, was more
soluble in water (although low in solubility in general) and had a higher capacity
to form hydrogen bonds than group IV, which was not inhibitory. Overall group I
and II were similar in structure and molecular characteristics, but group I was
more active. Compared to group II, group I was more capable of forming a
hydrogen bond, had a smaller surface area, and a lower hydrophilic/lipophilic
balance. Group IV included hydrocarbons like CYP, RAP, SAP, and LIM which
are inactive because of their lower water solubility and lower H-bonding capacity
(Griffin and others 1999).
Hydrophobic molecules cannot easily diffuse through the LPS of Gramnegative bacteria. In contrast, small hydrophilic compounds can pass through
porins. Group I is more likely to permeate because of its smaller size and
capacity to form H-bonds to interact with the water layer on the exterior of
bacteria (Griffin and others 1999). Griffin and others (1999) conclude that
“specificity and activity was not always defined by the functional group present
but were associated with H-bonding parameters.” However, they cautioned that
solubility and H-bonding did not explain all the patterns in antimicrobial activity
and there were other molecular properties to be measured.
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Sensitivity of Gram-negative and Gram-positive organisms
Most studies have found that Gram-positive organisms are more
susceptible than Gram-negative to essential oils and their components (as
reviewed by Burt 2004). This might be expected since the dense LPS of Gramnegative organisms is hydrophilic and acts as an impermeable barrier to
hydrophobic molecules, which can diffuse slowly (Vaara 1992). However, other
studies that that S. Typhimurium was more sensitive than L. monocytogenes
(Kim and others 1995a). Our study also found S. Typhimurium was more
susceptible than L. monocytogenes. Perhaps, it is more difficult for hydrophobic
EOC to penetrate the thick peptidoglycan layer of L. monocytogenes in order to
act on the cytoplasmic membrane. It is hypothesized that after they diffuse past
the LPS in Gram-negative bacteria, they can act on the proteins in the
periplasmic space and then pass through only a thin peptidoglycan layer to act
on the cytoplasmic membrane. More research is needed on the main target on
which these essential oils act.
The partitioning of EOC in the membrane may also help explain the
different susceptibility of Gram-negative and positive bacteria to EOC. The
optimal oil:water partition coefficient (log P) for Gram-negative and Gram-positive
bacteria is 4.0 and 6.0 for the oil phase, respectively. Aromatic solvents of 2.0 4.0 log P changed the cytoplasmic membrane organization in Gram-negative
bacteria (Denyer and Maillard 2002). CRV has a log P of 3.6, preferring to
partition in the nonpolar solvent more than water (Ultee and others 2002).
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Therefore, CRV may be more effective against Gram-negative bacteria since the
optimal log P of Gram-negative bacteria is closer to the log P of CRV.
Mechanisms of action
It has been suggested that carvacrol occupies more area than the typical
space between the fatty acid chains of two adjoining phospholipid molecules.
This interferes with the van der Waals interactions between the chains and
therefore affects fluidity (Ultee and others 2000; Ultee and others 2002). Liquidcrystalline is the optimal state of the membrane lipids in which fatty acyl chains
are loosely packed and interactions between the chains are not at a maximum
because the chains or its -CH2- groups is rotated (Seltmann and Holst 2002). If
the membranes become too fluid, additional carvacrol can continue to permeate
the membrane, accumulate, and cause more damage (Ultee and others 1998).
It was found that carvacrol expanded the single-membrane liposomes
prepared from phosphatidylethanoloamine shown by an increase in fluorescence
of a probe (Ultee and others 2002). It is believed that this swelling leads to a
destabilized membrane and therefore a leakage of ions. During exposure to
carvacrol, an influx of protons from outside the cytoplasmic membrane and efflux
of potassium ions in Bacillus cereus was reported (Ultee and others 1999). This
leakage was also evident in the decrease of the pH gradient across the
membrane (Ultee and others 2002). The leakage of ions leads to a drop in the
membrane potential and depletion of the intracellular ATP pool (Ultee and others
2002). It was found that 300 mg/L CRV reduced viable counts of Bacillus cereus
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cells in 30 min and depleted intracellular ATP within 7 min without a proportional
increase in extracellular ATP (Ultee and others 1999).
Similarly, Helander and others (1998) reported that CRV at 300 mg/L (MIC
= 451 mg/L) increased the uptake of hydrophobic fluorescent probe NPN in E.
coli O157:H7 and S. Typhimurium. Uptake of NPN occurred because the outer
membrane was no longer acting as a strong permeability barrier. CRV also
decreased intracellular ATP in E. coli O157:H7, but with a smaller increase in
extracellular ATP. These effects indicated that CRV disrupted the outer
membrane. In contrast, it was suggested that CIN did not disrupt the outer
membrane because at 264 mg/L (MIC = 396 mg/L) it did not increase the uptake
of NPN or influence intra- or extracellular ATP pools (Helander and others 1998)
. CRV was reported to impair the cell membrane and increase permeability
because of the increased fluorescence of nuclear stain EB after Staphyloccus
aureus and Pseudomonas aeruginosa were exposed to 0.1% CRV (Lambert and
others 2001).
Technical limitations of broth dilution assays
Compared to the macrodilution assay, the microtiter plate assay was less
laborious to prepare the concentrations and inoculate (which NCCLS suggests to
do within 15 min). Results were more difficult to reproduce with the microtiter
plates, especially due to the low solubility of CRV and RHO, which contributed to
turbidity. Oil droplets settled within CRV dispersions in tubes and wells, which
may not have contacted the cells uniformly during incubation. If the plates were
not uniformly manufactured, interaction between the antimicrobials and lipophilic
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components in the wells may have been inconsistent. It is more difficult to
assess the MLC with the microdilution method, but less broth is required (NCCLS
1993). The macrodilution method is more appropriate when there are fewer
assays to conduct, since preparing many sets of tubes can be tedious and more
operators are needed to inoculate during a short time (Collins and others 1995).
Limitations of minimum lethal or bactericidal concentration
There are microbiologic and technical problems with the MLC
determination (Amsterdam 1996). The definition of MLC is the concentration
resulting in a 99.9% decrease in the number of initial bacteria in the inoculum
(NCCLS 1993). Amsterdam (1996) asserted that it has not been demonstrated
that 99% is more clinically relevant than 98%. NCCLS (1993) noted that this
distinction might not have biological relevance. Bacteria also tend adhere and
proliferate above the meniscus of the medium to possibly avoid contact with the
antimicrobial (Amsterdam 1996). This happens more often with plastic test tubes
than with acid-treated borosilicate glassware or with plastic microtiter plates
(NCCLS 1993). In addition, the adhesion of bacteria to the interior of the test
vessel depends on the type of material (NCCLS 1993). NCCLS cautioned, “the
determination of the MLC is subject to methodological variables such that the
clinical relevance of MLC values is nearly impossible to assess.
A microbiologic complication is the “persistence”phenomenon, which
describes a small number (<0.1% of the inoculum) of cells, or “persisters,”that
survive the bactericidal activity of the antimicrobial because they are
metabolically inactive or replicating slowly (NCCLS 1993). If the persisters are
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retested, they are as susceptible as the original strain and no greater percentage
of cells that persist. The persistence phenomenon is a type of tolerance.
Tolerance is defined as the ability of the microorganism to escape lethal effect of
the antimicrobial, but the MIC remains the same since it can grow (NCCLS 1993;
Amsterdam 1996). Other types of tolerance are genotypic and phenotypic, which
can occur more often and are more relevant (Amsterdam 1996).
Applications of components to food
One of the limitations of this study is that the broth dilution assay is an
artificial way of bringing the antimicrobial and the pathogen in contact, but
outside of food. Once an antimicrobial is found to be effective with in vitro
methods, its action in a food system can be tested. Because of the interactions
of the antimicrobial with food components, the inhibitory effect is lower in foods
than in microbiological media. Foods high in fat would require higher
concentrations to inhibit growth (Zaika 1988).
Since essential oils are components are pungent, they may cause
undesirable flavors or aromas (López-Malo and others 2002). Although 300-400
mg/L was lethal to S. Typhimurium in-vitro in our study, higher levels would be
needed if the control microorganisms was intended. The concentrations needed
for lethal action by essential oils exceed tolerable taste thresholds. Therefore, to
achieve desired effects against microorganisms essential oils and their
components may be added to foods at inhibitory levels and be combined with
other antimicrobials or processing conditions (Brul and Coote 1999). Since these
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inhibitory levels are greater than those used for flavoring, manufacturers would
be required to submit a GRAS notice to FDA (Draughon 2004).
Although NCCLS suggested an inoculum of log 5.7 for clinical assays, this
may or may not be applicable in food. The selection of the inoculum size
depends on the food intended for application of the antimicrobial. Various foods
differ in their initial microflora as well as possible contaminating microorganisms.
The selection of the microorganism depends on the target food and whether the
natural microflora and/or contaminating microorganisms are of interest. The
intended use of the antimicrobial should be defined, suc h as to increase shelf life.
At normal usage levels most food antimicrobials do not inactivate pathogens
(Parish and Davidson 1993). Therefore, it would be beneficial to combine other
intervention strategies if antimicrobials are used. Food processing conditions
such as with those with heat will affect the activity of EOC due to their volatility.
At 60°C pure CIN was converted to benzaldehyde, but CIN in cinnamon oil was
stable (Friedman and others 2000). There is a shortage of knowledge about
these effects (Friedman and others 2002). More research is needed on
essential oils and components in foods as well as in combinations with other
intervention strategies for synergistic action while maintaining acceptable quality
and safety.
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Significant findings

Beta-caryophyllene, limonene, alpha-pinene, and thymol were not lethal to
S. Typhimurium and L. monocytogenes at 2800 mg/L and 3200 mg/L,
respectively. The most effective essential oil components against S.
Typhimurium were CIN and CRV (50% probability of lethality using an avg. of
280 mg/L and 1080 mg/L, respectively) with both methods. CIN (avg. 790 mg/L)
and RHO (avg. 1810 mg/L) were the most lethal against L. monocytogenes. L.
monocytogenes required higher doses of antimicrobial components to achieve
lethality regardless of which method was used to determine MLC. Since selected
components of essential oils were inhibitory to S. Typhimurium and L.
monocytogenes, combinations of these components may be useful as
antimicrobials and should be evaluated.
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PART 3. CHANGES IN FATTY ACID COMPOSITION ASSOCIATED WITH
EXPOSURE AND ADAPTATION TO TRANS-CINNAMALDEHYDE
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Abstract

Trans-cinnamaldehyde (CIN) is a major component found in the essential
oil fraction of cinnamon cassia oils. It has been reported to be inhibitory to
various pathogens. The mechanism of this inhibition is not fully understood, but
is assumed to occur at the membrane level. To increase understanding of the
inhibitory effect of CIN, the objective of this stud y was to evaluate changes in
bacterial membrane composition by observing changes in total phospholipid fatty
acid (PLFA) and fatty acid composition associated with exposure and adaptation
to CIN. Salmonella Typhimurium DT104 cells were grown for 24h at 35°C with or
without 250mg/L CIN in 9-ml brain heart infusion broth. Log 5.7 CFU/ml of
S.Typhimurium was inoculated into 200ml broth containing 250mg/L CIN. At 2h
and 24h, samples were centrifuged, washed, lyophilized, and extracted for lipids.
Fatty acid methyl esters prepared from phospholipids were quantified by GC-MS.
After 2h of exposure to CIN, the non-adapted treatment group had lower (p<0.05)
total phospholipid fatty acid (PLFA), lower C16:1w7c and unsaturated fatty acid
(UFA) and higher (p<0.05) C18:0, saturated fatty acid (SFA), and Cy17:0 to
C16:1w7c ratio than the non-adapted control. After 24h of exposure to CIN, the
non-adapted treatment group had lower (p<0.05) Cy17:0, Cy19:0, and UFA than
the non-adapted control and higher (p<0.05) C16:0 a nd SFA. At 2h, SFA/UFA
ratio in the membranes of adapted cells exposed to CIN was numerically higher
than in the non-adapted cells treated with CIN. At 24h the SFA /UFA ratios of the
adapted and non-adapted Salmonella were similar. Since the fatty acid
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composition and total PLFA of the non-adapted control and adapted controls
were similar at 2 and 24h, the adaptive response had been reversed since the
stressor, CIN, was not used to treat the adapted controls. It appears that CIN
treatment at sub-lethal concentrations decreased the fluidity of the Salmonella
membrane by increasing SFA. This decreased fluidity may prevent additional
CIN from permeating. The effect of bacterial growth in the presence of CIN on
the fatty acid composition was much smaller. Measurement of the membrane
transition temperature from gel-to-liquid-crystalline phase would indicate fluidity.
Investigation about the target site that CIN acts upon and the interactions of CIN
with membrane lipids and proteins would contribute to the understanding of its
mechanism of action and the bacterial response.

Introduction

Consumers desire high-quality, minimally processed foods that have fewer
preservatives and an extended shelf-life (Brul and Coote 1999). Studies have
frequently reported cinnamon essential oil to be highly active against various
microorganisms (Lis-Balchin and Deans 1997; Friedman and others 2002; Valero
and Salmerón 2003). Trans -cinnamaldehyde (CIN), which is a component found
in cinnamon oil, is used in candies and baked goods (Kim and others 1995).
Cinnamon has been used in human foods for thousands of years and has
been used as a deodorizer and sanitizer. The minimum inhibitory concentration
(MIC) of CIN against S. Typhimurium and E. coli O157:H7 was 396 mg/L
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(Helander and others 1998). The concentrations of CIN needed to achieve a
50% decrease in CFU in E. coli O157:H7, S. enterica Hadar, and L.
monocytogenes were 600, 400, and 100 mg/L, respectively (Friedman and
others 2002).
Concentrations that are lethal to bacteria are much higher than tolerable
taste thresholds. Therefore, it is preferable to use them at inhibitory
concentrations rather than at lethal concentrations (Brul and Coote 1999).
Knowledge about the mechanisms of action of antimicrobials is needed to
develop effective and economical combinations of antimicrobial additives and
formulations to prevent food from spoilage and pathogenic microorganisms
without sacrificing organoleptic qualities.
Compounds from essential oils are believed to disrupt the membrane (Brul
and Coote 1999), however, there are diverse chemical families representing
essential oil components. Lipophilic compounds, such as essential oil
components, have been shown to accumulate and act on the cell membrane
(Sikkema and others 1994, 1995; Ultee and others 1999). As they interact with
the phospholipid bilayer of the cell membrane, they may increase membrane
permeability and cause cellular constituents to leak (Sikkema and others 1994;
Ultee and others 1998).
Although a few studies have investigated the efficacy of CIN, only a
couple have examined its mechanism of inhibition. One study found that CIN at
0.3 ml/L was lethal to Bacillus cereus cells but no significant amount of protein
was lost. It was reported that treatment with CIN caused exponential phase cells
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to become long and filamentous and inhibited them from separating from each
other (Kwon and others 2003). It was suggested that CIN did not disrupt the
outer membrane of E. coli O157:H7 and S. Typhimurium because at 264 mg/L it
did not increase the uptake of a hydrophobic fluorescent probe or influence intraor extracellular ATP pools (Helander and others 1998).
When a microorganism is exposed to sublethal doses of a chemical that
negatively influences bacterial growth or survival, it may respond to protect itself,
or adapt, to increase its tolerance to the same or different type of stress. A lipid
can act as a sensor of stress and cause a change in transcription or translation of
stress-related proteins, which alter cell physiology to increase tolerance to stress.
A change in fluidity or membrane structure can be detected and the cell may
respond with alterations in bacterial membrane composition (Yousef and
Courtney 2003).
Changes in bacterial lipids in the membrane are a defense mechanism
used to maintain optimal fluidity in the liquid-crystalline phase for important cell
processes. Membrane fluidity is the “combined expression of the effects of [fatty
acid] chain conformation, lateral and rotational diffusion [of the lipids within the
membrane] and the resistance of the membrane to sheer forces”(Denich and
others 2003). The fluidity of the membrane affects the growth of the cell and the
proper functioning and structural integrity of the membrane (Denich and others
2003). For example, the percentage of unsaturated fatty acids in E. coli
phospholipids is usually about 50%. This percentage can decrease to 30%
without ceasing bacterial growth. If the percentage of saturated fatty acids
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decreases to less than 15% the membrane permeability increases (Seltmann
and Holst 2002). Lipids directly affect passive permeability and indirectly
influence cell processes because of their interactions with membrane proteins
(Russell and others 1995).
To maintain optimal fluidity the cell may change the fatty acid and
phospholipid head-group composition which affect the lipid membrane melting
point (Keweloh and Heipieper 1996). As melting point decreases, fluidity
increases (Casadei and others 2002). For example, fatty acids with high melting
points, such as saturated, long, and straight-chain fatty acids, decrease
membrane fluidity (Juneja and Davidson 1993). A change in the fatty acid
composition to decrease the fluidity has been shown to be an adaptive response
to the compensate for the fluidizing effect of an essential oil component (Ultee
and others 2000). No studies about the adaptive response to CIN have been
published. The objectives of this study were to determine:
1) the effect of exposure to CIN on the fatty acid composition of the
bacterial membrane of Salmonella,
2) whether changes in the fatty acid composition of the bacterial
membrane of Salmonella occur due to growth in the presence of CIN as a
possible adaptive response to CIN, and
3) whether reversal of these changes in fatty acid composition occur when
the stressor, CIN, was removed.
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Materials and methods

Bacterial culture preparation
Salmonella Typhimurium DT104 ATCC BAA-186 was obtained from the
American Type Culture Collection (ATCC, Rockville, MD). Experimental cultures
were maintained on Tryptic Soy Agar slants. A loopful of culture was used to
inoculate 9 ml o f BHI with S. Typhimurium. The BHI tube was incubated for 24 h
at 35°C. Then a loopful was transferred into 9 ml BHI and incubated for 21 h at
35°C.
Essential oil component
Stocks solutions of CIN (Fisher Scientific, Fairlawn, NJ) were prepared in
ethanol, absolute (Aldrich, St. Louis, MO). Sterile water dissolved into ethanol
served as the control stock solution. Aliquots of CIN stock solution were added
into 8 ml brain heart infusion broth, modified (BHI, BBL, Sparks MD) with 2%
Tween 20 (Fisher Scientific, Fairlawn, NJ) with glass beads. The final
concentration of Tween was 1% and ethanol was 0.5% during adaptation and
treatment. Tween and glass beads were used to aid with dispersion of CIN in
BHI. All BHI was prepared with phosphate buffer (0.1M, pH 7.2 + 0.1) instead of
water to prevent pH changes, which could affect the fatty acid composition of
bacterial membranes. The pH of BHI was adjusted to 7.35 (+ 0.1) prior to
autoclaving, after which the final pH was pH 7.2 (+ 0.1). Glass tubes containing
the stock and BHI were shaken vigorously forty times to disperse the oil-based
components.
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Adaptation
In our study adaptation was defined as growth in sublethal concentrations
of CIN for 24h. One ml of the 21-h culture was serially diluted 10-3 with three
tubes of 9 ml BHI. This dilution was repeated with another set of BHI tubes. The
diluted cultures from the two tubes of the 10-3 dilution were combined in a large
tube. Five ml of the diluted culture were used to inoculate a 5-ml BHI tube
containing CIN and a 5-ml BHI tube containing 0.5% ethanol control. Both tubes
had 1% Tween.
The stock and 5-ml CIN dispersions in BHI were prepared the day before,
refrigerated, and allowed to warm to room temperature for 30 min before the 5-ml
diluted culture was added. This inoculation halved the concentrations and the
final inoculum was approximately log 5.7 CFU/ml. The final concentration of
Tween was 1% and ethanol was 0.5%. The two inoculated BHI tubes containing
CIN or ethanol control were vortexed a nd the cells were allowed to adapt to CIN
or ethanol (non-adapted) by incubating in a shaking waterbath at 125 rpm for 24
h at 35°C.
Extrapolating from dose-response curves, the concentration that would
achieve a 25% probability of lethality was used to adapt cells. This low
probability of lethality was chosen to induce changes in the membrane lipid
composition yet also allow enough growth for harvesting cells for lipid analysis.
This 25% probability of lethality corresponded to 251 mg/L CIN. After a 24-hour
growth in or adaptation to 251 mg/L CIN, adapted cells were inoculated into 200
ml BHI in bottles to treat adapted cells with 251 mg/L CIN for 2 and 24 hours.
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After inoculation, the desired inoculum in these experiments was about log 5.7
CFU/ml to adhere to the same inoculum size as in the adaptation procedure.
The population of cells resulting after 24-h adaptation was tested since
these cells would be used to inoculate the bottles. The population of cells
adapted to CIN was log 8.5 CFU/ml (average of three repetitions). The control
population exposed to 0.5% ethanol was log 8.8 CFU/ml (average).
Treatment of adapted cells
A total of twelve screw-capped glass bottles containing 190 ml BHI were
prepared for two and twenty-four hour exposures to CIN. Ten ml CIN dispersion
were added to six bottles for a final concentration of 251 mg/L. Salmonella
adapted to CIN would be added to two bottles. Salmonella “adapted”only to
ethanol would be added to two bottles. Two bottles would not be inocula ted and
were designated as sterile CIN controls since the BHI broth media contained fatty
acids. Ten ml of ethanol solution were added to six bottles (with no CIN).
Salmonella adapted to CIN would be added to two bottles. Salmonella exposed
only to etha nol (non-adapted) would be added to two bottles. Two bottles were
not to be inoculated and were designated as sterile ethanol controls since the
BHI broth media contained fatty acids from the manufacturer formulation. The
final concentrations would contain about 1% Tween and 0.5% ethanol, similar to
those used to adapt cells. These twelve bottles containing CIN or ethanol were
shaken and stored at 4°C until two hours before use, at which time they were
allowed to warm to 25°C. Before adding adapted Salmonella, bottles were
shaken. The treatments for 2 and 24h incubation were: Sterile controls: sterile +
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CIN, sterile + ethanol, treatments: non-adapted Salmonella + CIN, adapted
Salmonella + CIN, inoculated controls: non-adapted + ethanol, adapted +
ethanol.
Tubes containing adapted cells were vortexed prior to inoculating
Salmonella into the designated bottles. Based on the preliminary data of
adapted cell counts, 212 µl of cells adapted to CIN and 166 µl of cells “adapted”
to ethanol were added to designated bottles for a final inoculum size of about log
5.7 CFU/ml. The bottles were shaken and incubated in a shaking waterbath at
125 rpm for either two or twenty-four hours. After incubation the samples were
centrifuged on a large volume centrifuge (Beckman J2-HS, Schaumberg, IL) at
12,000 rpm for 30 minutes at 4°C. The pellet was transferred from the centrifuge
bottles to centrifuge tubes and washed three times with 0.1 M phosphate buffer
(pH 7.2) at 10,000 rpm for 10 minutes at 4°C using a table -top centrifuge (Baxter
Biofuge 17 R, VWR Scientific Products, West Chester, PA). The pellet was
suspended in less than 1.5 ml phosphate buffer in small ampoules, wrapped in
parafilm and foil and frozen at -30°C. The pellet was lyophilized and ampoules
were wrapped until extraction.
Lipid extraction
Lipid extraction and analysis procedures were developed by Dr. David C.
White’s lab, the University of TN Center for Biomarker Analysis. Lipids from 8-18
mg lyophilized cells were extracted using a modified Bligh/Dyer method (Guckert
and others 1985; Guckert and others 1986). The extraction solvent contained 4
ml phosphate buffer, 10 ml methanol, and 5 ml chloroform. After three hours the
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phases were split with 5 ml water and 5 ml chloroform and allowed to sit
overnight for layer separation. The lower chloroform layer was removed and
dried under nitrogen. The total lipid extract was suspended in chloroform and
separated into the lipid classes (neutral lipids, glycolipids, and polar lipids) with
silicic acid (500 mg) columns using three solvents of increasing polarity (5 ml
chloroform, 5 ml acetone, and 10 ml methanol) to elute the lipid classes from the
silicic acid stationary phase (Guckert and others 1985; Guckert and others 1986).
Analysis of fatty acid methyl esters
To prepare fatty acid methyl esters (FAME) in a mild alkaline methanolic
transesterification reaction, 0.5 ml chloroform, 0.5 ml methanol, and 1 ml of
methanolic KOH were added to the dried polar lipids and heated at 60°C for 30
minutes. To extract the FAME, 2 ml hexanes, 200 µl glacial acetic acid, and 2 ml
nanopure water was added. After centrifuging, the hexane layer was removed.
This was repeated twice. The FAME were dried under nitrogen and transferred
three times with 100 µl hexanes to autosampling vials.
The samples were diluted with hexanes containing a 21:0 internal
standard (50pmol/µl). The samples and a vial of GC-MIX (mixture of 20 FAME
standards) were analyzed on a HP6890 gas chromatograph (GC) coupled to a
HP5973 mass spectrophotometer (MS). The GC was equipped with a RJX1
fused silica capillary column (60m, 250µm internal diameter x 25 µm film
thickness, Restek, Bellefonte, PA). The column was programmed from an initial
temperature of 60°C for 2 min then raised at a rate of 10°C/min to 150°C. The
temperature was increased at 30°C/min to a final temperature of 312°C. The
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injector port temperature was 230°C in split-less mode. Helium was used as the
carrier gas at a flow rate of 1.41 ml/min. Fatty acids were identified by
comparison of retention times to the FAME standards and a mass spectral data
library. Fatty acids were quantified based on comparison to the 21:0 internal
standard and area under each sample peak and standard peak.
Statistical analysis
Box and whisker plots were generated with Statistica (StatsSoft, Inc.,
Tulsa, OK) to compare total phospholipid fatty acid (PLFA) and fatty acid
composition. The 2 and 24h data were divided and a randomized block design
with blocking on each of three replications was used to test the effect of
treatments or controls on total PLFA and fatty acids for 2h or 24h. Data were
analyzed using SAS (Statistical Analysis System, Cary, NC) to compare
differences in total PLFA and fatty acids between treatment and control groups
within 2h or 24h with alpha value at 0.05. The generalized linear model (GLM)
was used to test for differences in total PLFA and fatty acids between 2 and 24h
within each treatment or control group with a Bonferonni correction factor. This
correction minimized Type I error, which increases with the number of statistical
tests. The Bonferonni p value was calculated as the alpha value at 0.10 divided
by 6 (the number of follow-up tests conducted to test the interaction between the
6 treatments at 2h or 24h), which equals 0.017.
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Results

Total phospholipid fatty acid (PLFA)
Total phospholipid fatty acid (PLFA ) is the sum of all fatty acids that were
hydrolyzed from phospholipids in the membrane. The mean total PLFA is shown
in Table 3.1. Depicted in Figures 3.1 and 3.2 are box and whisker plots
representing the mean, standard error, and standard deviation of the total PLFA
of the sterile groups of Salmonella under each of the experimental treatments.
The boundaries of the box around the mean consist of the mean + standard
error. The standard error is the standard deviation of the sample mean and is
computed as the standard deviation divided by the square root of the sample
size. The horizontal bars represent the mean + standard deviation. The
standard deviation is the positive square root of the variance. The variance is the
sum of the squared deviations from the mean divided by the sample size minus
one.
An analysis was performed to determine if there was a correlation
between total PLFA and occurrence of specific fatty acids. It was found that
higher total PLFA was positively correlated to the presence of C15:0 (R2=0.81),
Cy17:0 (R2=0.91), C17:0 (R2=0.78), Cy19:0 (R2=0.85), ratio of Cy17:0 to
C16:1w7c (R2=0.82), and the ratio of Cy19:0 to C18:1w7c (R2=0.83). The
correlation of total PLFA to cyclopropyl fatty acids was expected because as cells
age and enter stationary phase, the cyclopropyl fatty acids increase (Guckert and
White 1988; Casadei and others 2002).
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Table 3.1. Comparison of total PLFA and fatty acid (FA) composition of CIN -adapted or non-adapted cells with or
without trans-cinnamaldehyde (CIN) to inoculated controls (+ EtOH) and sterile controls after 2h and 24h incubation.
Treatment/control
and incubation hr

Total
PLFA
(pmol/mg)

C12:0
(%)

C14:0
(%)

C15:0
(%)

C16:1w7c
(%)

C16:0
(%)

Cy17:0
(%)

C17:0
(%)

C18:1w9c
(%)

2h
Sterile + CIN

42.9 B

39.8 A

29.3 A

0.0

0.0 C

18.0 B

0.0 B

0.0

0.9

191.9 B

35.4 A

29.0 A

0.0

0.0 C

21.6 AB

0.0 B

0.0

1.2

1817.5 B

19.4 AB

16.6 BC

0.0

5.2 B

27.3 AB

2.5 A

0.0

1.9

635.2 B

22.1 AB

19.8 AB

0.0

2.5 BC

25.2 AB

1.1 ABZ

0.0 Z

2.3

Non-adapt + EtOH

7625.3 AZ

0.8 B

7.8 C

0.0 Z

25.7 AZ

29.5 AZ

2.3 ABZ

0.0 Z

0.5

Adapt + EtOH

3729.1 BZ

0.9 B

7.8 BC

0.0

25.8 AZ

29.7 ABZ

2.0 ABZ

0.0

0.4

741.6 B

46.5 A

27.2 A

0.0 B

0.0 C

16.7 D

0.0 C

0.0 C

1.3 B

2396.1 B

23.7 B

31.7 A

0.0 B

0.0 C

21.7 C

0.0 C

0.0 C

3.9 A

Non-adapt + CIN

41495.6 A

4.8 C

8.8 B

0.1 AB

14.6 AB

40.8 A

8.6 B

0.0 BC

0.3 B

Adapt + CIN

53991.8 A

0.2 C

5.9 B

0.1 AB

16.1 A

41.9 A

11.7 AB

0.1 AB

0.1 B

Non-adapt + EtOH

69791.6 A

0.3 C

7.7 B

0.2 A

13.7 B

36.7 B

16.0 A

0.1 AB

0.3 B

Adapt + EtOH

64520.6 A

0.2 C

7.4 B

0.1 AB

14.0 B

38.4 AB

15.3 A

0.0 BC

0.2 B

Sterile + EtOH
Non-adapt + CIN
Adapt + CIN

24h
Sterile + CIN
Sterile + EtOH

ABCD: Means in a column with different superscripts within 2h or 24h are different (p<0.05).
Z: Means in a column are different from 2h to 24h within a treatment or control group (Bonferroni p<0.017).
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Table 3.1. Continued.

Treatment/control C18:1w7c
and incubation hr
(%)

C18:1w7t
(%)

C18:0
(%)

Cy19:0
(%)

Sat. FA
(%)

Unsat.
FA (%)

Cy17 to
C16:1
ratio

Cy19 to
C18:1
ratio

SFA to
UFA
ratio

2-h
Sterile + CIN

0.6 C

0.2

11.2 A

0.0

98.3 A

1.7 C

0.0

0.0

18.1 AB

Sterile + EtOH

0.9 C

0.2

11.7 A

0.0

97.7 A

2.3 C

0.0

0.0

30.0 A

Non-adapt + CIN

17.4 ABC

0.4

9.3 A

0.0

72.5 B

27.4 B

0.5 A

0.0

4.9 BC

Adapt + CIN

13.7 BC

0.3

12.9 AZ

0.0

80.1 AB

19.9 BC

0.2 AB

0.0

8.7 BC

Non-adapt + EtOH

32.6 AZ

0.0

0.9 B

0.0 Z

38.9 CZ

61.1 AZ

0.1 BZ

0.0 Z

0.6 CZ

Adapt + EtOH

32.4 ABZ

0.0

1.0 B

0.0

39.4 CZ

60.6 AZ

0.1 BZ

0.0

0.7 CZ

24-h
Sterile + CIN

1.0 B

0.5 AB

6.9 B

0.0 C

97.2 A

2.8 C

0.0 B

0.0 B

17.1 A

Sterile + EtOH

1.5 B

0.7 A

16.7 A

0.0 C

93.8 A

6.2 C

0.0 B

0.0 B

15.4 A

Non-adapt + CIN

19.8 A

0.0 B

1.7 B

0.4 BC

56.2 B

43.8 B

0.6 AB

0.0 AB

1.4 B

Adapt + CIN

22.6 A

0.0 AB

0.4 B

0.9 AB

48.6 BC

51.4 AB

0.7 AB

0.0 AB

0.9 B

Non-adapt + EtOH

23.2 A

0.0 B

0.5 B

1.2 A

45.6 C

54.4 A

1.2 A

0.1 A

0.8 B

Adapt + EtOH

23.0 A

0.0 B

0.4 B

0.8 AB

46.6 BC

53.4 AB

1.1 A

0.0 AB

0.9 B

ABCD: Means in a column with different superscripts within 2h or 24h are different (p<0.05).
Z: Means in a column are different from 2h to 24h within a treatment or control group (Bonferroni p<0.017) .
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Figure 3.1. Comparison of total PLFA or biomass of CIN -adapted or
non-adapted cells with or without CIN to inoculated controls (+EtOH)
and sterile controls after 2 -hr incubation
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Figure 3.2. Comparison of total PLFA or biomass of CIN -adapted or
non-adapted cells with or without CIN to inoculated controls (+EtOH)
and sterile controls after 24-hr incubation
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Comparison of total PLFA and each fatty acid across sterile, treatment,
and control groups (refer to Table 3.1 for means).
Total PLFA. Mean total PLFA of treatment groups at 2h is shown in Table
3.1. Two outlying data points were eliminated. One 2h replicate of the adapted
control (+ ethanol or EtOH) had a total PLFA of 124.1 pmol/mg. One 24h
replicate of the adapted treatment (+ CIN) had a total PLFA of 228.1 pmol/mg.
These were eliminated because of their low total PLFA, which indicated very low
or no growth and their fatty acid compositions correlated highly with the sterile
groups. This replicate of the adapted treatment was likely to have been
completely inhibited by CIN since the concentrations used for adaptation and
treatment were the dosage at which 25% probability of lethality was predicted.
In the 2 -hr samples, the non-adapted Salmonella inoculated EtOH control
(no CIN) had the highest total PLFA (Figure 3.1 and Table 3.1). The total PLFA
of the non-adapted Salmonella inoculated EtOH control was highest because the
cells were not exposed to CIN and were able to grow more quickly than the other
groups even at 2 hours. The total PLFA of all other groups was lower and not
different from each other (p>0.05).
Although not significantly (p>0.05) higher, the adapted control appeared to
have more total PLFA than the non-adapted and adapted cells treated with CIN.
The bacteria in the adapted and non-adapted EtOH controls seemed to grow
faster because they were not inhibited by CIN. The sterile controls contained
very low total PLFA because they were not inoculated (Figures 3.1 and 3.2). The
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total PLFA found in uninoculated controls was due to the fatty acids present in
the culture medium from the manufacturer’s formulation of BHI.
At 24h of incubation the total PLFA of all inoculated groups was
significantly (p<0.05) higher than the sterile groups (Figure 3.2). Only the
adapted and non-adapted EtOH controls had a significantly (p<0.001 and
p<0.05, respectively) higher total PLFA at 24h compared to 2h (Table 3.1). The
adapted and non-adapted treatment groups had a trend of increasing total PLFA
over time, but this was not significantly different (p>0.05 and p>0.02,
respectively). The wide variability within the groups probably obscured the
significance of this increase.
C12:0 fatty acid. At 2h of incubation, the C12:0 fatty acid detected in the
sterile groups was from the culture medium (Figure 3.3). The sterile groups had
more C12:0 fatty acid than the non-adapted and adapted controls. This
difference indicates that even at 2h the bacteria in the controls were growing and
using C12:0, and therefore decreasing the relative percentage of C12:0. The
abundance of C12:0 in the non-adapted and adapted treatment groups did not
differ from each other and the sterile controls. The growth of bacterial cells in the
treatment groups was inhibited by CIN so lipid biosynthesis by the anaerobic
pathway was decelerated. They incorporated C12:0 from the medium but could
not oxidize and convert it to other fatty acids in the presence of CIN.
At 24h all four inoculated groups contained significantly (p<0.05) less
C12:0 than sterile groups (Figure 3.4). This reflects the difference in total PLFA
at 24h and utilization of C12:0. The bacteria in the inoculated groups had more
90
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Figure 3.3. Comparison of C12:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 3.4. Comparison of C12:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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time to grow and utilize 12:0. There were no significant (p>0.05) differences
among the inoculated groups because the bacteria in the treatment groups were
able to grow and convert 12:0 to another fatty acid.
However, the wider standard error of the non-adapted cells treated with
CIN implies that some Salmonella cells in a culture were less able to decrease
the proportion 12:0 than others because they were more inhibited due to CIN
exposure. This wider range of response indicates that a population of nonadapted cells can display a range of sensitivity to CIN and therefore a range in
the ability to grow and decrease the percentage of C12:0.
In contrast, the adapted cells group seem to be less inhibited than its nonadapted counterpart because they were able to decrease C12:0 percentage
more readily with a narrower range of error. The population of adapted cells
seems to demonstrate more similar sensitivity to CIN than non-adapted cells.
The groups did not have more C12:0 fatty acid at 24h compared to 2h.
C14:0 fatty acid. At 2 and 24h, the sterile groups had similar percentages
of C14:0 (Figures 3.5 and 3.6). Even at 2h the inoculated controls (+EtOH) were
able to grow and convert 14:0, which resulted in significantly (p<0.05) lower
C14:0 than the sterile groups. The level of C14:0 in the adapted and nonadapted cells treated with CIN was in between that of the sterile and inoculated
controls. The growth of bacterial cells in the treatment groups was inhibited by
CIN so lipid biosynthesis was decelerated. They incorporated C14:0 from the
medium but could not oxidize and convert it to other fatty acids as well as the
inoculated controls.
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Figure 3.5. Comparison of C14:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 3.6. Comparison of C14:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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At 24h the bacteria in all four inoculated groups grew and the proportion of
C14:0 was significantly (p<0.05) lower than the sterile groups (Figure 3.6). The
abundance of C14:0 did not differ significantly (p>0.05) among inoculated groups
because the bacteria in the treatment groups grew and were able to convert 14:0
to another fatty acid. As with C12:0 at 24h, the wider standard error indicates
that some non-adapted cells treated with CIN were not as able to lower the
percentage of C14:0 as quickly as the adapted cells treated with CIN and
inoculated controls since the cells were more inhibited by exposure to CIN. The
percentage of C14:0 did not differ from 2h to 24h for all groups.
C15:0 fatty acid. C15:0 was detected at very low percentages at 2h
(Figure 3.7). There were no significant (p<0.05) differences among the groups.
Only the non-adapted control had a significantly (p<0.) higher abundance C15:0
at 24h than at 2h (Table 3.1). At 24 hours the bacteria in the non-adapted control
produced significantly (p<0.05) more C15:0 than the very low level present in the
culture medium of the sterile controls (Figure 3.8). Among the inoculated groups
there were no significant (p>0.05) differences at 24h.
C16:1w7c fatty acid. At 2h the inoculated controls (+EtOH) were able to
produce more C16:1w7c than all the other groups since the bacteria were not
inhibited by CIN (Figure 3.9). The non-adapted and adapted treatment groups
were still inhibited by C IN at 2h and not able to produce as much C16:1w7c. At
24h, the levels of C16:1w7c produced by bacteria in the four inoculated groups
was greater (p<0.05) than the low amount present in the culture medium of the
sterile controls (Figure 3.10). C16:1w7c in the adapted cells treated with CIN
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Figure 3.7. Comparison of C15:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 3.8. Comparison of C15:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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Figure 3.9. Comparison of C16:1w7c fatty acid of CIN -adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation

C16:1w7c Fatty acid (relative %)

18

14

10

6

2
盨td. Dev.
盨td. Err.

-2
Sterile
+CIN

Sterile Nonadapt
+EtOH
+CIN

Adapt Nonadapt Adapt
+CIN
+EtOH
+EtOH

Mean

Treatment

Figure 3.10. Comparison of C16:1w7c fatty acid of CIN -adapted or
non-adapted cells with or without CIN to inoculated controls (+EtOH)
and sterile controls after 24-hr incubation
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were higher than in the inoculated controls. Only the adapted and non-adapted
controls significantly (p<0.0001 and p<0.0005) decreased C16:1w7c from 2h to
24h (Table 3.1). In contrast, there was a trend of increased C16:1w7c at 24h
produced by the two treatment groups exposed to CIN, but this was not
significant (p>0.04 and p>0.02, respectively).
C16:0 fatty acid. At 2h there was a broad range of converting C16:0 in the
non-adapted and adapted cells treated with CIN (Figure 3.11). The broad range
reflected the different CIN sensitivities of cells in the population. In contrast, the
inoculated controls had a narrower range. Overall, the sterile groups did not
differ from inoculated groups in percentage of C16:0.
At 24h, the percentage of C16:0 in the inoculated groups was significantly
(p<0.05) higher than the sterile groups (Figure 3.12). The non-adapted and
adapted cells treated with CIN produced more C16:0 than the non-adapted
control. Only the non-adapted and adapted controls produced more C16:0 at
24h than at 2h (p<0.001 and p<0.01, respectively) (Table 3.1). The non-adapted
treatment group seemed to synthesize more C16:0 at 24h, but this was not
significant (p>0.04), and perhaps obscured by variation within the group.
Cy17:0 fatty acid. The percentage of Cy17:0 did not differ among the four
inoculated groups at 2h (Figure 3.13). The non-adapted cells treated with CIN
had a significantly (p<0.05) higher percentage of Cy17:0 than the steriles. Again,
there is a wide range of response from the non-adapted cells treated with CIN.
At 24h Cy17:0 was more abundant in the control than in the sterile groups
and non-adapted treatment group, which was inhibited by CIN (Figure 3.14).
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Figure 3.11. Comparison of C16:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 3.12. Comparison of C16:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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Figure 3.13. Comparison of Cy17:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 3.14. Comparison of Cy17:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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This indicated that the controls reached stationary phase sooner since they were
not inhibited. The adapted cells treated with CIN did not differ from the nonadapted treated cells and the controls. The adapted treatment and control
groups formed significantly (p<0.05 and p<0.005, respectively) more Cy17:0 at
24h than at 2h (Table 3.1).
C17:0 fatty acid. At 2h, there were no differences (p>0.05) in C17:0
among all the groups (Figure 3.15). The pattern of wider standard errors in the
non-adapted treatment group and adapted control group resembled that of C15:0
at 2h. At 24h the non-adapted control produced more C17:0 than the sterile
groups, adapted control, and non-adapted cells treated with CIN (Figure 3.16).
Compared to 2h, C17:0 was significantly more abundant in the adapted
treatment and non-adapted control groups at 24h (p<0.0005 and p<0.005,
respectively) (Table 3.1).
C18:1w9c fatty acid. The percentages of C18:1w9c among all six groups
were not significantly (p>0.05) different at 2h (Figure 3.17). The four inoculated
groups did not differ from the sterile + CIN group in this fatty acid at 24h (Figure
3.18). The sterile + EtOH group had more C18:1w9c than all other groups. The
abundance of this fatty acid did not differ from 2h to 24h within each group,
except for a slight, but insignificant (p>0.02) decrease in the adapted cells treated
with CIN.
C18:1w7c fatty acid. The non-adapted control had higher (p<0.05) levels
of C18:1w7c than the sterile groups at 2 and 24h (Figures 3.19 and 3.20). This
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Figure 3.15. Comparison of C17:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 3.16. Comparison of C17:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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Figure 3.17. Comparison of C18:1w9c fatty acid of CIN -adapted or
non-adapted cells with or without CIN to inoculated controls (+EtOH)
and sterile controls after 2 -hr incubation
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Figure 3.18. Comparison of C18:1w9c fatty acid of CIN -adapted or
non-adapted cells with or without CIN to inoculated controls (+EtOH)
and sterile controls after 24-hr incubation
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Figure 3.19. Comparison of C18:1w7c fatty acid of CIN -adapted or
non-adapted cells with or without CIN to inoculated controls (+EtOH)
and sterile controls after 2 -hr incubation
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Figure 3.20. Comparison of C18:1w7c fatty acid of CIN -adapted or
non-adapted cells with or without CIN to inoculated controls (+EtOH)
and sterile controls after 24-hr incubation
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fatty acid was not detected in the medium. As seen with other fatty acids, there
was a wide standard error of C18:1w7c produced in the non-adapted and
adapted cells treated with CIN, which reflected the range of sensitivity of cells to
CIN. At 24h, these cells were able to grow and synthesize at proportions similar
to the control groups because the percentage of C18:1w7c was not different
(Figure 3.20). All four inoculated groups produced more of this fatty acid than the
sterile groups. Compared across time, only the controls significantly (p<0.02)
decreased C18:1w7c from 2h to 24h (Table 3.1).
C18:1w7t fatty acid. The abundance of C18:1w7t at 2h did not differ
among the groups (Figure 3.21). It was only present in the sterile groups at 2
and 24h and i n the treatment groups at 2h, but depleted at 24h. It was only
present in the treatment groups because the bacteria were inhibited by CIN and
had not yet metabolized it. There were no significant changes in C18:1w7t from
2h to 24h and no differences among groups at 24h (Figure 3.22).
C18:0 fatty acid. At 2h, the non-adapted and adapted controls lowered
the proportion of C18:0 because they were able to grow (Figure 3.23). The nonadapted and adapted cells treated with CIN had percentages of C18:0 similar to
those of the sterile groups. They had incorporated C18:0 from the medium. The
growth of bacterial cells in the treatment groups was inhibited by CIN so lipid
biosynthesis was decelerated. They incorporated C18:0 from the medium but
could not oxidize and convert it to other fatty acids as well as the inoculated
controls, but this changed at 24h (Figure 3.24).
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Figure 3.21. Comparison of C18:1w7t fatty acid of CIN-adapted or
non-adapted cells with or without CIN to inoculated controls (+EtOH)
and sterile controls after 2 -hr incubation
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Figure 3.22. Comparison of C18:1w7t fatty acid of CIN-adapted or
non-adapted cells with or without CIN to inoculated controls (+EtOH)
and sterile controls after 24-hr incubation
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Figure 3.23. Comparison of C18:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 3.24. Comparison of C18:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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At 24h, as the cells grew in the non-adapted and adapted treatment
groups, they were able to convert C18:0 to another fatty acid and therefore
decrease the percentage of C18:0 (Figure 3.24). The percentage of C18:0
significantly (p<0.005) decreased from 2h to 24h in adapted cells treated with
CIN (Table 3.1). Therefore, the abundance of C18:0 did not differ among the
inoculated groups. There was a pattern of decreased fatty acid over time in the
non-adapted control, but this was not significant.
Cy19:0 fatty acid. Cy19:0 was not detected in any group at 2h (Figure
3.25). However, at 24h the non-adapted control had formed more Cy19:0 than
the non-adapted treatment because it reached stationary phase sooner (Figure
3.26). Since the treatment group had a longer lag phase it did not produce as
much Cy19:0. There were no differences among the treatment groups and the
adapted control at 24h. The non-adapted control formed significantly (p<0.01)
more Cy19:0 at 24h than at 2h (Table 3.1). The same trend occurred with the
adapted treatment group, but this was not significant.
Saturated fatty acids. At 2h, the control groups had less SFA than the
other groups (Figure 3.27). At 24h, the treatment groups were able to decrease
the percentage of SFA to similar levels as the controls (Figure 3.28). These fatty
acids were highest in the sterile groups. There was wide variation in the nonadapted treatment group and more SFA than in the non-adapted control. From
2h to 24h, the controls significantly (p<0.02) produced more SFA (Table 3.1).
Monounsaturated fatty acids. The controls synthesized more UFA than
the other groups at 2h (Figure 3.29). At 24h (Figure 3.30) the treatment groups
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Figure 3.25. Comparison of Cy19:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 3.26. Comparison of Cy19:0 fatty acid of CIN-adapted or nonadapted cells with or without CIN to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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Figure 3.27. Comparison of saturated fatty acids of CIN-adapted or
non-adapted cells with or without CIN to inoculated controls (+EtOH)
and sterile controls after 2 -hr incubation
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Figure 3.28. Comparison of saturated fatty acids of CIN-adapted or
non-adapted cells with or without CIN to inoculated controls (+EtOH)
and sterile controls after 24-hr incubation
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Figure 3.29. Comparison of monounsaturated fatty acids of CINadapted or non-adapted cells with or without CIN to inoculated controls
(+EtOH) and sterile controls after 2-hr incubation
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Figure 3.30. Comparison of monounsaturated fatty acids of CINadapted or non-adapted cells with or without CIN to inoculated controls
(+EtOH) and sterile controls after 24-hr incubation
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produced more UFA to levels similar to the controls. These fatty acids were
higher in the non-adapted control than in the non-adapted treatment. The
controls significantly (p<0.02) decreased UFA from 2h to 24h (Table 3.1).
Ratio of Cy17:0 to C16:1w7c. C16:1w7c is the precursor to Cy17:0.
There were no values for this ratio in the sterile groups because no Cy17:0 was
present in the culture medium nor bacterial cells to form it (Figures 3.31 and
3.32). The ratio did not differ between the treatments groups or between the
control groups at 2h. The non-adapted treatment group had a higher ratio than
the control groups. At 24h, there were no differences among the inoculated
groups, although the ratio appears to be higher in the control groups, suggesting
earlier entry into the stationary phase (Figure 3.32). From 2h to 24h, the ratio
increased significantly (p<0.01) for the control groups (Table 3.1). The ratio
increases in the treatment groups were not significant, but probably obscured by
the wide variation at 2h.
Ratio of Cy19:0 to C18:1w7c. C18:1w7c is the precursor to Cy19:0. The
ratios of Cy19:0 to C18:1w7c were zero at 2h since no Cy19:0 was detected
(Figure 3.33). At 24h, the ratios were not different among the inoculated groups
(Figure 3.34). The ratio increased from 2 to 24h for the non-adapted control
group only (p<0.02) (Table 3.1). There were slight increases in the adapted
treatment and adapted control groups, but these were not significant.
Ratio of saturated to unsaturated fatty acids. At 2 and 24h, the sterile
groups had a higher ratio because of the medium (Figures 3.35 and 3.36). It
seemed that that these ratios were varied more in treatment groups. This
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Figure 3.31. Comparison of ratio of Cy17:0 to 16:1w7c fatty acid of
CIN-adapted or non-adapted cells with or without CIN to inoculated
controls (+EtOH) and sterile controls after 2 -hr incubation
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Figure 3.32. Comparison of ratio of Cy17:0 to 16:1w7c fatty acid of
CIN-adapted or non-adapted cells with or without CIN to inoculated
controls (+EtOH) and sterile controls after 24-hr incubation
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Figure 3.33. Comparison of ratio of Cy19:0 to 18:1w7c fatty acid of
CIN-adapted or non-adapted cells with or without CIN to inoculated
controls (+EtOH) and sterile controls after 2 -hr incubation
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Figure 3.34. Comparison of ratio of Cy19:0 to 18:1w7c fatty acid of
CIN-adapted or non-adapted cells with or without CIN to inoculated
controls (+EtOH) and sterile controls after 24-hr incubation
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Figure 3.35. Comparison of ratio of saturated to unsaturated fatty
acids of CIN -adapted or non-adapted cells with or without CIN to
inoculated controls (+EtOH) and sterile controls after 2-hr incubation
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Figure 3.36. Comparison of ratio of saturated to unsaturated fatty
acids of CIN -adapted or non-adapted cells with or without CIN to
inoculated controls (+EtOH) and sterile controls after 24-hr incubation
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indicated that the groups were more inhibited by CIN and the cells differed in
their sensitivity to CIN. Their ratios were numerically greater than in the controls.
They were less able to decrease the ratio of SFA to UFA than the controls
because they were inhibited. However, the ratios of the four inoculated groups
did not differ significantly (p>0.05) from each other.
At 24h, all four inoculated groups had lower ratios than the sterile groups
(Figure 3.36). From 2h to 24h, the ratio increased significantly (p<0.02) only in
the controls (Table 3.1). Numerically, it seemed that the ratio decreased for the
treatment groups. However, this was not significant (p>0.1) and the difference
may have been obscured by the variability at 2h.

Discussion

Anaerobes, facultative anaerobes, and also some aerobic bacteria
synthesize lipids via the anaerobic pathway, which has been studied in E. coli.
The starting reactants are acetyl-CoA and 3 malonyl-ACP. A trans double bond
is produced during elongation. From that point, it can be reduced to form a
saturated fatty acid or isomerized into a cis-monoenoic fatty acid. This cis fatty
acid cannot be reduced and remain unchanged with further elongation. These
saturated and cis-unsaturated chains are incorporated into phospholipids of the
membrane. Since the degree of saturation cannot change after synthesis, the
ratio of SFA to UFA cannot be changed in cells that cease growth. Phospholipid
biosynthesis quickly decelerates if growth stops. However, post-synthesis
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modification of cis-monoenoic fatty acids to their cyclopropyl derivatives and
trans-isomers can still occur (Diefenbach and others 1992; Keweloh and
Heipieper 1996).
The uptake of fatty acids from the culture medium can occur by acyl-chain
unspecific or active or passive transport. They are oxidized or incorporated in
membrane lipids, which is regulated. Biosynthesis is regulated as well
(Diefenbach and others 1992; Keweloh and Heipieper 1996).
Membrane fluidity has been correlated with changes in fatty acid
composition (Mazzotta and Montville 1997). Certain types of lipid may have a
greater influence on the fluidity than other. For example, converting a cismonoenoic acid to its trans -isomer greatly reduces fluidity, but not as significant
as a change in cis to saturated fatty acids (Keweloh and Heipieper 1996).
The melting points of unsaturated fatty acid (UFA) and branched chain
fatty acids are lower than that of saturated fatty acids (SFA). There are
hydrophobic interactions among acyl chains of SFA. In membranes rich with
SFA the membrane is packed and rigid. The chain can extend at its maximum if
the saturated chain rotates into a trans -conformation (Keweloh and Heipieper
1996).
In contrast, the double bond in cis-UFA creates a 30°angle in the acyl
chain. This kink disrupts the ordered packing of the acyl chains in the membrane
(Keweloh and Heipieper 1996). Therefore, an increase in UFA causes a
decrease in the temperature for the transition from the gel to the liquid-crystal
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membrane phase and an increase in fluidity (Keweloh and Heipieper 1996;
Casadei and others 2002).
A shortening in the acyl chain length will also lower the melting
temperature and increase fluidity. A change in the degree of saturation is
thought to be more effective than a change in the chain length (Keweloh and
others 1991). Cyclopropyl fatty acids (CFA) are more physically similar to cismonoenoic fatty acids, which are precursors of CFA. Trans-fatty acids are more
stable and resemble SFA (Guckert and others 1986). Trans -UFA acyl chains are
long and extended, packing more rigidly and occupying lower molar volume in
the membrane to significantly increase the phase transition temperature
(Diefenbach and others 1992; Keweloh and Heipieper 1996).
The ratio of UFA to SFA indicates membrane fluidity. Casadei and
colleagues (2002) developed a fluidity index that was calculated as the ratio of
UFA plus cyclopropane fatty acids (CFA) in stationary phase to SFA. They
extracted phospholipids from E. coli grown at different temperatures and
measured the phase transition temperatures by DSC.
Casadei and colleagues (2002) confirmed the validity of the fluidity index
as an indicator of membrane fluidity. They found that there was a direct linear
relationship between the phase transition temperature and growth temperature
and then an inverse linear relationship between the phase transition temperature
and the fluidity index of phospholipids. The proportion of SFA increased while
the proportion of UFA decreased with increasing growth temperature in
stationary and exponential phase cells. The fluidity index was slightly greater in
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exponential than stationary phase cells. They reported that the abundance of
CFA increased and C18:1 and C16:1 decreased in stationary phase cells. Since
most of the treatment groups in this present data contained mostly SFA, a ratio
was calculated of SFA to UFA plus CFA.
The measurement of the ester-linked phospholipid fatty acids (PLFA) is
useful. The PLFA content quantitatively indicates the viable biomass since they
have a high turnover rate and are present in consistent abundance in cell
membranes. When cells die or lyse, hydrolysis of phospholipids quickly occur
and the polar head group and diglyceride remain (White and Ringelberg 1997).
In addition to providing an estimate of the viable biomass, PLFAs can
indicate nutritional and physiological status using the ratio of trans -monoenoic
fatty acids to their cis homologues and the ratio of cyclopropyl derivatives to their
monoenoic fatty acid precursors (White and Ringelberg 1997). During starvation
of cultures of Vibrio cholerae, the trans/cis ratio increased. The cis-monoenoic
fatty acids (such as 16:1w7c and 18:1w7c) decreased and the SFA, CFA, and
trans-monoenoic fatty acids increased. During starvation, membrane fluidity
decreased overall (Guckert and others 1986).
When loss of phospholipid occurred during starvation, cis-monoenoic
acids were preferentially utilized to possibly enhance survival. Cis fatty acids
have faster turnover than saturated fatty acids and are more easily metabolized.
During starvation, bacteria may synthesize trans-monoenoic acids, which
bacteria do not readily metabolize, or transmethylate unstable cis- monoenoic
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fatty acids to form their cyclopropyl derivatives to survive (Guckert and others
1986).
It has been suggested that CFA are more stable to turnover and
degradation (Guckert and others 1986). CFAs were formed (with a decline in
their cis-fatty acid precursors) in Vibrio cholerae and Pseudomonas putida as
cells aged and entered the stationary phase (Guckert and others 1986;
Diefenbach and others 1992; Loffeld and Keweloh 1996). It has been
hypothesized that CFA are formed under stress when growth stops (Guckert and
others 1986).
The objectives in our study were to:
1) Determine the effect of exposure to CIN on the fatty acid composition of
the bacterial membrane of Salmonella.
At 2h the non-adapted treatment group had significantly (p<0.05) lower
total PLFA and lower (p<0.05) C16:1w7c than the non-adapted control (+ EtOH),
which contributed to lower (p<0.05) UFA and a higher (p<0.05) Cy17:0 to
C16:1w7c ratio. C18:0 was also higher (p<0.05), which increased the
abundance of the saturated fatty acids. CIN decreased the fluidity of the
membrane within 2h of exposure and inhibited growth. At 2h, the non-adapted +
CIN group had a numerically higher SFA to UFA ratio than the non-adapted +
EtOH group, which also suggested that CIN decreased fluidity. However, this
difference lessened at 24h.
At 24h the non-adapted treatment group had significantly (p<0.05) higher
C16:0, but lower Cy17:0 and Cy19:0 than the non-adapted control. Similar to
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results at 2h, CIN decreased the fluidity. SFA was significantly (p<0.05) higher
and UFA was significantly (p<0.05) lower in the non-adapted treatment group
than in the non-adapted control. The total PLFA of the non-adapted treatment
group was lower than the control group, which indicated lower lipid biosynthesis
and growth. The non-adapted treatment group had a numerically higher SFA to
UFA ratio than the non-adapted control group, which indicated that long -term CIN
exposure reduced fluidity.
2) Determine whe ther changes in the fatty acid composition of the
bacterial membrane of Salmonella occur due to growth in the presence of CIN as
a possible adaptive response to CIN.
At 2h and 24h there were no significant (p>0.02) differences in the total
PLFA or fatty acids between the treatment groups as a function of the incubation
time (Table 3.1). However, at 2h the SFA to UFA ratio of the adapted treatment
group was numerically higher than that of non-adapted group. This suggested
that adaptation decreased membrane fluidity.
At 24h, the SFA to UFA ratio was smaller in the adapted than non-adapted
group, perhaps because the numeric increase in C16:1w7c in the adapted
treatment was more drastic than in the non-adapted group. At 24h the difference
in the SFA to UFA ratio between the groups is considerably smaller, perhaps
because the 24h growth allowed adaptation of the non-adapted treatment group,
which allowed it to synthesize lipid similarly to the adapted treatment group.
3) Determine whether reversal of these changes in fatty acid composition
occurs when the stressor, CIN, is removed.
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At 2h and 24h there were no significant (p>0.05) differences in the fatty
acids between the groups. Even the SFA to UFA ratios were similar. This
indicated that any changes during adaptation (in the absence of subsequent
exposure) were not maintained. At 24h, the total PLFA of the non-adapted
control was numerically higher than that of the adapted control, which may
indicate that the initial adaptation caused some growth inhibition.
4) Determine whether any adaptive changes in the fatty acid composition
are maintained after subsequent exposure to the CIN.
At 2h the adapted treatment group had less C16:1w7c than the adapted
control, which decreased the overall UFA, and more C18:0 which increased the
abundance of SFA. The SFA to UFA ratio in the adapted treatment was also
numerically greater. CIN adaptation and subsequent exposure decreased the
fluidity within 2h, and also inhibited growth as shown in the numerically lower
total PLFA.
At 24h the only significant (p<0.05) difference was that the adapted
treatment group produced more C16:1w7c. The adapted treatment group had a
numerically higher SFA to UFA ratio than the adapted control at 24h, but not as
higher as it was at 2h. Therefore, at 24h the membrane was less fluid in the
adapted control.
Adaptation, in terms of decreased fluidity, seems to have been maintained with
subsequent exposure for 2 and 24h.
5) Determine the effect of growth in the presence of CIN (adaptation) and
subsequent CIN treatment on affect fatty acid composition.
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Overall, most of the changes were in the longer chain fatty acids than in
the shorter chain fatty acids such as C12:0, 14:0, and 15:0. At 2h compared to
the non-adapted control, the adapted treatment group had lower total PLFA,
C16:1w7c, C18:1w7c, and monounsaturated fatty acids and higher C14:0, C18:0,
and SFA. Therefore, with adaptation and subsequent exposure, CIN caused a
decrease in fluidity. At 24h, the group had higher C16:1w7c and C16:0 than the
non-adapted control. The SFA to UFA ratio of the adapted treatment was much
greater than the control at 2h, but that magnitude of difference declined at 24h.
It appears that in both treatment groups the membrane became more fluid
and in the control groups less fluid with time. At 24h differences between the
treatments and controls had decreased compared to 2h in terms of the SFA to
UFA ratio. With only 2h of exposure to CIN, both treatment groups synthesized a
numerically higher proportion of SFA (compared to the non-adapted control) in
response to CIN. Perhaps this response to 2h incubation was more similar to an
adaptation. The length of time needed for an adaptation to develop to CIN is not
known.
Significant (p<0.02) changes from 2h to 24h occurred mostly with the
control groups and occasionally with the adapted treatment group. However,
significant differences may not have been detected due to variability within these
treatment groups. At 2h, the proportions of C12:0, C14:0 and C18:0 of the
treatment groups were more similar to that sterile controls or in between that of
the sterile controls and inoculated controls. It is hypothesized that the bacteria of
the treatment groups had incorporated these fatty acids from the medium but
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were not able to convert them to other fatty acids because growth was inhibited
by CIN treatment. With time, the non-adapted treatment overcame the inhibition
and was able to grow and synthesize phospholipids (as evidenced by the
numerical increase in total PLFA and decrease in these fatty acids) for a more
favorable proportion of SFA to UFA ratio that is closer to homeostasis such as in
the non-adapted + EtOH group.
The concentration of membrane fatty acids in the controls was expected to
increase in the SFA to UFA ratio because C16:1w7c and C18:1w7c typically
decline and CFA increase in stationary phase (Casadei and others 2002). These
significant (p<0.02) changes occurred in the controls from 2 to 24h. Over time,
SFA increased in the controls, which was a sign of starvation, along with the
decrease in C16:1w7c and C18:1w7c and increase in CFA (Guckert and others
1986). The treatments did not seem to have entered stationary phase over time
because there were numerical increases in C16:1w7c and C18:1w7c. However,
there was also a significant increase of Cy17:0 in the adapted treatment and a
numerical increase in the non-adapted treatment as well as numeric increases in
Cy19:0.
Since lipophilic compounds accumulate a nd act on the membrane, it was
expected that membranes would respond to CIN, which is a lipophilic, aromatic
aldehyde. Carvacrol, which is a lipophilic and phenolic essential oil component,
was found to expand the liposomal membrane using fluorescent probes. This
suggested an increased fluidity (Ultee and others 2002). If the membranes
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become too fluid, additional carvacrol can continue to permeate the membrane,
accumulate, and cause more damage (Ultee and others 1998).
It is believed that this swelling leads to a destabilized membrane and
therefore a leakage of ions (Ultee and others 2002). During exposure to
carvacrol (CRV), an influx of protons and efflux of potassium ions in Bacillus
cereus was reported (Ultee and others 1999). This leakage was also evident in
the decrease of the pH gradient across the membrane (Ultee and others 2002).
The leakage of ions leads to a drop in the membrane potential and depletion of
the intracellular ATP pool (Ultee and others 2002). It was found that 300 mg/L of
CRV reduced viable count of Bacillus cereus cells in 30 min and depleted
intracellular ATP within 7 min without a proportional increase in extracellular ATP
(Ultee and others 1999).
There was no literature that has determined the precise mechanism of
action of CIN. Helander and others (1998), who reported that carvacrol at 300
mg/L (MIC = 451 mg/L) increased the uptake of hydrophobic fluorescent probe
NPN in E. coli O157:H7 and S. Typhimurium and decreased intracellular ATP in
E. coli O157:H7, but with a smaller increase in extracellular ATP. Uptake of NPN
occurred because the outer membrane was no longer acting as a strong
permeability barrier. These effects indicated that CRV disrupted the outer
membrane. In contrast, it was suggested that CIN did not disrupt the outer
membrane of E. coli O157:H7 and S. Typhimurium because at 264 mg/L it did
not increase the uptake of NPN or influence intra- or extracellular ATP pools of
(Helander and others 1998).
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No literature has been published that has investigated the adaptation to
CIN. There was a study that examined the adaptive response of Bacillus cereus
to CRV (Ultee and others 2000). They reported that after CRV was added to
exponentially growing, non-adapted cells there was a decrease in the melting
temperature (Tm) of the membrane (20.5°C to 12.6°C). This disagreed with the
finding in this present study that exposure to CIN decreased membrane fluidity
as reflected by the higher SFA to UFA ratio. Ultee and others (2000) reported
that compared to non-adapted cells, cells adapted to 60 mg/L exhibited a less
fluid membrane because the Tm increased from 20.5°C to 28.3°C. Iso-C13:0 ,
C14:0 and iso-C15:0 fatty acids (which are higher melting) increased in the
membrane lipid composition of B. cereus cells incubated with 60 mg/L carvacrol.
Similarly, this study found a higher SFA to UFA ratio with adaptation, which
indicated decreased fluidity.
Greater saturation found with adaptation to phenol was suggested to
result in a more rigid membrane that compensated for an increase in fluidity and
permeability caused by phenol. Saturated fatty acids have acyl chains that are
packed more closely, which could limit the entry of phenol and therefore, its toxic
effect (Keweloh and others 1991). In the same way, the increase of saturation
upon exposure and adaptation to CIN could reduce its accessibility into or its
impact on the cell.
CIN did not disrupt the outer membrane because it did not increase the
uptake of a hydrophobic probe or affect ATP pools according to Helander and
others (1998). Therefore, it is reasonable that an increase in fluidity upon
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exposure or adaptation was not observed in this present study. It appears that
the mechanism of action of CIN is not an increase in permeability. Its
mechanism is unlikely to be related to an interaction with acyl chains as with
CRV. The carbonyl group of aldehydes can bind to metal ions, sulfhydryl groups,
amino acids, and proteins (Bowles and Miller 1993). CIN was found to be an
effective inhibitor of histidine decarboxylase activity of Enterobacter aerogenes
and its carbonyl group was suggested as the functional group (Wendakoon and
Sakaguchi 1995).

Significant findings

After 2h of exposure to CIN, the non-adapted treatment group had
significantly (p<0.05) lower total phospholipid fatty acid (PLFA), lower C16:1w7c
and unsaturated fatty acid (UFA) and higher (p<0.05) C18:0, saturated fatty acid
(SFA), and Cy17:0/C16:1w7c ratio than the non-adapted control. After 24h of
exposure to CIN, the non-adapted treatment group had significantly (p<0.05)
lower Cy17:0, Cy19:0, and UFA than the non-adapted control and higher
(p<0.05) C16:0 and SFA. At 2h, the SFA/UFA ratio in the membranes of adapted
cells exposed to CIN was numerically higher than in the non-adapted cells
treated with CIN. Although there were no significant differences in fatty acids as
a function of incubation time, at 24h the SFA /UFA ratios of the adapted and nonadapted Salmonella were similar. Since the fatty acid composition and total
PLFA of the non-adapted control and adapted controls were similar at 2 and 24h,
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the adaptive response had been reversed since the stressor, CIN, was not used
to treat the adapted controls.
Most of the changes from 2 to 24h occurred in the membrane of the nonadapted and adapted control Salmonella. Over time there was a decrease
(p<0.01) in C16:1w7c, C18:1w7c, and UFA and an increase (p<0.01) in total
PLFA, C16:0, Cy17:0, SFA, Cy17:0/ C16:1w7c ratio, and SFA/UFA ratio in the
control groups. In the adapted and non-adapted treated Salmonella there was a
numerical decrease in SFA/UFA ratio from 2 to 24h
Since fatty acid composition is one of the factors that affect membrane
fluidity it appears that short- and long-term treatment with CIN at sub-lethal
concentrations decreased the fluidity of the Salmonella membrane by
significantly increasing the proportion of saturated fatty acids. This decreased
fluidity may prevent additional CIN from permeating. The effect of bacterial
growth in the presence of CIN on the fatty acid composition was much smaller.
Determination of any changes in the phospholipid head groups would be useful
because of their affect on fluidity. Measurement of the membrane transition
temperature from gel-to-liquid-crystalline phase by Fourier-transformed infrared
spectrometry would indicate the interaction between their acyl chains and
therefore fluidity. A nuclear magnetic resonance spectrometer or a LangmuirBlodgett trough can also measure fluidity. Investigation about the target site that
CIN acts upon and the specific interactions of CIN with membrane lipids and
proteins using differential scanning calorimetry would contribute to the
understanding of its mechanism of action and the bacterial response.
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PART 4. CHANGES IN FATTY ACID COMPOSITION ASSOCIATED WITH
EXPOSURE AND ADAPTATION TO CARVACROL
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Abstract

Carvacrol (CRV) is a component found in the essential oil fraction of
oregano oil and is inhibitory to various pathogens. The objective of this study
was to evaluate changes in bacterial membrane composition by observing
changes in total phospholipid fatty acid (PLFA) and fatty acid composition
associated with exposure and adaptation to CRV. Salmonella Typhimurium
DT104 cells were grown for 24h at 35°C with or without 871 mg/L CRV in 9-ml ml
brain heart infusion broth. Log 5.7 CFU/ml of S. Typhimurium was inoculated
into 200ml broth containing 871 mg/L CRV. At 2h and 24h, samples were
centrifuged, washed, lyophilized, and e xtracted for lipids. Fatty acid methyl
esters prepared from phospholipids were quantified by GC-MS. Compared to the
non-adapted Salmonella at 2h, the non-adapted treatment had lower (p<0.05)
C16:1w7c, Cy17:0, C18:1w7c, and unsaturated fatty acid (UFA) and higher
(p<0.05) C14:0, C18:1w9c, C18:0, saturated fatty acid (SFA), and SFA/UFA
ratio. At 24h, the non-adapted treatment had lower (p<0.05) total phospholipid
fatty acid (PLFA), lower (p<0.05) Cy17:0, C17:0, C18:1w7c, and UFA than the
non-adapted control and higher (p<0.05) C16:1w7c and SFA. At 2h there were
no significant differences between the fatty acid compositions of adapted
Salmonella treated with CRV and non-adapted cells treated with CRV. At 24h,
the adapted cells treated with CRV had lower (p<0.05) C16:1w7c and UFA and
higher (p<0.05) SFA than non-adapted cells treated with CRV. The SFA/UFA
ratio was numerically higher in the adapted Salmonella than the non-adapted
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cells at 24h. Since the fatty acid composition and total PLFA of the non-adapted
control and adapted controls were similar, the adaptive response had been
reversed since the stressor, CRV, was not used to treat the adapted controls. It
appears that CRV treatment at sub -lethal concentrations decreased the fluidity of
the Salmonella membrane by increasing SFA. This decreased fluidity may
prevent additional CRV from permeating. The effect of bacterial growth in the
presence of CRV on the fatty acid composition was much smaller. Measurement
of the membrane transition temperature from gel-to-liquid-crystalline phase would
indicate fluidity. Investigation about the target site that CRV acts upon and the
interactions of CRV with membrane lipids and proteins would contribute to the
understanding of its mechanism of action and the bacterial response.

Introduction

Consumers desire high-quality, minimally processed foods that have fewer
preservatives and an extended shelf-life (Brul and Coote 1999). Studies have
reported oregano essential oil to be highly active against various microorganisms
(Lis-Balchin and Deans 1997; Hammer and others 1999 ; Friedman and others
2002; Valero and Salmerón 2003). Carvacrol (CRV), the bioactive component
found in oregano and thyme essential oils, is used in baked goods, nonalcoholic
beverages, and chewing gum (Ultee and others 1999). In-vitro studies have
reported the antimicrobial activity of CRV against E. coli O157:H7, S. enterica
Hadar, S. Typhimurium, and L. monocytogenes were (Kim and others 1995a;
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Helander and others 1998; Friedman and others 2002). It has been tested in
fish cubes (Kim and others 1995b) and rice (Ultee and others 2000a).
Concentrations that are lethal to bacteria are much higher than tolerable
taste thresholds. Therefore, it is preferable to use them at inhibitory
concentrations rather than at lethal concentrations (Brul and Coote 1999).
Knowledge about the mechanisms of action of antimicrobials is needed to
develop effective and economical combinations of antimicrobial additives and
formulations to protect foods from spoilage and pathogenic microorganisms
without sacrificing organoleptic qualities.
Compounds from essential oils are believed to disrupt the membrane (Brul
and Coote 1999), however, there are diverse chemical families representing
essential oil components. Lipophilic compounds, such as essential oil
components, have been shown to accumulate and act on the cell membrane
(Sikkema and others 1994, 1995). As they interact with the phospholipid bilayer
of the cell membrane, they may increase membrane permeability and cause
cellular constituents to leak (Sikkema and others 1994; Ultee and others 1998).
Although a several studies have investigated the efficacy of CRV, only a
few have examined its mechanism of inhibition. It was suggested that CRV
disrupts the outer membrane because it decreases the intracellular ATP and
increases extracellular ATP in E. coli O157:H7 (Helander and others 1998). Due
to its hydroxyl group, it caused potassium ions to leak, reduced intracellular pH,
dissipated the membrane potential, and depleted the intracellular ATP of B.
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cereus cells, which would result in lethality (Ultee and others 1999; Ultee and
others 2002).
When a microorganism is exposed to sublethal doses of a chemical that
negatively influences bacterial growth or survival, it may respond to protect itself,
or adapt, to increase its tolerance. A lipid can act as a sensor of stress and
cause a change the synthesis of stress-related proteins, which alter cell
physiology to increase tolerance to stress. A change in fluidity or membrane
structure can be detected and the cell may respond with alterations in membrane
composition (Yousef and Courtney 2003).
Changes in bacterial lipids in the membrane are a defense mechanism
used to maintain optimal fluidity in the liquid-crystalline phase for important cell
processes. Membrane fluidity is the “combined expression of the effects of [fatty
acid] chain conformation, lateral and rotational diffusion [of the lipids within the
membrane] and the resistance of the membrane to sheer forces”(Denich and
others 2003). The fluidity of the membrane affects the growth of the cell and the
proper functioning and structural integrity of the membrane (Denich and others
2003). For example, the percentage of unsaturated fatty acids in E. coli
phospholipids is usually about 50%. This percentage can decrease to 30%
without ceasing bacterial growth. If the percentage of saturated fatty acids
decreases to less than 15% the membrane permeability increases (Seltmann
and Holst 2002). Lipids directly affect passive permeability and indirectly
influence cell processes because of their interactions with membrane proteins
(Russell and others 1995).
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Membrane fluidity is determined by the effect of changes in the fatty acid
and phospholipid head-group composition, which modify the lipid membrane
melting point (Keweloh and Heipieper 1996). As melting point decreases, fluidity
increases (Casadei and others 2002). For example, fatty acids with high melting
points, such as saturated, long, and straight-chain fatty acids, decrease
membrane fluidity (Juneja and Davidson 1993).
Since CRV is lipophilic it accumulated and expanded liposomal
membranes. This swelling was suggested to cause a destabilized membrane in
B. cereus, which increased fluidity as shown by a decrease in the membrane
transition temperature from gel to liquid-crystalline phase (Tm). This led to
increased passive permeability and therefore a leakage of ions. Adaptation to
CRV of B. cereus cells caused an increase in Tm and fatty acid acids with higher
melting points, which resulted in decreased sensitivity. This reduction in fluidity
was an adaptive response to the compensate for the fluidizing and
permeabilizing effect of CRV (Ultee and others 1999; Ultee and others 2000b).
The objectives of this study were to determine:
1) the effect of exposure to CIN on the fatty acid composition of the
bacterial membrane of Salmonella,
2) whether changes in the fatty acid composition of the bacterial
membrane of Salmonella occur due to growth in the presence of CIN as a
possible adaptive response to CIN, and
3) whether reversal of these changes in fatty acid composition occur when
the stressor, CIN, was removed.
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Materials and methods

Essential oil component
Stock solutions of CRV (Aldrich, Milwaukee, WI) were prepared in ethanol,
absolute (Aldrich, St. Louis, MO). Sterile water dissolved into ethanol served as
the control stock solution. Aliquots of CRV stock solution were added into 8 ml
brain heart infusion broth, modified (BHI, BBL, Sparks MD) with 2% Tween 20
(Fisher Scientific, Fairlawn, NJ) with glass beads. The final concentration of
Tween was 1% and ethanol was 0.5% during adaptation and treatment. Tween
and glass beads were used to aid with dispersion of CRV in BHI. All BHI was
prepared with phosphate buffer (0.1M, pH 7.2 + 0.1) instead of water to prevent
pH changes, which could affect the fatty acid composition of bacterial
membranes. The pH of BHI was adjusted to 7.35 (+ 0.1) prior to autoclaving,
after which the final pH was pH 7.2 (+ 0.1). Glass tubes containing the stock and
BHI were shaken vigorously forty times to disperse the oil-based components.
Dispersions became cloudy-white.
Bacterial culture preparation
Salmonella Typhimurium DT104 ATCC BAA-186 was obtained from the
American Type Culture Collection (A TCC, Rockville, MD). Experimental cultures
were maintained on Tryptic Soy Agar slants. A loopful of culture was used to
inoculate 9 ml of BHI with S. Typhimurium. The BHI tube was incubated for 24 h
at 35°C. Then a loopful was transferred into 9 ml BHI and incubated for 21 h at
35°C.
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Adaptation
In our study adaptation was defined as growth in sublethal concentrations
of CRV for 24h. On the day of adapting cells to antimicrobials, one ml of the 21-h
culture was serially diluted into two sets of three tubes of 9 ml BHI. The diluted
cultures from the two tubes of the 10-3 dilution were combined in a large tube.
Five ml of the diluted culture were used to inoculate a 5-ml BHI tube containing
CRV and a 5-ml BHI tube containing 0.5% ethanol control. Both tubes had 1%
Tween.
The stock and 5-ml CRV dispersions in BHI were prepared the day before,
refrigerated, and allowed to warm to room temperature for 30 min before the 5-ml
diluted culture was added. This inoculation halved the concentrations and the
final inoculum was approximately log 5.7 CFU/ml. The final concentration of
Tween was 1% and ethanol was 0.5%. The two inoculated BHI tubes containing
CRV or ethanol control were vortexed and the cells were allowed to adapt to
CRV or ethanol (non-adapted) by incubating in a shaking waterbath at 125 rpm
for 24 h at 35°C.
Extrapolating from dose-response curves, the concentrations that would
achieve a 25% probability of lethality were initially used to adapt cells. This low
probability of lethality was chosen to induce changes in the membrane lipid
composition yet also allow enough growth for harvesting cells for lipid analysis.
This 25% probability of lethality corresponded to 1023 mg/L CRV. After a 24hour growth in or adaptation to 1023 mg/L CRV, adapted cells would be
inoculated into 200 ml BHI in bottles to treat adapted cells to sublethal
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concentrations of CRV for 2 and 24 hours. After inoculation, the desired
inoculum in these experiments was about log 5.7 CFU/ml to adhere to the same
inoculum size as in the adaptation procedure.
The population o f cells resulting after 24-h adaptation was tested since
these cells would be used to inoculate the bottles. The population of cells
exposed to CRV was log 5 CFU/ml. To inoculate several bottles to a final
inoculum of log 5.7 CFU/ml with a log 5 CFU/ml culture would be impossible.
Then cells were exposed to CRV concentrations corresponding to 15%, 10%,
and 5%, after which the cell count was about log 6 CFU/ml. To inoculate bottles
with 200 ml BHI would have required a very large inoculum volume of “adapted”
cells. There was concern that these were new non-adapted cells that survived
and were able to grow under stressed conditions with no physiological changes.
Finally after three repetitions, the count of cells exposed 871 mg/L CRV, which
corresponded to 2.5% probability of lethality, was log 8.1 CFU/ml. The control
population “adapted”to 0.5% ethanol was log 8.8 CFU/ml (average).
Treatment of adapted cells
A total of twelve screw-capped glass bottles containing 190 ml BHI were
prepared for two and twenty-four hour exposures to CRV. Ten ml CRV
dispersion were added to six bottles for a final concentration of 871 mg/L.
Salmonella adapted to CRV would be added to two bottles. Salmonella
“adapted”only to ethanol would be added to two bottles. Two bottles would not
be inoculated and were designated as sterile CRV controls since the BHI broth
media contained fatty acids. Ten ml of ethanol solution were added to six bottles
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(with no CRV). Salmonella adapted to CRV would be added to two bottles.
Salmonella “adapted”only to ethanol would be added to two bottles. Two bottles
were not to be inoculated and were designated as sterile ethanol controls since
the BHI broth media contained fatty acids from the manufacturer formulation.
The final concentrations would contain about 1% Tween and 0.5% ethanol,
similar to those used to adapt cells. These twelve bottles containing CRV or
ethanol were shaken and stored at 4°C until two hours before use, at which time
they were allowed to warm to 25°C. Before adding adapted Salmonella, bottles
were shaken. The treatments for 2 and 24h incubation were: Sterile controls:
sterile + CRV, sterile + ethanol, treatments: non-adapted Salmonella + CRV,
adapted Salmonella + CRV, inoculated controls: non-adapted + ethanol, adapted
+ ethanol.
Tubes containing adapted cells were vortexed to inoculating Salmonella
into the designated bottles. Based on the preliminary data of adapted cell
counts, 872 µl of cells adapted to CRV and 166 µl of cells exposed to ethanol
(non-adapted) were added to designated bottles for a final inoculum size of about
log 5.7 CFU/ml. The bottles were shaken and incubated in a shaking waterbath
at 125 rpm for either two or twenty-four hours. After incubation the samples were
centrifuged on a large volume centrifuge (Beckman J2-HS, Schaumberg, IL) at
12,000 rpm for 30 mi nutes at 4°C. The pellet was transferred from the centrifuge
bottles to centrifuge tubes and washed three times with 0.1 M phosphate buffer
(pH 7.2) at 10,000 rpm for 10 minutes at 4°C using a table -top centrifuge (Baxter
Biofuge 17 R, VWR Scientific Products, West Chester, PA). The pellet was
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suspended in less than 1.5 ml phosphate buffer in small ampoules, wrapped in
parafilm and foil and frozen at -30°C. The pellet was lyophilized and ampoules
were wrapped until extraction.
Lipid extraction
Lipid extraction and analysis procedures were developed by Dr. David C.
White’s lab, the University of TN Center for Biomarker Analysis. Lipids from 8-18
mg lyophilized cells were extracted using a modified Bligh/Dyer method (Guckert
and others 1985; Guckert and others 1986). The extraction solvent contained 4
ml phosphate buffer, 10 ml methanol, and 5 ml chloroform. After three hours the
phases were split with 5 ml water and 5 ml chloroform and allowed to sit
overnight for layer separation. The lower chloroform layer was removed and
dried under nitrogen. The total lipid extract was suspended in chloroform and
separated into the lipid classes (neutral lipids, glycolipids, and polar lipids) with
silicic acid (500 mg) columns using three solvents of increasing polarity (5 ml
chloroform, 5 ml acetone, and 10 ml metha nol) to elute the lipid classes from the
silicic acid stationary phase (Guckert and others 1985; Guckert and others 1986).
Analysis of fatty acid methyl esters
To prepare fatty acid methyl esters (FAME) in a mild alkaline methanolic
transesterification reaction, 0.5 ml chloroform, 0.5 ml methanol, and 1 ml of
methanolic KOH were added to the dried polar lipids and heated at 60°C for 30
minutes. To extract the FAME, 2 ml hexanes, 200 µl glacial acetic acid, and 2 ml
nanopure water was added. After centrifuging, the hexane layer was removed.
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This was repeated twice. The FAME were dried under nitrogen and transferred
three times with 100 µl hexanes to autosampling vials.
The samples were diluted with hexanes containing a 21:0 internal
standard (50pmol/µl). The samples and a vial of GC-MIX (mixture of 20 FAME
standards) were analyzed on a HP6890 gas chromatograph (GC) coupled to a
HP5973 mass spectrophotometer (MS). The GC was equipped with a RJX1
fused silica capillary column (60m, 250µm internal diameter x 25 µm film
thickness, Restek, Bellefonte, PA). The column was programmed from an initial
temperature of 60°C for 2 min then raised at a rate of 10°C/min to 150°C. The
temperature was increased at 30°C/min to a final temperature of 312°C. The
injector port temperature was 230°C in split-less mode. Helium was used as the
carrier gas at a flow rate of 1.41 ml/min. Fatty acids were identified by
comparison of retention times to the FAME standards and a mass spectral data
library. Fatty acids were quantified based on comparison to the 21:0 internal
standard and area under each sample peak and standard peak.
Statistical analysis
Box and whisker plots were generated with Statistica (StatsSoft, Inc.,
Tulsa, OK) to compare total PLFA and fatty acid composition. The 2 and 24h
data were divided and a randomized block design with blocking on each of three
replications was used to test the effect of treatments or controls on total PLFA
and fatty acids for 2h or 24h. Data were analyzed using SAS (Statistical Analysis
System, Cary, NC) to compare differences in total PLFA and fatty acids between
treatment and control groups within 2h or 24h with alpha value at 0.05. The
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generalized linear model (GLM) was used to test for differences in total PLFA
and fatty acids between 2 and 24h within each treatment or control group with a
Bonferonni correction factor. This correction minimized Type I error, which
increases with the number of statistical tests. The Bonferonni p value was
calculated as the alpha value at 0.10 divided by 6 (the number of follow-up tests
conducted to test the interaction between the 6 treatments at 2h or 24h), which
equals 0.017.

Results

Total phospholipid fatty acid (PLFA)
Total phospholipid fatty acid (PLFA ) is the sum of all fatty acids that were
hydrolyzed from phospholipids in the membrane. The mean total PLFA is shown
in Table 4.1. Depicted in Figures 4.1 and 4.2 are box and whisker plots
representing the mean, standard error, and standard deviation of the total PLFA
of the sterile groups of Salmonella under each of the experimental treatments.
The boundaries of the box around the mean consist of the mean + standard
error. The standard error is the standard deviation of the sample mean and is
computed as the standard deviation divided by the square root of the sample
size. The horizontal bars represent the mean + standard deviation. The
standard deviation is the positive square root of the variance. The variance is the
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Table 4.1. Comparison of total PLFA and fatty acid (FA) composition of CRV-adapted or non-adapted cells with or
without carvacrol (CRV) to inoculated controls (+EtOH) and sterile controls after 2h and 24h incubation.
Treatment/control
and incubation hr

Total
PLFA
(pmol/mg)

C12:0
(%)

C14:0
(%)

C15:0
(%)

C16:1w7c
(%)

C16:0
(%)

Cy17:0
(%)

C17:0
(%)

C18:1w9c
(%)

2h
Sterile + CRV

1987.2

34.9 A

29.6 A

0.0

0.0 B

19.1 C

0.0 B

0.0

2.3 AB

Sterile + EtOH

191.9

35.4 A

29.0 A

0.0

0.0 B

21.6 BC

0.0 B

0.0

1.2 B

Non-adapt + CRV

729.3 Z

15.0 BC

27.3 A

0.0

0.3 BZ

28.1 AB

0.1 BZ

0.0

4.3 A

Adapt + CRV

7333.2

31.9 AB

28.8 AZ

0.0

1.7 BZ

20.9 BCZ

0.0 B

0.0

2.2 AB

Non-adapt + EtOH

7625.3 Z

0.8 C

7.8 B

0.0 Z

25.7 AZ

29.5 AZ

2.3 AZ

0.0 Z

0.5 B

Adapt + EtOH

2799.4 Z

2.2 C

8.1 B

0.0 Z

23.8 AZ

31.9 A

2.4 AZ

0.0 Z

0.4 B

Sterile + CRV

2221.6 B

36.1 A

26.7 A

0.0 B

0.1 D

16.6 B

0.0 C

0.0 C

5.7 A

Sterile + EtOH

2396.1 B

23.7 B

31.7 A

0.0 B

0.0 D

21.7 B

0.0 C

0.0 C

3.9 A

24h

19541.1 B

3.5 CD

6.6 B

0.1 B

22.9 A

42.1 A

4.0 BC

0.0 C

0.2 B

8524.0 B

7.9 C

9.2 B

0.0 B

16.6 B

41.3 A

4.3 B

0.0 C

0.3 B

Non-adapt + EtOH

69791.6 A

0.3 D

7.7 B

0.2 A

13.7 C

36.7 A

16.0 A

0.1 B

0.3 B

Adapt + EtOH

70051.4 A

1.0 CD

7.4 B

0.2 A

11.9 C

36.6 A

16.6 A

0.2 A

0.2 B

Non-adapt + CRV
Adapt + CRV

ABCD: Means in a column with different superscripts within 2h or 24h are different (p<0.05).
Z: Means in a column are different from 2h to 24h within a treatment or control group (Bonferroni p<0.017).
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Table 4.1. Continued.

Treatment/control C18:1w7c
and incubation hr
(%)

C18:1w7t
(%)

C18:0
(%)

Cy19:0
(%)

Sat. FA
(%)

Unsat.
FA (%)

Cy17 to
C16:1
ratio

Cy19 to
C18:1
ratio

SFA to
UFA
ratio

2h
Sterile + CRV

1.1 B

0.4

12.6 A

0.0

96.2 AB

3.8 BC

0.0

0.0

20.8 AB

Sterile + EtOH

0.9 B

0.2

11.7 AB

0.0

97.7 A

2.3 C

0.0

0.0

30.0 A

Non-adapt + CRV

4.1 BZ

0.5

20.2 A

0.0

90.6 BZ

9.4 B

0.4

0.0

12.6 B

Adapt + CRV

3.6 BZ

0.7

10.2 ABC

0.0

91.8 ABZ

8.2 BCZ

0.0

0.0

11.9 BZ

Non-adapt + EtOH

32.6 AZ

0.0

0.9 C

0.0 Z

38.9 CZ

61.1 AZ

0.1 Z

0.0 Z

0.6 CZ

Adapt + EtOH

30.0 A

0.0

1.2 BC

0.0 Z

43.4 C

56.6 AZ

0.1 Z

0.0

0.8 C

24h
Sterile + CRV

2.6 C

0.6 AB

11.6 B

0.0 B

90.9 A

9.1 D

0.0 B

0.0 B

10.2 B

Sterile + EtOH

1.5 C

0.7 A

16.7 A

0.0 B

93.8 A

6.2 D

0.0 B

0.0 B

15.4 A

Non-adapt + CRV

19.4 B

0.0 AB

1.1 C

0.1 B

53.5 C

46.5 B

0.2 B

0.0 B

1.2 C

Adapt + CRV

17.3 B

0.0 B

2.9 C

0.1 B

61.3 B

38.7 C

0.3 B

0.0 B

1.6 C

Non-adapt + EtOH

23.2 A

0.0 B

0.5 C

1.2 A

45.6 D

54.4 A

1.2 A

0.1 A

0.8 C

Adapt + EtOH

23.6 A

0.0 B

0.6 C

1.7 A

46.0 D

54.0 A

1.4 A

0.1 A

0.9 C

ABCD: Means in a column with different superscripts within 2h or 24h are different (p<0.05).
Z: Means in a column are different from 2h to 24h within a treatment or control group (Bonferroni p<0.017).
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Figure 4.1. Comparison of total PLFA or biomass of CRV-adapted or
non-adapted cells with or without CRV to inoculated controls (+EtOH)
and sterile controls after 2 -hr incubation
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Figure 4.2. Comparison of total PLFA or biomass of CRV-adapted or
non-adapted cells with or without CRV to inoculated controls (+EtOH)
and sterile controls after 24-hr incubation
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sum of the squared deviations from the mean divided by the sample size minus
one.
An analysis was performed to determine if there was a correlation
between total PLFA and occurrence of specific fatty acids. It was found that
higher total PLFA was positively correlated to the presence of C15:0 (R2=0.81),
Cy17:0 (R2=0.91), C17:0 (R2=0.78), Cy19:0 (R2=0.85), ratio of Cy17:0 to
C16:1w7c (R2=0.82), and the ratio of Cy19:0 to C18:1w7c (R2=0.83). The
correlation of total PLFA to cyclopropyl fatty acids was expected because as cells
age and enter stationary phase, the cyclopropyl fatty acids increase (Guckert and
White 1988; Casadei and others 2002).
Comparison of total PLFA and each fatty acid across sterile, treatment,
and control groups (refer to Table 4.1 for means).
Total PLFA. Mean total PLFA of treatment groups at 2h is shown in Table
4.1. There we re no significant (p>0.05) differences among the total PLFA of all
groups at 2h (Figure 4.1). The total PLFA found in uninoculated controls was
due to the fatty acids present in the culture medium from the manufacturer’s
formulation of BHI. There was a wide range in total PLFA in the adapted and
non-adapted treatment groups. This range may be due to the variation in
sensitivity of the cells to CRV. The total PLFA of the adapted control (+EtOH)
was numerically lower than the non-adapted control because it may have still
been inhibited but the difference was not significant. The total PLFA of the CRV
non-adapted Salmonella was significantly (p<0.05) less than CRV adapted
Salmonella after 2h indicating a more rapid growth of adapted cells.
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At 24h the total PLFA of the Salmonella inoculated control groups (no
CIN) exceeded those of the sterile and treatment groups because the bacteria
were not inhibited by CRV (Figure 4.2). The total PLFA did not differ significantly
(p>0.05) among sterile and treatment groups. From 2h to 24h the total PLFA
increased significantly (p<0.01) for the controls and the non-adapted treatment
group (+CRV) (Table 4.1).
C12:0 fatty acid. At 2h, the sterile groups contained more C12:0 than the
control groups (Figure 4.3). The bacteria in the controls were able to decrease
the proportion of this fatty acid within 2h as they grew and used C12:0. The level
of C12:0 in the treatment groups was similar to that of the sterile groups. Since
bacterial growth was still inhibited by CRV, lipid biosynthesis by the anaerobic
pathway was decelerated. They incorporated C12:0 from the medium but could
not oxidize and convert it to other fatty in the presence of CRV.
The wider standard error of the non-adapted cells treated with CRV
implies that some Salmonella cells in a culture were less able to decrease the
proportion 12:0 than others because they were more inhibited due to CRV
exposure. This wider range of response indicates that a population of nonadapted cells can display a range of sensitivity to CRV and therefore a range in
the ability to grow and decrease the percentage of C12:0.
At 24h, all four inoculated groups had significantly (p<0.05) less C12:0
than the sterile groups (Figure 4.4). The bacteria in the treatment groups were
able to grow and convert 12:0 to another fatty acid. The adapted treatment had a
higher percentage of C12:0 than the non-adapted control. The percentage C12:0
149
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Figure 4.3. Comparison of C12:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 4.4. Comparison of C12:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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did not significantly (p>0.05) change in any group from 2 to 24h, except for a
decrease in the adapted treatment group, but this was not significant (p>0.05)
and may have been obscured by variation within the group.
C14:0 fatty acid. At 2h, the proportion of this fatty acid in the treatment
groups did not differ from the sterile groups. They incorporated C12:0 from the
medium. Bacterial growth in the treatment groups was still inhibited and could
not convert C14:0 to another fatty acid as well as the inoculated controls (Figure
4.5). C14:0 was higher in these groups than in the controls, which had a
significantly (p<0.05) lower percentage of C14:0 as they grew within 2h.
From 2h to 24h, C14:0 decreased significantly (p<0.01) in the adapted
treatment group as cells grew (Table 4.1). The non-adapted treatment group
showed a similar trend, but this was not significant (p>0.05). At 24h there were
no differences among the inoculated groups and they had a significantly (p<0.05)
lower C14:0 percentage than the sterile groups (Figure 4.6). Bacteria in the
treatments grew and converted C14:0 to another fatty acid.
C15:0 fatty acid. At 2h C15:0 was not detected in any group (Figure 4.7).
The control groups significantly (p<0.01) increased C15:0 from 2h to 24h (Table
4.1). They had a higher relative abundance of C15:0 than the other groups at
24h (Figure 4.8).
C16:1w7c fatty acid. At 2h C16:1w7c was at a higher percentage in the
control groups than in the other groups (Figure 4.9). Compared to 2h, C16:1w7c
decreased significantly (p<0.005) in the control groups at 24h (Table 4.1 and
Figure 4.10). In contrast, the treatment groups significantly (p<0.005) produced
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Figure 4.5. Comparison of C14:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 4.6. Comparison of C14:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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Figure 4.7. Comparison of C15:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 4.8. Comparison of C15:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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Figure 4.9. Comparison of C16:1w7c fatty acid of CRV-adapted or
non-adapted cells with or without CRV to inoculated controls (+EtOH)
and sterile controls after 2 -hr incubation
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Figure 4.10. Comparison of C16:1w7c fatty acid of CRV-adapted or
non-adapted cells with or without CRV to inoculated controls (+EtOH)
and sterile controls after 24-hr incubation
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more of this fatty acid with time. At 24h, the non-adapted treatment group
produced the most C16:1w7c, followed by the adapted treatment group (Figure
4.10). The percentage was lower in the controls and least in the sterile groups.
C16:0 fatty acid. At 2h C16:0 was highest in the control groups as they
grew (Figure 4.11). The percentage of fatty acid in the treatment groups was in
between that of the control and sterile groups since they were still inhibited.
From 2h to 24h, the non-adapted control and the adapted treatment group
produced significantly (p<0.02 and p<0.001) more C16:0 (Table 4.1). In the nonadapted control there was a trend of increased C16:0 from over time, but this
was not (p>0.05). At 24h C16:0 was more abundant in the inoculated groups
than the sterile groups. The abundance of this fatty acid did not differ among
inoculated groups (Figure 4.12).
Cy17:0 fatty acid. At 2h Cy17:0 was highest in the control groups (Figure
4.13). There were no differences among the sterile and treatment groups. Over
time Cy17:0 significantly increased in the control groups and the non-adapted
treatment group (p<0.02 and p<0.001) (Table 4.1). At 24h Cy17:0 was still the
most relatively abundant in the control groups since they reached stationary
phase earlier and second highest in the adapted treatment group (Figure 4.14).
The abundance of Cy17:0 of the non-adapted treatment did not differ significantly
(p>0.05) from its adapted counterpart.
C17:0 fatty acid. At 2h none of the groups synthesized C17:0 (Figure
4.15). Compared to 2h, the controls produced more (p<0.005) C17:0 at 24h
(Table 4.1). At 24h (Figure 4.16) the percentage of C17:0 was greatest in the
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Figure 4.11. Comparison of C16:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 4.12. Comparison of C16:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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Figure 4.13. Comparison of Cy17:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 4.14. Comparison of Cy17:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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Figure 4.15. Comparison of C17:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 4.16. Comparison of C17:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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adapted control, followed by the non-adapted control. There was no significant
(p>0.05) difference among the sterile and treatment groups.
C18:1w9c fatty acid. At 2h there was no definite pattern of differences
among the groups due to the wide variability of the sterile and treatment groups,
except that the controls appeared to have the lowest percentage of C18:1w9c
and least variability (Figure 4.17). The abundance of C18:1w9c decreased in the
non-adapted treatment and adapted control groups from 2h to 24h (Figure 4.18),
but this was not significant (p>0.02). There were no significant changes in the
other groups over time.
C18:1w7c fatty acid. At 2h the abundance of C18:1w7c was highest in the
control groups (Figure 4.19). It was lowest in the sterile and treatment groups.
From 2h to 24h, the non-adapted control significantly (p<0.02) decreased the
proportion of C18:1w7c (Table 4.1). The adapted control exhibited a similar
declining trend, but this was not significant (p>0.02). In contrast, the nonadapted and adapted treatment groups produced significantly (p<0.005) more of
this fatty acid over time. At 24h, C18:1w7c was most abundant in the controls,
followed by the treatment groups, and then the sterile groups (Figure 4.20).
C18:1w7t fatty acid. At 2h the percentages of C18:1w7t did not differ
significantly (p>0.05) among the groups perhaps due do the variability within
groups (Figure 4.21). It was detected in the sterile groups at 2 and 24h and in
the treatment groups at 2h, but was depleted at 24h (Figure 4.22). It was present
in the treatment groups because the cells were inhibited by CRV and had not yet
metabolized it. There were no significant (p>0.05) changes across time within
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Figure 4.17. Comparison of C18:1w9c fatty acid of CRV-adapted or
non-adapted cells with or without CRV to inoculated controls (+EtOH)
and sterile controls after 2 -hr incubation
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Figure 4.18. Comparison of C18:1w9c fatty acid of CRV-adapted or
non-adapted cells with or without CRV to inoculated controls (+EtOH)
and sterile controls after 24-hr incubation
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Figure 4.19. Comparison of C18:1w7c fatty acid of CRV-adapted or
non-adapted cells with or without CRV to inoculated controls (+EtOH)
and sterile controls after 2 -hr incubation
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Figure 4.20. Comparison of C18:1w7c fatty acid of CRV-adapted or
non-adapted cells with or without CRV to inoculated controls (+EtOH)
and sterile controls after 24-hr incubation
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Figure 4.21. Comparison of C18:1w7t fatty acid of CRV-adapted or
non-adapted cells with or without CRV to inoculated controls (+EtOH)
and sterile controls after 2 -hr incubation
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Figure 4.22. Comparison of C18:1w7t fatty acid of CRV-adapted or
non-adapted cells with or without CRV to inoculated controls (+EtOH)
and sterile controls after 24-hr incubation
162

each group. At 24h the sterile + EtOH group had significantly (p<0.05) more
C18:1w7t than the control and adapted treatment groups. The wide variability in
the sterile group may have been due to very small pellets that were obtained
after centrifuging and washing (Figure 4.22).
C18:0 fatty acid. At 2h non-adapted control had decreased C18:0 to a
proportion lower than the sterile groups and the non-adapted treatment group,
which were similar (Figure 4.23). The percentage of C18:0 was higher in the
non-adapted treatment than in the non-adapted control because cells were still
inhibited by CRV. The percentage of C18:0 in the treatment groups was more
similar to the sterile groups than the inoculated controls. The treatment groups
had incorporated C18:0 but were unable to convert it as well as the inoculated
controls.
Within each group C18:0 did not differ significantly (p>0.05) across time
(possibly obscured by within-group variation), although there is a declining trend
of C18:0 in the adapted treatment group. At 24h the treatment groups grew and
converted C18:0 to another fatty acid. Therefore, there were no differences
among the inoculated groups and C18:0 percentages were lower than in the
sterile groups (Figure 4.24).
Cy19:0 fatty acid. At 2h Cy19:0 was not detected in any group (Figure
4.25). Compared to 2h, the controls formed more Cy19:0 at 24h as they entered
stationary phase earlier (p<0.01) (Table 4.1). At 24h Cy19:0 was most abundant
in the control groups and least in the sterile and treatment groups (Figure 4.26).
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Figure 4.23. Comparison of C18:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 4.24. Comparison of C18:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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Figure 4.25. Comparison of Cy19:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 2-hr incubation
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Figure 4.26. Comparison of Cy19:0 fatty acid of CRV-adapted or nonadapted cells with or without CRV to inoculated controls (+EtOH) and
sterile controls after 24-hr incubation
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Saturated fatty acids. At 2h the percentages of saturated fatty acids were
similar in the sterile and treatment groups (Figure 4.27). The fatty acids were
much lower in the control groups since the cells were not inhibited. The
percentage of SFA significantly (p<0.005) declined over time in the treatment
groups as they grew, but it increased for the non-adapted control (p<0.01)
(Table 4.1). At 24h, the abundance of SFA was highest in the sterile groups,
followed by the adapted treatment and then the non-adapted treatment group
(Figure 4.28). The controls contained the least SFA.
Monounsaturated fatty acids. At 2h UFA were highest in the control group
(Figure 4.29). They were lowest in the sterile and treatment groups. Compared
to 2h, UFA significantly (p<0.005) increased at 24h for the treatment groups, but
decreased for the non-adapted control (p<0.01) (Table 4.1). At 24h the
abundance of UFA was highest in the control groups, followed by the nonadapted treatment and then the adapted treatment group (Figure 4.30). These
fatty acids were lowest in the sterile groups.
Ratio of Cy17:0 to C16:1w7c. At 2h there were no differences in the ratios
among the groups (Figure 4.31). There was a larger standard error for the nonadapted CRV due to variation in both Cy17:0 and its precursor, which reflected
the range in sensitivity. Over time, this ratio significantly (p<0.005) increased in
the control groups, indicating earlier entry into the stationary phase (Table 4.1).
At 24h the ratio was highest in the control groups and lowest in the sterile and
treatment groups (Figure 4.32).
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Figure 4.27. Comparison of saturated fatty acids of CRV-adapted or
non-adapted cells with or without CRV to inoculated controls (+EtOH)
and sterile controls after 2 -hr incubation
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Figure 4.28. Comparison of saturated fatty acids of CRV-adapted or
non-adapted cells with or without CRV to inoculated controls (+EtOH)
and sterile controls after 24-hr incubation
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Figure 4.29. Comparison of monounsaturated fatty acids of CRVadapted or non-adapted cells with or without CRV to inoculated
controls (+EtOH) and sterile controls after 2 -hr incubation
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Figure 4.30. Comparison of monounsaturated fatty acids of CRVadapted or non-adapted cells with or without CRV to inoculated
controls (+EtOH) and sterile controls after 24-hr incubation
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Figure 4.31. Comparison of ratio of Cy17:0 to 16:1w7c fatty acids of
CRV-adapted or non-adapted cells with or without CRV to inoculated
controls (+EtOH) and sterile controls after 2 -hr incubation
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Figure 4.32. Comparison of Cy17:0 to 16:1w7c fatty acids of CRVadapted or non-adapted cells with or without CRV to inoculated
controls (+EtOH) and sterile controls after 24-hr incubation
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Ratio of Cy19:0 to C18:1w7c. The ratios were zero because Cy19:0 was
undetected at 2h (Figure 4.33). From 2h to 24h, this ratio increased significantly
(p<0.02) for the non-adapted control (Table 4.1). A similar trend occurred in the
adapted control, but this was not significant (p>0.05). At 24h the ratio was
highest in the control groups and lowest in the sterile and treatment groups
(Figure 4.34).
Ratio of saturated to unsaturated fatty acids. At 2h, this ratio was lowest
in the control groups, which were able to grow and decrease the proportion of
SFA (Figure 4.35). The ratio was highest for the sterile groups, followed by the
treatment groups, although there is some overlap between the sterile + CRV and
treatment groups.
Compared to 2h, this ratio drastically (p<0.02) decreased at 24h in the
adapted treatment group (and numerically in the non-adapted treatment group),
but increased significantly (p<0.01) in the non-adapted control group (Table 4.1).
At 24h, the ratio was lowest in all the inoculated groups (Figure 4.36). It was
highest in the sterile + EtOH group followed by the sterile + CRV group.

Discussion

Anaerobes, facultative anaerobes, and also some aerobic bacteria
synthesize lipids via the anaerobic pathway, which has been studied in E. coli.
The starting reactants are acetyl-CoA and 3 malonyl-ACP. A trans double bond
is produced during elongation. From that point, it can be reduced to form a
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Figure 4.33. Comparison of ratio of Cy19:0 to 18:1w7c fatty acids of
CRV-adapted or non-adapted cells with or without CRV to inoculated
controls (+EtOH) and sterile controls after 2 -hr incubation
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Figure 4.34. Comparison of Cy19:0 to 18:1w7c fatty acids of CRVadapted or non-adapted cells with or without CRV to inoculated
controls (+EtOH) and sterile controls after 24-hr incubation
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Figure 4.35. Comparison of ratio of saturated to unsaturated fatty
acids of CRV-adapted or non-adapted cells with or without CRV to
inoculated controls (+EtOH) and sterile controls after 2-hr incubation
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Figure 4.36. Comparison of ratio of saturated to unsaturated fatty
acids of CRV-adapted or non-adapted cells with or without CRV to
inoculated controls (+EtOH) and sterile controls after 24-hr incubation
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saturated fatty acid or isomerized into a cis-monoenoic fatty acid. This cis fatty
acid cannot be reduced and remain unchanged with further elongation. These
saturated and cis-unsaturated chains are incorporated into phospholipids of the
membrane. Since the degree of saturation cannot change after synthesis, the
ratio of SFA to UFA cannot be changed in cells that cease growth. Phospholipid
biosynthesis quickly decelerates if growth stops. However, post-synthesis
modification of cis-monoenoic fatty acids to their cyclopropyl derivatives and
trans-isomers can still occur (Diefenbach and others 1992; Keweloh and
Heipieper 1996).
The uptake of fatty acids from the culture medium can occur by acyl-chain
unspecific or active or passive transport. They are oxidized or incorporated in
membrane lipids, which is regulated. Biosynthesis is regulated as well
(Diefenbach and others 1992; Keweloh and Heipieper 1996).
Membrane fluidity has been correlated with changes in fatty acid
composition (Mazzotta and Montville 1997). Certain types of lipid may have a
greater influence on the fluidity than other. For example, converting a cismonoenoic acid to its trans -isomer greatly reduces fluidity, but not as significantly
as a change in cis to saturated fatty acids (Keweloh and Heipieper 1996).
The melting points of unsaturated fatty acid (UFA) and branched chain
fatty acids are lower than that of saturated fatty acids (SFA). There are
hydrophobic interactions among acyl chains of SFA. In membranes rich with
SFA the membrane is packed and rigid. The chain can extend at its maximum if
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the saturated chain rotates into a trans -conformation (Keweloh and Heipieper
1996).
In contrast, the double bond in cis-UFA creates a 30°angle in the acyl
chain. This kink disrupts the ordered packing of the acyl chains in the membrane
(Keweloh and Heipieper 1996). Therefore, an increase in cis UFA causes a
decrease in the temperature for the transition from the gel to the liquid-crystal
membrane phase and an increase in fluidity (Keweloh and Heipieper 1996;
Casadei and others 2002).
A shortening in the acyl chain length will also lower the melting
temperature and increase fluidity. A change in the degree of saturation is
thought to be more effective than a change in the chain length (Keweloh and
others 1991). Cyclopropyl fatty acids (CFA) are more physically similar to cismonoenoic fatty acids, which are precursors of CFA. Trans-fatty acids are more
stable and resemble SFA (Guckert and others 1986). Trans -UFA acyl chains are
long and extended, packing more rigidly and occupying lower molar volume in
the membrane. Trans UFA decrease the phase transition temperature, but not
as drastically as cis UFA (Diefenbach and others 1992; Keweloh and Heipieper
1996).
The ratio of UFA to SFA indicates membrane fluidity. Casadei and
colleagues (2002) developed a fluidity index that was calculated as the ratio of
UFA plus cyclopropane fatty acids (CFA) in stationary phase to SFA. They
extracted phospholipids from E. coli grown at different temperatures and
measured the phase transition temperatures by DSC.
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Casadei and colleagues (2002) confirmed the validity of the fluidity index
as an indicator of membrane fluidity. They found that there was a direct linear
relationship between the phase transition temperature and growth temperature
and then an inverse linear relationship between the phase transition temperature
and the fluidity index of phospholipids. The proportion of SFA increased while
the proportion of UFA decreased with increasing growth temperature in
stationary and exponential phase cells. The fluidity index was slightly greater in
exponential than stationary phase cells. They reported that the abundance of
CFA increased and C18:1 and C16:1 decreased in stationary phase cells. Since
most of the treatment groups in this present data contained mostly SFA, a ratio
was calculated of SFA to UFA plus CFA.
The measurement of the ester-linked phospholipid fatty acids (PLFA) is
useful. The PLFA content quantitatively indicates the viable biomass since they
have a high turnover rate and are present in consistent abundance in cell
membranes. When cells die or lyse, hydrolysis of phospholipids quickly occur
and the polar head group and diglyceride remain (White and Ringelberg 1997).
In addition to providing an estimate of the viable biomass, PLFAs can
indicate nutritional and physiological status using the ratio of trans -monoenoic
fatty acids to their cis homologues and the ratio of cyclopropyl derivatives to their
monoenoic fatty acid precursors (White and Ringelberg 1997). During starvation
of cultures of Vibrio cholerae, the trans/cis ratio increased. The cis-monoenoic
fatty acids (such as 16:1w7c and 18:1w7c) decreased and the SFA, CFA, and
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trans-monoenoic fatty acids increased. During starvation, membrane fluidity
decreased overall (Guckert and others 1986).
When loss of phospholipid occurred during starvation, cis-monoenoic
acids were preferentially utilized to possibly enhance survival. Cis fatty acids
have faster turnover than saturated fatty acids and are more easily metabolized.
During starvation, bacteria may synthesize trans-monoenoic acids, which
bacteria do not readily metabolize, or transmethylate unstable cis- monoenoic
fatty acids to form their cyclopropyl derivatives to survive (Guckert and others
1986).
It has been suggested that CFA are more stable to turnover and
degradation (Guckert and others 1986). CFAs were formed (with a decline in
their cis-fatty acid precursors) in Vibrio cholerae and Pseudomonas putida as
cells aged and entered the stationary phase (Guckert and others 1986;
Diefenbach and others 1992; Loffeld and Keweloh 1996). It has been
hypothesized that CFA are formed under stress when growth stops (Guckert and
others 1986).
The objectives in our study were to:
1) Determine the effect of exposure to CRV on the fatty acid composition
of the bacterial membrane of Salmonella.
Compared to the non-adapted Salmonella at 2h, the non-adapted
treatment had lower (p<0.05) C16:1w7c, Cy17:0, C18:1w7c, and unsaturated
fatty acid (UFA) and higher (p<0.05) C14:0, C18:1w9c, C18:0, saturated fatty
acid (SFA), and SFA/UFA ratio. The SFA to UFA ratio was drastically (p<0.05)
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greater than the control. Therefore, CRV exposure caused a less fluid
membrane. The total PLFA was numerically much lower, indicating that CRV
inhibited growth.
At 24h, the non-adapted treatment had lower (p<0.05) total phospholipid
fatty acid (PLFA), lower (p<0.05) C15:0, Cy17:0, C17:0, C18:1w7c, 19:0, and
UFA than the non-adapted control and higher (p<0.05) C16:1w7c and SFA. The
SFA to UFA ratio was only slightly higher, but not significant as it was at 2h. This
suggested that CRV exposure for 24h decreased membrane fluidity. The total
PLFA of the non-adapted treatment was significantly (p<0.05) lower because of
growth inhibition by CRV.
2) Determine whether changes in the fatty acid composition of the
bacterial membrane of Salmonella occur due to growth in the presence of CIN as
a possible adaptive response to CRV.
At 2h there were no significant (p>0.05) differences in the total PLFA or
fatty acids between the treatment groups as a function of incubation time,
especially within the non-adapted group in which some cells may have exhibited
a range of sensitivity to CRV. The SFA to UFA ratio was numerically higher in
the non-adapted treatment group. The effect of CRV adaptation was unclear at
2h. Since the concentration used for adaptation and treatment corresponded to
a 2.5% probability of lethality, the effect of CRV was not pronounced.
At 24h the only significant (p<0.05) difference was a lower abundance of
C16:1w7c in the adapted treatment, which led to lower (p<0.05) unsaturated fatty
acid and higher (p<0.05) saturated fatty acids. The SFA to UFA ratio was slightly
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higher in the adapted treatment group. This suggested that adaptation to CRV
decreased the fluidity of the membrane.
3) Determine whether reversal of these changes in fatty acid composition
occurs when the stressor, CRV, is removed.
There were no differences at 2h. However, at 24h the adapted control
produced more C17:0 than the non-adapted. Although this difference in fatty
acid was not seen in the adapted treatment, it seems that adaptation of a less
fluid membrane was maintained.
4) Determine whether any adaptive changes in the fatty acid composition
are maintained after subsequent exposure to the CRV.
Compared to the adapted control at 2h, the adapted treatment group was
found to have more C12:0, C14:0, and SFA and less C16:1w7c, C16:0, Cy17:0,
C18:1w7c, and UFA. The SFA to UFA ratio was much greater in the treatment.
Therefore, even after CRV exposure the adaptation of less fluid membrane is
maintained.
At 24h it had higher SFA and lower total PLFA, C15:0, C16:1w7c, Cy17:0,
C17:0, C18:1w7c, Cy19:0, and UFA. The SFA to UFA ratio was only slightly
higher, but not significant as it was at 2h. This suggested that adaptation with
subsequent CRV exposure for 24h decreased membrane fluidity, keeping the
adaptive response. The total PLFA was significantly (p<0.05) lower, indicating
that CRV inhibited growth.
5) Determine the effect of growth in the presence of CRV (adaptation) and
subsequent CRV treatment on affect fatty acid composition.
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The adapted treatment group had more C12:0, C14:0, C16:0, SFA, and
and less C16:1w7c, Cy17:0, C18:1w7c, and UFA at 2h. The SFA to UFA ratio
was significantly (p<0.05) and drastically greater than the non-adapted control.
At 24h, this group had a lower total PLFA, C16:1w7c, Cy17:0, C17:0,
C18:1w7c, Cy19:0 and monounsaturated fatty acids and higher C12:0 and
C15:0. The SFA to UFA ratio was only slightly higher, but not significant as it
was at 2h. CRV adaptation and treatment decreased membrane fluidity and
inhibited growth.
Overall, most of the changes were in the longer chain fatty acids than in
the shorter chain fatty acids. It appears that both treatment groups became more
fluid and the control groups became less fluid with time. At 2h the SFA to UFA
ratios of the treatment groups were significantly (p<0.05) greater than those of
the control groups. However at 24h, the magnitude of the difference decreased.
Perhaps this response to 2h incubation is more similar to an adaptation.
Significant changes from 2h to 24h occurred mostly with the control
groups and occasionally with the adapted treatment group. However, significant
differences may not have been detected due to variability within these treatment
groups. At 2h, the proportions of C12:0, C14:0 and C18:0 of the treatment
groups were more similar to that sterile controls or in between that of the sterile
controls and inoculated controls. It is hypothesized that the bacteria of the
treatment groups had incorporated these fatty acids from the medium but were
not able to convert them to other fatty acids because growth was inhibited by
CRV treatment. With time, the non-adapted treatment overcame the inhibition
179

and was able to grow and synthesize phospholipids (as evidenced by the
numerical increase in total PLFA and decrease in these fatty acids) for a more
favorable proportion of SFA to UFA ratio that is closer to homeostasis such as in
the non-adapted + EtOH group.
The controls were expected to increase in this ratio because C16:1w7c
and C18:1w7c decline and CFA increase in stationary phase (Casadei and
others 2002). These changes occurred in the controls from 2 to 24h. Over time,
SFA increased in the controls, which was a sign of starvation, along with the
decrease in C16:1w7c and C18:1w7c and significant increase in CFA (Guckert
and others 1986). The treatments did not seem to have entered stationary phase
over time because there were significant increases in C16:1w7c and C18:1w7c.
However, there were a significant increase Cy17:0 in the non-adapted treatment
and a numerical increase in Cy17:0 in the adapted treatment as well as numeric
increases in Cy19:0.
Essential oil components, such as CRV, act on the membrane, as
because they are lipophilic (Sikkema and others 1995; Ultee and others 1999).
Lipophilic compounds accumulate in the cell membrane, which was
demonstrated in liposomes synthesized from E. coli lipids (Sikkema and others
1995). As the CRV interacts with phospholipid bilayer, it may increase
membrane permeability and cause cellular constituents to leak (Ultee and others
1998).
It has been suggested that CRV occupies more area than the typical
space between the fatty acid chains of two adjoining phospholipid molecules.
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This interferes with the van der Waals interactions between the chains and
therefore affect fluidity (Ultee and others 2000b; Ultee and others 2002). If the
membranes become too fluid, additional CRV can continue to permeate the
membrane, accumulate, and cause more damage (Ultee and others 1998).
It was found that CRV expanded the liposomal membrane using
fluorescent probes (Ultee and others 2002). It is believed that this swelling leads
to a destabilized membrane a nd therefore a leakage of ions. During exposure to
CRV, an influx of protons and efflux of potassium ions in Bacillus cereus was
reported (Ultee and others 1999). This leakage was also evident in the decrease
of the pH gradient across the membrane (Ultee and others 2002). Griffin and
others (1999) categorized CRV in a group of oxygenated terpenoids with high
antimicrobial activity associated with higher hydrogen binding capacity, this
hypothesis is reasonable. The leakage of ions leads to a drop in the membrane
potential and depletion of the intracellular ATP pool (Ultee and others 2002). It
was found that 300 mg/L of CRV reduced viable counts of Bacillus cereus cells in
30 min and depleted intracellular ATP within 7 min without a proportional
increase in extracellular ATP (Ultee and others 1999).
Similarly, Helander and others (1998), reported that CRV at 300 mg/L
(MIC = 451 mg/L) increased the uptake of hydrophobic fluorescent probe NPN in
E. coli O157:H7 and S. Typhimurium and decreased intracellular ATP in E. coli
O157:H7, but with a smaller increase in extracellular ATP. These effects
indicated that CRV disintegrated the outer membrane (Helander and others
1998). It was suggested that CRV impaired the cell membrane and increased
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permeability because of the increased fluorescence of nuclear stain EB after
Staphyloccus aureus and Pseudomonas aeruginosa were exposed to 0.1% CRV
(Lambert and others 2001).
Ultee and others (2000) investigated the adaptation of Bacillus cereus to
CRV. Overnight cultures were diluted 100-fold in BHI+0.5% glucose and
incubated with or without CRV (0 - 60 mg/L) at 30°C for 4h. These exponentially
growing cells were centrifuged and washed with 25 mM phosphate buffer (pH
7.0) or buffer with added 60 mg/L CRV (sublethal). The pellet was measured by
Fourier-transformed infrared spectra, which determined the degree of interaction
between acyl chains. This interaction indicated the membrane ordering and
fluidity.
They reported that after CRV was added to non-adapted cells there was a
decrease in the melting temperature (Tm) of the membrane (20.5°C to 12.6°C).
Compared to non-adapted cells, cells adapted to 60 mg/L exhibited a less fluid
membrane because the T m increased from 20.5°C to 28.3°C. When adapted
cells were exposed again to CRV, the Tm decreased again to 19.5°C, which was
the same value as non-adapted cells with no exposure to CRV (Ultee a nd others
2000b).
In the same study, iso-C13:0 , C14:0 and iso-C15:0 fatty acids (which are
higher melting) increased in the membrane lipid composition of B. cereus cells
incubated with 60 mg/L CRV. Cis-C16:1 fatty acid decreased. These changes
correlated with the decrease in membrane fluidity of cells adapted to CRV.
However, the decrease in long chain fatty acids (C18:0) did not correlate with the
182

decrease in fluidity. Cells adapted to CRV had additional phospholipids
compared to non-adapted cells. There were no noticeable differences in
proportions of phosphatidylethanolamine (PE), diphosphatidylglycerol (DPG),
and phosphatidylglycerol (PG). No glycolipids were detected. They reported
that B. cereus did not metabolize CRV since 98% of it remained after 74h of
incubation. Cells adapted to CRV were less sensitive when subsequently
exposed to CRV as indicated by longer times to kill 50% of cells (Ultee and
others 2000b).
In this present study, the microorganism, adaptation process, comparison
of various treatment groups was different from the study of Ultee and others
(2000). The concentration of CRV (871 mg/L) was considerably higher. Their
finding that adaptation reduced the fluidity of the membrane agreed with the data
in this study. In contrast, they reported an increase in fluidity with exposure to
CRV, which contradicted with this study. This study found that the SFA to UFA
ratio was higher in the non-adapted treated cells. When adapted cells were
subsequently exposed to CRV in this study, the SFA to UFA ratio was greater
than that of the non-adapted control. This disagreed with the finding of Ultee and
others (2000), which reported that the fluidity of the adapted cells subsequently
exposed to CRV was similar to the non-adapted control.
In a related study of late-log phase Pseudomonas putida cells, which were
adapted to 0.5g phenol in agar and subsequently exposed to 0.25 – 1.25g
phenol/l for 3h, it was found that C16:0 and C16:1 trans was greater and
C16:1cis and C18:1cis was less than the adapted control (Heipieper and others
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1992). A comparison of results in this study reveals both agreements and
differences. The adapted treatment group had a lower relative percentage of
C16:0, C16:1w7c, and C18:1w7c at 2h .
Keweloh and others (1991) found that exponentially growing E. coli K-12
cells exposed for 4h with 0.5 or 1g/l phenol in the growth medium had higher
amounts of C16:0 than in the control, which differed slightly from this present
study. The treatment groups had lower C16:0 percentages than the controls at
2h, but they were higher than the controls at 24h. They also reported that the
proportions of C16:1 and C18:1 were lower in the treated cells with an increase
in cyclopropane fatty acids, which agreed with this study. Overall, they found
that there was a higher degree of saturation, which was similar to this study. It
was suggested that greater saturation results in a more rigid membrane that
compensates for increase in fluidity and permeability caused by phenol.
Saturated fatty acids have acyl chains that are packed more closely, which could
limit the entry of phenol and therefore, its toxic effect (Keweloh and others 1991).
In the same way, the increase of saturation upon exposure and adaptation to
CRV could (a phenolic compound) reduce its accessibility into or its impact on
the cell.
The effect of Tween 20 was not investigated in this study. It is possible
that use of 1% Tween 20 affected the fatty acid composition. L. monocytogenes
grown in BHI broth with 0.1% Tween at 30°C and harvested in mid-log phase
was found to have lower C15:0, C17:0, anteiso-, and iso-fatty acids and higher
straight-chain, even-numbered fatty acids with no significant change in anionic
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phospholipid. Despite these modifications that were expected to decrease
fluidity, no significant change in fluidity was detected. Cells adapted to Tween
were more sensitive because of increased binding to nisin (Li and others 2002).

Significant findings

Compared to the non-adapted Salmonella at 2h, the non-adapted
treatment had lower (p<0.05) C16:1w7c, Cy17:0, C18:1w7c, and unsaturated
fatty acid (UFA) and higher (p<0.05) C14:0, C18:1w9c, C18:0, saturated fatty
acid (SFA), and SFA/UFA ratio. At 24h, the non-adapted treatment had lower
(p<0.05) total phospholipid fatty acid (PLFA), lower (p<0.05) C15:0, Cy17:0,
C17:0, C18:1w7c, Cy19:0, and UFA than the non-adapted control and higher
(p<0.05) C16:1w7c and SFA. At 2h there were no significant differences
between the fatty acid compositions of adapted Salmonella treated with CRV and
non-adapted cells treated with CRV. At 24h, the adapted cells treated with CRV
had lower (p<0.05) C16:1w7c and UFA and higher (p<0.05) SFA than nonadapted cells treated with CRV. The SFA/UFA ratio was numerically higher in
the adapted Salmonella than the non-adapted cells at 24h. Since the fatty acid
composition and total PLFA of the non-adapted control and adapted controls
were similar, the adaptive response had been reversed since the stressor, CRV,
was not used to treat the adapted controls.
Most of the changes from 2 to 24h occurred in the membrane of the nonadapted and adapted control Salmonella. Over time there was a decrease in
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C16:1w7c (p<0.01), C18:1w7c, and UFA (p<0.01) and an increase in total PLFA
(p<0.01), C16:0, Cy17:0 (p<0.01), SFA, Cy17:0/ C16:1w7c ratio (p<0.01), and
SFA/UFA ratio in the control groups. In the adapted and non-adapted treated
Salmonella there was a decrease in C14:0, SFA (p<0.01), and SFA/UFA ratio
and an increase in C16:0, Cy17:0, C18:1w7c (p<0.01), and UFA from 2 to 24h.
Since fatty acid composition is one of the factors that affect membrane
fluidity it appears that short- and long-term treatment with CRV at sub-lethal
concentrations decreased the fluidity of the Salmonella membrane by
significantly increasing the proportion of saturated fatty acids. This decreased
fluidity may prevent additional CRV from permeating. The effect of bacterial
growth in the presence of CRV on the fatty acid composition was much smaller.
Determination of any changes in the phospholipid head groups would be useful
because of their affect on fluidity. Measurement of the membrane transition
temperature from gel-to-liquid-crystalline phase by Fourier-transformed infrared
spectrometry would indicate the interaction between their acyl chains and
therefore fluidity. A nuclear magnetic resonance spectrometer or a LangmuirBlodgett trough can also measure fluidity. Investigation about the target site that
CRV acts upon and the specific interactions of CRV with membrane lipids and
proteins using differential scanning calorimetry would contribute to the
understanding of its mechanism of action and the bacterial response.
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SAS program to compare the effectiveness of essential oil components
tested against L. monocytogenes using microdilution method
/* This SAS program generates SAS Probit models (probability of lethality) to
compare the effectiveness of essential oil components tested against L.
monocytogenes using microdilution method (microtiter plates)*/
data multi;
input stock $ chemical $ Dose Response N;
dose=log10(dose); label dose=Log10(Dose) ppm;
datalines;
Nov17 CRV 3200 2 2
Nov17 CRV 3000 2 2
Nov17 CRV 2800 2 2
Nov17 CRV 2600 1 2
Nov17 CRV 2400 2 2
Nov17 CIN 1200 2 2
Nov17 CIN 1000 2 2
Nov17 CIN 800 2 2
Nov17 CIN 600 0 2
Nov17 CIN 400 0 2
Nov17 CIN 200 0 2
*rest of data not included in appendix;
;
proc sort; by chemical dose;
symbol v=dot color=blue;
* For each chemical, test for a stock effect;
goptions ftext='Arial/bold' htext=12pt;
proc probit order=internal data=multi; by chemical;
class stock;
Stock: model Response/N= Dose stock / inversecl;
predpplot var=dose level=('None') cfit=red haxis=2.5 to 3.7 by .1
cframe=ligr inborder;
ippplot var=dose level=('None') cfit=red vaxis=2.5 to 3.7 by .1 cframe=ligr
inborder;
* Summarize data across stocks;
proc summary nway data=multi; class chemical dose; var Response N;
output out=multisum sum=;
proc print data=multisum; var chemical dose Response N;
* For each chemical, analyze summarized data;
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proc probit order=internal data=multisum; by chemical;
Overall: model Response/N= Dose / lackfit aggregate inversecl;
predpplot var=dose level=('None') cfit=red haxis=2.5 to 3.7 by .1 cframe=ligr
inborder
vref(intersect)=(0.50,0.99) vreflabels=('Probability=0.50' 'Probability=0.99');
lpredplot var=dose level=('None') cfit=red haxis=2.5 to 3.7 by .1
cframe=ligr inborder
vaxis = -15 to 5 by 5;
ippplot var=dose level=('None') cfit=red vaxis=2.5 to 3.7 by .1 cframe=ligr
inborder
href(intersect)=0.50 hreflabels=('Probability=0.50');
ippplot var=dose level=('None') cfit=red vaxis=2.5 to 3.7 by .1 cframe=ligr
inborder
href(intersect)=0.99 hreflabels=('Probability=0.99');
proc probit order=internal data=multisum;
class chemical;
Chemical: model Response/N = chemical chemical*Dose / lackfit aggregate
noint inversecl;
run;
data fill; input chemical $;
do dose = 2.4 to 3.8 by 0.025;
output;
end;
datalines;
CIN
CRV
EUG
RHO
data new; set multisum fill;
proc sort data=new; by chemical dose;
proc genmod order=internal data=new;
class chemical;
output out=stats l=lower p=prob u=upper;
model Response/N = chemical chemical*Dose / noint dist=binomial
link=probit type3 wald;
run;
data forplot; length chemical $ 8; set stats;
p = Response/N;
if p = 0 then prob = 0;
else if p = 1 then prob = 1;
else if 0 < p < 1 then prob = p;
if p ne . then do; o utput; return; end;
chemical=substr(chemical,1,3)||' prd'; output;
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prob=lower; chemical=substr(chemical,1,3)||' lci'; output;
prob=upper; chemical=substr(chemical,1,3)||' uci'; output;
proc sort data=forplot; by chemical dose;
proc gplot data=forplot;
plot prob*dose=chemical / haxis = 2.2 to 3.6 by 0.1
vaxis = 0 to 1 by 0.1 grid nolegend;
/* Chemicals in the footnote statement should be in alphabetical order,
and the order of colors should match that given in the symbol statements which
follow*/
/*footnote c=black 'Chemical: ' c=blue ' CIN ' c=red now black' CRV '
c=big now vpar ' EUG ' c=orange ' RHO ';*/
label prob=Probability;
symbol1 v=circle color=blue i=none;
symbol2 v=none color=blue i=join line=2;
symbol3 v=none color=blue i=join line=1;
symbol4 v=none color=blue i=join line=2;
symbol5 v=x color=black i=none;
symbol6 v=none color=black i=join line=2;
symbol7 v=none color=black i=join line=1;
symbol8 v=none color=black i=join line=2;
symbol9 v=triangle color=vpar i=none;
symbol10 v=none color=vpar i=join line=2;
symbol11 v=none color=vpar i=join line=1;
symbol12 v=none color=vpar i=join line=2;
symbol13 v=square color=orange i=none;
symbol14 v=none color=orange i=join line=2;
symbol15 v=none color=orange i=join line=1;
symbol16 v=none color=orange i=join line=2;
run; quit; run; footnote;
SAS program to compare the effectiveness of essential oil components
tested against L. monocytogenes using macrodilution method
/* This SAS program generates SAS Probit models (probability of lethality) to
compare the effectiveness of essential oil components tested against L.
monocytogenes using macrodilution method (glass tubes)*/
data multi;
input stock $ chemical $ Dose Response N;
dose=log10(dose); label dose=Log10(Dose) ppm;
datalines;
Jun20 CRV 3200 4 4
Jun20 CRV 3000 4 4
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Jun20 CRV 2800 4 4
Jun20 CRV 2600 4 4
Jun20 CIN 1200 4 4
Jun20 CIN 1000 4 4
Jun20 CIN 800 4 4
Jun20 CIN 600 4 4
*rest of data not included in appendix;
;
proc sort; by chemical dose;
symbol v=dot color=blue;
* For each chemical, test for a stock effect;
goptions ftext='Arial/bold' htext=12pt;
proc probit order=internal data=multi; by chemical;
class stock;
Stock: model Response/N= Dose stock / inversecl;
predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1
cframe=ligr inborder;
ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr
inborder;
* Summarize data across stocks;
proc summary nway data=multi; class chemical dose; var Response N;
output out=multisum sum=;
proc print data=multisum; var chemical dose Response N;
* For each chemical, analyze summarized data;
proc probit order=internal data=multisum; by chemical;
Overall: model Response/N= Dose / lackfit aggregate inversecl;
predpplot var=dose level=('None') cfit=red haxis=2.5 to 3.7 by .1 cframe=ligr
inborder
vref(intersect)=(0.25,0.95) vreflabels=('Probability=0.25' 'Probability=0.95');
lpredplot var=dose level=('None') cfit=red haxis=2.5 to 3.7 by .1
cframe=ligr inborder
vaxis = -15 to 5 by 5;
ippplot var=dose level=('None') cfit=red vaxis=2.5 to 3.7 by .1 cframe=ligr
inborder
href(intersect)=0.95 hreflabels=('Probability=0.95');
ippplot var=dose level=('None') cfit=red vaxis=2.5 to 3.7 by .1 cframe=ligr
inborder
href(intersect)=0.25 hreflabels=('Probability=0.25');
proc probit order=internal data=multisum;
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class chemical;
Chemical: model Response/N = chemical chemical*Dose / lackfit aggregate
noint inversecl;
run;
data fill; input chemical $;
do dose = 2.4 to 3.8 by 0.025;
output;
end;
datalines;
CIN
CRV
EUG
LNO
RHO
data new; set multisum fill;
proc sort data=new; by chemical dose;
proc genmod order=internal data=new;
class chemical;
output out=stats l=lower p=prob u=upper;
model Response/N = chemical chemical*Dose / noint dist=binomial
link=probit type3 wald;
run;
data forplot; length chemical $ 8; set stats;
p = Response/N;
if p = 0 then prob = 0;
else if p = 1 then prob = 1;
else if 0 < p < 1 then prob = p;
if p ne . then do; output; return; end;
chemical=substr(chemical,1,3)||' prd'; output;
prob=lower; chemical=substr(chemical,1,3)||' lci'; output;
prob=upper; chemical=substr(chemical,1,3)||' uci'; output;
proc sort data=forplot; by chemical dose;
proc gplot data=forplot; legend1;
plot prob*dose=chemical / haxis = 2.2 to 3.6 by 0.1
vaxis = 0 to 1 by 0.1 grid nolegend;
/* Chemicals in the footnote statement should be in alphabetical order,
and the order of colors should match that given in the symbol statements which
follow*/
/*footnote c=black 'Chemical: ' c=blue ' CIN ' c=red now black' CRV '
c=big now vpar ' EUG ' c=orange ' RHO ';*/
label prob=Probability;
symbol1 v=circle color=blue i=none;
symbol2 v=none color=blue i=join line=2;
symbol3 v=none color=blue i=join line=1;
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symbol4 v=none color=blue i=join line=2;
symbol5 v=x color=black ci=black cv=black i=none;
symbol6 v=none color=black i=join line=2;
symbol7 v=none color=black i=join line=1;
symbol8 v=none color=black i=join line=2;
symbol9 v=triangle color=vpar cv=vpar i=none;
symbol10 v=none color=vpar i=join line=2;
symbol11 v=none color=vpar i=join line=1;
symbol12 v=none color=vpar i=join line=2;
symbol13 v=dot color=lime cv=lime i=none;
symbol14 v=none color=lime i=join line=2;
symbol15 v=none color=lime i=join line=1;
symbol16 v=none color=lime i=join line=2;
symbol17 v=square color=orange cv=orange i=none;
symbol18 v=none color=orange i=join line=2;
symbol19 v=none color=orange i=join line=1;
symbol20 v=none color=orange i=join line=2;
run; quit; run; footnote;
SAS program to compare the macrodilution and microdilution methods
within a component against L. monocytogenes
/* This SAS program compares the macrodilution and microdilution methods
within a component, against L. monocytogenes */
data lmtubes;
input stock $ chemical $ Dose Response N;
method='tubes';
dose=log10(dose); label dose=log10(dose);
org='lm';
datalines;
Jun20 CRV 3200 4 4
Jun20 CRV 3000 4 4
Jun20 CRV 2800 4 4
Jun20 CRV 2600 4 4
Jun20 CIN 1200 4 4
Jun20 CIN 1000 4 4
Jun20 CIN 800 4 4
Jun20 CIN 600 4 4
*rest of data not included in appendix;
;
goptions ftext='Arial/bold' htext=12pt;
data lmmicro;
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input stock $ chemical $ Dose Response N;
method='micro';
dose=log10(dose); label dose=log10(dose);
datalines;
Oct23 LNO 2800 0 4
Oct23 LNO 2400 0 4
Oct23 LNO 2000 0 4
Oct23 LNO 1600 0 4
Oct23 LNO 1200 0 4
Oct24 LNO 2800 0 4
Oct24 LNO 2400 0 4
Oct24 LNO 2000 0 4
Oct24 LNO 1600 0 4
Oct24 LNO 1200 0 4
*rest of data not included in appendix;
;
data multi; set lmtubes lmmicro;
* Summarize data across stocks;
proc summary nway data=multi; class chemical method dose; var Response N;
output out=multisum sum=;
proc print data=multisum; var chemical method dose Response N;
* For each chemical, analyze summarized data;
proc probit order=internal data=multisum; by chemical;
class method;
Overall: model Response/N= Dose method / lackfit aggregate inversecl;
predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1
cframe=ligr inborder
vref(intersect)=0.95 vreflabels=('Probability=0.95');
predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1
cframe=ligr inborder
vref(intersect)=0.25 vreflabels=('Probability=0.25');
lpredplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1
cframe=ligr inborder
vaxis = -15 to 5 by 5;
ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr
inborder
href(intersect)=0.95 hreflabels=('Probability=0.95');
ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr
inborder
href(intersect)=0.25 hreflabels=('Probability=0.25');
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proc probit order=internal data=multisum;
class chemical method;
Chemical: model Response/N = chemical method chemical*method
chemical*Dose
method*Dose / lackfit aggregate inversecl;
where chemical eq 'CIN' or chemical eq 'CRV' or chemical eq 'EUG' or
chemical eq 'RHO';
run;
SAS program to compare the effectiveness of essential oil components
tested against S. Typhimurium using microdilution method
/* This SAS program generates SAS Probit models (probability of lethality) to
compare the effectiveness of essential oil components tested against S.
Typhimurium using microdilution method (microtiter plates)*/
data multi;
input stock $ chemical $ Dose Response N;
dose=log10(dose); label dose=Log10(Dose) ppm;
datalines;
Nov17 CRV 1600 2 2
Nov17 CRV 1400 2 2
Nov17 CRV 1200 0 2
Nov17 CRV 1000 0 2
Nov17 CRV 800 0 4
Nov17 CIN 800 2 2
Nov17 CIN 600 2 2
Nov17 CIN 400 2 2
Nov17 CIN 200 0 4
*rest of data not included in appendix;
;
goptions ftext='Arial/bold' htext=12pt;
proc sort; by chemical dose;
symbol v=dot color=blue;
* For each chemical, test for a stock effect;
proc probit order=internal data=multi; by chemical;
class stock;
Stock: model Response/N= Dose stock / inversecl;
predpplot var=dose level=('None') cfit=red haxis=2.2 to 3.7 by .1
cframe=ligr inborder;
ippplot var=dose level=('None') cfit=red vaxis=2.2 to 3.7 by .1 cframe=ligr
inborder;
199

* Summarize data across stocks;
proc summary nway data=multi; class chemical dose; var Response N;
output out=multisum sum=;
proc print data=multisum; var chemical dose Response N;
* For each chemical, analyze summarized data;
proc probit order=internal data=multisum; by chemical;
Overall: model Response/N= Dose / lackfit aggregate inversecl;
predpplot var=dose level=('None') cfit=red haxis=2.2 to 3.7 by .1
cframe=ligr inborder
vref(intersect)=(0.25,0.95) vreflabels=('Probability=0.25' 'Probability=0.95');
lpredplot var=dose level=('None') cfit=red haxis=2.2 to 3.7 by .1
cframe=ligr inborder
vaxis = -15 to 5 by 5;
ippplot var=dose level=('None') cfit=red vaxis=2.2 to 3.7 by .1 cframe=ligr
inborder
href(intersect)=0.95 hreflabels=('Probability=0.95');
ippplot var=dose level=('None') cfit=red vaxis=2.2 to 3.7 by .1 cframe=ligr
inborder
href(intersect)=0.25 hreflabels=('Probability=0.25');
proc probit order=internal data=multisum;
class chemical;
Chemical: model Response/N = chemical chemical*Dose / lackfit aggregate
noint inversecl;
run;
data fill; input chemical $;
do dose = 2.2 to 3.7 by 0.025;
output;
end;
datalines;
CIN
CRV
EUG
LNO
RHO
data new; set multisum fill;
proc sort data=new; by chemical dose;
proc genmod order=internal data=new;
class chemical;
output out=stats l=lower p=prob u=upper;
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model Response/N = chemical chemical*Dose / noint dist=binomial
link=probit type3 wald;
run;
data forplot; length chemical $ 8; set stats;
p = Response/N;
if p = 0 then prob = 0;
else if p = 1 then prob = 1;
else if 0 < p < 1 then prob = p;
if p ne . then do; output; return; end;
chemical=substr(chemical,1,3)||' prd'; output;
prob=lower; chemical=substr(chemical,1,3)||' lci'; output;
prob=upper; chemical=substr(chemical,1,3)||' uci'; output;
proc sort data=forplot; by chemical dose;
proc gplot data=forplot;
plot prob*dose=chemical / haxis = 2.2 to 3.6 by 0.1
vaxis = 0 to 1 by 0.1 grid nolegend;
/* Chemicals in the footnote statement should be in alphabetical order,
and the order of colors should match that given in the symbol statements which
follow*/
/*footnote c=black 'Chemical: ' c=blue ' CIN ' c=red now black' CRV '
c=big now vpar ' EUG ' c=orange ' RHO ';*/
label prob=Probability;
symbol1 v=circle color=blue i=none;
symbol2 v=none color=blue i=join line=2;
symbol3 v=none color=blue i=join line=1;
symbol4 v=none color=blue i=join line=2;
symbol5 v=x color=black i=none;
symbol6 v=none color=black i=join line=2;
symbol7 v=none color=black i=join line=1;
symbol8 v=none color=black i=join line=2;
symbol9 v=triangle color=vpar i=none;
symbol10 v=none color=vpar i=join line=2;
symbol11 v=none color=vpar i=join line=1;
symbol12 v=none color=vpar i=join line=2;
symbol13 v=dot color=lime i=none;
symbol14 v=none color=lime i=join line=2;
symbol15 v=none color=lime i=join line=1;
symbol16 v=none color=lime i=join line=2;
symbol17 v=square color=orange i=none;
symbol18 v=none color=orange i=join line=2;
symbol19 v=none color=orange i=join line=1;
symbol20 v=none color=orange i=join line=2;
run; quit; run; footnote;
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SAS program to compare the effectiveness of essential oil components
tested against S. Typhimurium using macrodilution method
/* This SAS program generates SAS Probit models (probability of lethality) to
compare the effectiveness of essential oil components tested against S.
Typhimurium using macrodilution method (glass tubes) and includes contrasts
that were from the results of the dissertation*/
data multi;
input stock $ chemical $ Dose Response N;
dose=log10(dose); label dose=Log10(Dose) ppm;
datalines;
Mar16 CRV 1600 4 4
Mar16 CRV 1400 3 4
Mar16 CRV 1200 1 4
Mar16 CRV 1000 0 4
Mar16 CRV 800 0 4
Mar16 CIN 400 4 4
Mar16 CIN 200 0 4
*rest of data not included in appendix;
;
goptions ftext='Arial/bold' htext=12pt;
proc sort; by chemical dose;
symbol v=dot color=blue;
* For each chemical, test for a stock effect;
proc probit order=internal data=multi; by chemical;
class stock;
Stock: model Response/N= Dose stock / inversecl;
predpplot var=dose level=('None') cfit=red haxis=2 to 3.4 by .1
cframe=ligr inborder;
ippplot var=dose level=('None') cfit=red vaxis=2 to 3.4 by .1 cframe=ligr
inborder; run;
* Summarize data across stocks;
proc summary nway data=multi; class chemical dose; var Response N;
output out=multisum sum=;
proc print data=multisum; var chemical dose Response N;
* For each chemical, analyze summarized data;
goptions ftext='Arial/bold' htext=12pt;
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proc probit order=internal data=multisum; by chemical;
Overall: model Response/N= Dose / lackfit aggregate inversecl;
predpplot var=dose level=('None') cfit=red haxis=2 to 3.4 by .1
cframe=ligr inborder
vref(intersect)=(0.25,0.95) vreflabels=('Probability=0.25' 'Probability=0.95');
lpredplot var=dose level=('None') cfit=red haxis=2 to 3.4 by .1 cframe=ligr
inborder
vaxis = -15 to 5 by 5;
ippplot var=dose level=('None') cfit=red vaxis=2 to 3.4 by .1 cframe=ligr
inborder
href(intersect)=0.95 hreflabels=('Probability=0.95');
ippplot var=dose level=('None') cfit=red vaxis=2 to 3.4 by .1 cframe=ligr
inborder
href(intersect)=0.25 hreflabels=('Probability=0.25'); run;
proc probit order=internal data=multisum;
class chemical;
Chemical: model Response/N = chemical chemical*Dose / lackfit aggregate
noint inversecl;
run;
data fill; input chemical $;
do dose = 2 to 3.4 by 0.025;
output;
end;
datalines;
CIN
CRV
EUG
LNO
data new; set multisum fill;
proc sort data=new; by chemical dose;
proc genmod order=internal data=new;
class chemical;
output out=stats l=lower p=prob u=upper;
model Response/N = chemical chemical*Dose / noint dist=binomial
link=probit type3 wald;
contrast 'CIN vs. CRV int' chemical 1 -1 0 0 / wald;
contrast 'CRV vs. EUG int' chemical 0 1 -1 0 / wald;
contrast 'EUG vs. LNO int' chemical 0 0 1 -1 / wald;
contrast 'CIN vs. LNO int' chemical 1 0 0 -1 / wald;
contrast 'CRV vs. LNO int' chemical 0 1 0 -1 / wald;
contrast 'CIN vs. avg CRV-LNO int' chemical 1 -0.5 0 -0.5 / wald;
contrast 'CIN vs. avg CRV-LNO slope' chemical*Dose 1 -0.5 0 -0.5 /
wald;
contrast 'CIN vs. CRV slope' chemical*Dose 1 -1 0 0 / wald;
203

contrast 'CRV vs. E UG slope' chemical*Dose 0 1 -1 0 / wald;
contrast 'EUG vs. LNO slope' chemical*Dose 0 0 1 -1 / wald;
contrast 'CIN vs. LNO slope' chemical*Dose 1 0 0 -1 / wald;
contrast 'CRV vs. LNO slope' chemical*Dose 0 1 0 -1 / wald;
estimate 'CIN vs. CRV int' chemical 1 -1 0 0;
estimate 'CRV vs. EUG int' chemical 0 1 -1 0;
estimate 'EUG vs. LNO int' chemical 0 0 1 -1;
estimate 'CIN vs. CRV slope' chemical*Dose 1 -1 0 0;
estimate 'CRV vs. EUG slope' chemical*Dose 0 1 -1 0;
estimate 'EUG vs. LNO slope' chemical*Dose 0 0 1 -1;
estimate 'CRV vs. LNO int' chemical 0 1 0 -1;
estimate 'CRV vs. LNO slope' chemical*dose 0 1 0 -1;
contrast 'CIN vs. CRV int/slope' chemical 1 -1 0 0, chemical*dose 1 -1 0
0 / wald;
contrast 'CIN vs. LNO i nt/slope' chemical 1 0 0 -1, chemical*dose 1 0 0 -1 /
wald;
contrast 'CRV vs. LNO int/slope' chemical 0 1 0 -1, chemical*dose 0 1 0 1 / wald;
contrast 'CIN vs. avg CRV-LNO int/slope' chemical 1 -0.5 0 -0.5,
chemical*Dose 1 -0.5 0 -0.5 / wald;
run;
data forplot; length chemical $ 8; set stats;
p = Response/N;
if p = 0 then prob = 0;
else if p = 1 then prob = 1;
else if 0 < p < 1 then prob = p;
if p ne . then do; output; return; end;
chemical=substr(chemical,1,3)||' prd'; output;
prob=lower; chemical=substr(chemical,1,3)||' lci'; output;
prob=upper; chemical=substr(chemical,1,3)||' uci'; output;
proc sort data=forplot; by chemical dose;
proc gplot data=forplot;
plot prob*dose=chemical / haxis = 2.2 to 3.6 by 0.1
vaxis = 0 to 1 by 0.1 grid nolegend;
/* Chemicals in the footnote statement should be in alphabetical order,
and the order of colors should match that given in the symbol statements which
follow*/
/*footnote c=black 'Chemical: ' c=blue ' CIN ' c=red now black' CRV '
c=big now vpar ' EUG ' c=orange ' RHO ';*/
label prob=Probability;
symbol1 v=circle color=blue i=none;
symbol2 v=none color=blue i=join line=2;
symbol3 v=none color=blue i=join line=1;
symbol4 v=none color=blue i=join line=2;
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symbol5 v=x color=black i=none;
symbol6 v=none color=black i=join line=2;
symbol7 v=none color=black i=join line=1;
symbol8 v=none color=black i=join line=2;
symbol9 v=triangle color=vpar i=none;
symbol10 v=none color=vpar i=join line=2;
symbol11 v=none color=vpar i=join line=1;
symbol12 v=none color=vpar i=join line=2;
symbol13 v=dot color=lime i=none;
symbol14 v=none color=lime i=join line=2;
symbol15 v=none color=lime i=join line=1;
symbol16 v=none color=lime i=join line=2;
run; quit; run; footnote;
SAS program to compare the macrodilution and microdilution methods
within a component against S. Typhimurium
/* This SAS program compares the macrodilution and microdilution methods
within a component, against S. Typhimurium */
data sttubes;
input stock $ chemical $ Dose Response N;
method='tubes';
dose=log10(dose); label dose=log10(dose);
org='st';
datalines;
Dec9 RHO 1800 0 5
Dec9 RHO 1600 0 5
Dec9 RHO 1400 0 5
Dec9 RHO 1200 0 5
Jan22 RHO 1400 0 3
Jan22 RHO 1000 0 3
Feb8 RHO 1800 0 3
Feb8 RHO 1600 0 3
Feb13 RHO 2800 0 3
Feb13 RHO 2000 0 3
*rest of data not included in appendix;
;
goptions ftext='Arial/bold' htext=12pt;
data stmicro;
input stock $ chemical $ Dose Response N;
method='micro';
dose=log10(dose); label dose=log10(dose);
205

datalines;
Nov17 CRV 1600 2 2
Nov17 CRV 1400 2 2
Nov17 CRV 1200 0 2
Nov17 CRV 1000 0 2
Nov17 CRV 800 0 4
Nov17 CIN 800 2 2
Nov17 CIN 600 2 2
Nov17 CIN 400 2 2
Nov17 CIN 200 0 4
*rest of data not included in appendix;
;
data multi; set sttubes stmicro;
* Summarize data across stocks;
proc summary nway data=multi; class chemical method dose; var Response N;
output out=multisum sum=;
proc print data=multisum; var chemical method dose Response N;
* For each chemical, analyze summarized data;
proc probit order=internal data=multisum; by chemical;
class method;
Overall: model Response/N= Dose method / lackfit aggregate inversecl;
predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1
cframe=ligr inborder
vref(intersect)=0.95 vreflabels=('Probability=0.95');
predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1
cframe=ligr inborder
vref(intersect)=0.25 vreflabels=('Probability=0.25');
lpredplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1
cframe=ligr inborder
vaxis = -15 to 5 by 5;
ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr
inborder
href(intersect)=0.95 hreflabels=('Probability=0.95');
ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr
inborder
href(intersect)=0.25 hreflabels=('Probability=0.25');
proc probit order=internal data=multisum;
class chemical method;
Chemical: model Response/N = chemical method chemical*method
chemical*Dose
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method*Dose / lackfit aggregate inversecl;
where chemical eq 'CIN' or chemical eq 'CRV' or chemical eq 'EUG' or
chemical eq 'LNO';
run;
SAS program to compare the concentrations of components needed to be
lethal against S. Typhimurium and L. monocytogenes
/* This SAS program compares the concentrations of components needed to be
lethal against S. Typhimurium and L. monocytogenes within the macrodilution
method */
data lmtubes;
input stock $ chemical $ Dose Response N;
method='tubes';
dose=log10(dose); label dose=log10(dose);
org='LM';
datalines;
Jun20 CRV 3200 4 4
Jun20 CRV 3000 4 4
Jun20 CRV 2800 4 4
Jun20 CRV 2600 4 4
Jun20 CIN 1200 4 4
Jun20 CIN 1000 4 4
Jun20 CIN 800 4 4
Jun20 CIN 600 4 4
*rest of data not included in appendix;
;
goptions ftext='Arial/bold' htext=12pt;
data sttubes;
input stock $ chemical $ Dose Response N;
method='tubes';
dose=log10(dose); label dose=log10(dose);
org='ST';
datalines;
Mar16 CRV 1600 4 4
Mar16 CRV 1400 3 4
Mar16 CRV 1200 1 4
Mar16 CRV 1000 0 4
Mar16 CRV 800 0 4
Mar16 CIN 400 4 4
Mar16 CIN 200 0 4
*rest of data not included in appendix;
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;
data multi; set lmtubes sttubes;
* Summarize data across stocks;
proc summary nway data=multi; class chemical org dose; var Response N;
output out=multisum sum=;
proc print data=multisum; var chemical org dose Response N;
* For each chemical, analyze summarized data;
proc probit order=internal data=multisum; by chemical;
class org;
Overall: model Response/N= Dose org / lackfit aggregate inversecl;
predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1
cframe=ligr inborder
vref(intersect)=0.95 vreflabels=('Probability=0.95');
predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1
cframe=ligr inborder
vref(intersect)=0.25 vreflabels=('Probability=0.25');
lpredplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1
cframe=ligr inborder
vaxis = -15 to 5 by 5;
ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr
inborder
href(intersect)=0.95 hreflabels=('Probability=0.95');
ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr
inborder
href(intersect)=0.25 hreflabels=('Probability=0.25');
proc probit order=internal data=multisum;
class chemical org;
Chemical: model Response/N = chemical org chemical*org chemical*Dose
org*Dose / lackfit aggregate inversecl;
where chemical eq 'CIN' or chemical eq 'CRV' or chemical eq 'EUG' or
chemical eq 'RHO';
run;

SAS program to compare the differences in biomass and fatty acids among
CIN-treatment and control groups within 2h or 24h for S. Typhimurium
/* This SAS program compares the differences in biomass and fatty acids among
CIN-treatment and control groups within 2h or 24h for S. Typhimurium. Arnold
Saxton’s mmaov macro analyzed the imported 2h or 24h CIN data set using
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Randomized Block Design with blocking on each replicate. The first %mmaov
compares biomass among groups, averaging 2h and 24h together. Also includes
comparing % fatty acids within a group and within 2h or 24h. Raw data not
included in appendix. */
PROC IMPORT OUT= WORK.CIN
DATAFILE= "C:\Documents and Settings\Valerie Ling \My
Documents\Val's Research\Results\CINLipids\CINData.xls"
DBMS=EXCEL2000 REPLACE;
SHEET="Sheet1$";
GETNAMES=YES;
RUN;
%include 'c:\mmaov.sas';
%mmaov(cin,bio,class=block treat hour,fixed=treat hour(treat), random=block);
run;
data cin2; set cin; if hour eq 2;
data cin24; set cin; if hour eq 24;
%include 'c:\mmaov.sas';
%mmaov(cin2,bio,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,bio,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,c12_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,c12_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,c14_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,c14_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,c15_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,c15_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,c16_1w7c,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,c16_1w7c,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,c16_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,c16_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,cy17_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,cy17_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,c17_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,c17_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,c18_1w9c,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,c18_1w9c,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,c18_1w7c,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,c18_1w7c,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,c18_1w7t,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,c18_1w7t,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,c18_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,c18_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,cy19_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,cy19_0,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,nsats,class=block treat,fixed=treat,random=block); run;
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%mmaov(cin24,nsats,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,monos,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,monos,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,cy17to16,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,cy17to16,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,cy19to18,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,cy19to18,class=block treat,fixed=treat,random=block); run;
%mmaov(cin2,satunsat,class=block treat,fixed=treat,random=block); run;
%mmaov(cin24,satunsat,class=block treat,fixed=treat,random=block); run;
proc sort data=cin; by treat hour block;
proc transpose data=cin out=cinout; by treat hour block; var c12_0--cy19_0;
proc sort data=cinout; by treat hour block descending col1; run;
proc anova; by treat hour; class _name_; model col1=_name_;
means _name_ / tukey lines; run; quit; run;
SAS program to compare the differences in biomass and fatty acids
between the 2 or 24h data within a CIN-treatment or control group for S.
Typhimurium
/* This SAS program compares the differences in biomass and fatty acids
between the 2 or 24h data within a CIN-treatment or control group for S.
Typhimurium. */
PROC IMPORT OUT= WORK.CIN
DATAFILE= "C:\Documents and Settings\Valerie Ling \My Documen
ts\Val's Research\Results\CINLipids\CINData.xls"
DBMS=EXCEL2000 REPLACE;
SHEET="Sheet1$";
GETNAMES=YES;
RUN;
*test for interaction term, where is the interaction? Use Bonferonni correction.
This is alpha .10 divided by 6 follow-up tests used to test interaction between
hour and treatment i.e. each pair - treat 1 at 2h vs 24h. .1/6 = 0.017 new alpha
with B. correction to minimize Type I error, which increases with # of tests. We
can be sure that the differences we find are true and not due to chance.';
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model bio=hour;
means hour; lsmeans hour;
run; quit;
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proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model c12_0=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model c14_0=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model c15_0=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model c16_1w7c=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model c16_0=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model cy17_0=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
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class hour;
model c17_0=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model c18_1w9c=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model c18_1w7c=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model c18_1w7t=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model c18_0=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model cy19_0=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model nsats=hour;
means hour; lsmeans hour;
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run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model monos=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model cy17to16=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model cy19to18=hour;
means hour; lsmeans hour;
run; quit;
proc sort data=cin; by treat;run;
proc glm data=cin;
by treat;
class hour;
model satunsat=hour;
means hour; lsmeans hour;
run; quit;

/* To run the same SAS programs for CRV, import the CRV data file and use
“Find and Replace”under the “Edit”menu to find “CIN”and replace with “CRV” */
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